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CHAPTER I 
 
STRUCTURE AND FUNCTION OF NEUROTRANSMITTER:SODIUM SYMPORTERS 
 
Physiological significance of neurotransmitter transporters 
 In the central nervous system (CNS), the termination of neurotransmitter signaling across 
the chemical synapse is achieved primarily through a high affinity re-uptake mechanism mediated 
by integral membrane proteins collectively known as neurotransmitter transporters (1). These 
transporters couple the energy of pre-existing ion gradients to the movement of neurotransmitter 
from the synaptic cleft to the cytoplasm, thereby controlling the magnitude and duration of post-
synaptic receptor stimulation (2). Once in the cytoplasm, neurotransmitter substrates are recycled 
into vesicular storage compartments (mediated by other specialized transporters), reducing the 
need for de novo transmitter synthesis and preparing the neuron for subsequent rounds of 
neurotransmitter release (3). Two distinct families of neurotransmitter transporters are responsible 
for modulating synaptic tone in the CNS, namely the glutamate transporters (SLC1) and the 
Na+/Cl--dependent neurotransmitter transporters (SLC6) (4). These families are distinguished by 
the transported substrates, protein primary sequence, transport coupling ions and expression sites. 
The focus of this chapter pertains to the biological significance of Na+/Cl--dependent 
neurotransmitter transporters, although some comparisons will be made with the glutamate 
transporters. 
Biology of neurotransmitter sodium:symporters  
 The family of Na+/Cl--dependent neurotransmitter transporters includes the biogenic 
monoamine transporters such as those for dopamine (DAT), serotonin (SERT), norepinephrine 
(NET) and gamma-aminobutyric acid (GABA, GAT) (1).  Furthermore, this family includes 
transporters for amino acids as well as prokaryotic homologs (5). Due to the high intracellular 
concentration of neurotransmitter relative to the synapse, these transporters and the glutamate 
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transporters utilize the electrochemical Na+ gradient established by the plasma membrane ion 
pump, the Na+/K+-ATPase, to catalyze the thermodynamically unfavorable movement of 
neurotransmitter substrates from the extracellular space into the cytoplasm (6,7). Since the 
transport of substrate is coupled to the movement of Na+ ions down their concentration gradient 
(symport), these secondary active transporters are also known as neurotransmitter:sodium 
symporters (NSS). In general, substrate transport is strictly coupled to the inwardly directed Na+ 
gradient since substitution of this cation with others (e.g. NMDG+, Li+ or K+) greatly reduces or 
eliminates specific transport activity (8,9). Disrupting the physiological Na+ gradient by elevating 
the intracellular Na+ concentration may also inhibit cytoplasmic substrate release from the DAT 
(8). Glutamate transport is coupled not only to the inwardly directed Na+ gradient, but to the 
outwardly directed K+ gradient as well (10).  
 Although studies have shown that Cl- is required for efficient NSS activity, Cl- may 
allosterically regulate transport instead of contributing to the energetics of ion-coupled substrate 
translocation. Indeed the Cl- equilibrium potential typically approximates the resting membrane 
potential (-70 mV), conferring little thermodynamic advantage to coupling transport to the Cl- 
gradient. However, Cl- was found to modulate the kinetics of GABA transport by altering the 
affinity of Na+ and substrate to the GAT-1 (11). Even though Cl- associated flux was observed 
during transport, Cl- did not contribute to the net charge of a transport event or alter the 
stoichiometry of Na+ or GABA. Interestingly, substitution of intracellular Cl- by acetate- has been 
found to reduce the turnover rate of the DAT, suggesting that Cl- regulates the velocity of DAT 
turnover (8). Similarly, intracellular Cl- facilitated serotonin-dependent ionic currents, implying a 
regulatory role for Cl- in the transport mechanism of the SERT (12). Some have suggested that 
Cl- transport may counterbalance the net positive charge (see below) associated with the coupled 
translocation of substrate and Na+, a compensatory mechanism for transport-related membrane 
depolarization (13,14).  
 Kinetic experiments indicate that these transporters display variable ion/substrate 
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stoichiometry associated with transport (9,15). Studies suggest that the DAT and the GAT have 
an ion-to-substrate stoichiometry of 2Na+:1Cl-:1DA(GABA), resulting in electrogenic transport 
(i.e. possesses a net charge flux) into the cell (9). In contrast, SERT and NET only co-transport 
one Na+ and one Cl- per substrate (15).  Additionally, the SERT is also dependent on the efflux of 
a single K+ following substrate translocation. Since serotonin is likely to be positively charged at 
physiological pH, serotonin transport is theoretically electroneutral (1 net positive charge into the 
cell versus 1 net positive charge out) (16). However, ionic currents mediated by the SERT and 
other NSS have been observed to exceed (up to 100 fold) the predicted current levels from 
stoichiometric coupling (17). Electrophysiological experiments have demonstrated that these 
transporters also possess substrate-induced currents uncoupled from transport and substrate-
independent "leak" currents, suggesting that these transporters possess properties of ion channels 
(12,18-21). A small Cl- flux not stoichiometrically linked to transport, yet elicited by low 
dopamine concentrations has been observed for the DAT, a current which may modulate cell 
excitability (22). Similarly, an uncoupled Cl- conductance is a feature of glutamate transporters 
(10,14). These currents may have a significant impact on voltage-dependent events, such as 
neurotransmitter release and the opening of Ca2+ channels. Thus the presence of these currents 
suggests that neurotransmitter transporters impact the electrical and physiological properties of 
the neuron besides controlling neurotransmitter homeostasis. Certainly uncoupled currents have 
led to different hypotheses regarding the mechanism of Na+-coupled transport, and the 
corresponding models will be presented later in this chapter.  
 Regardless of the mechanism of ion/substrate transport, uptake experiments have 
revealed that NSS display surprisingly slow turnover rates. These transporters typically display 
turnover rates of 1 to 15 molecules s-1, requiring at least 60 ms for a transporter to bind substrate, 
release it into the cytoplasm and re-face to the binding-competent configuration (23). In contrast, 
acetylcholine signal termination by acetylcholinesterase at nicotinic synapses is quite efficient 
with an observed turnover rate on the order of 104 s-1 (24,25). Despite slow turnover rates, 
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neurotransmitter clearance by NSS has been observed to occur within a few milliseconds (23). 
This rate of clearance necessitates a transporter density at the plasma membrane of about 103µm-2, 
which has been observed for both the glutamate transporter and NSS systems (26,27). Consistent 
with electrogenic transport, the uptake velocity is influenced by the plasma membrane potential, 
emphasizing the thermodynamic dependence of transport on the electrical gradient across the 
membrane. Indeed, when measured in Xenopus laevis oocytes, the DAT uptake velocity increased 
when the membrane was hyperpolarized and decreased when the membrane was depolarized 
(21). Although serotonin transport is reportedly electroneutral, an increase in uptake with 
membrane hyperpolarization has also been observed for the SERT from Drosophila 
heterologously expressed in oocytes (28). Under physiological conditions following an action 
potential, transient depolarization of the plasma membrane during neurotransmitter release may 
reduce re-uptake to allow for sufficient interaction of ligands with post-synaptic receptors (29).  
 Importantly, the brain expression pattern of neurotransmitter transporters provides insight 
into the tight control of synaptic transmission and the systems that they regulate in the CNS. 
Expression of the glutamate transporters, or excitatory amino acid transporters (EAATs), such as 
GLT-1 (EAAT2) and GLAST-1 (EAAT1), has been identified on astroglial cells which surround 
excitatory synapses (10,30). Other members (EAAT3 and EAAT4) have been observed outside 
the postsynaptic density on the cell bodies and dendrites where they function to prevent spill-over 
of glutamate into neighboring synapses (30). EAAT5 is primarily expressed in the retina where it 
plays a central role in the regulation of glutamatergic signaling and, therefore, visual processing 
(31). Because glutamate stimulation of postsynaptic AMPA and NMDA receptors can lead to a 
large Ca2+ influx, glutamate transporters are critical regulatory components to prevent excitotoxic 
cell death. Indeed, these transporters maintain exquisite control of the extracellular glutamate 
concentration, approximately 100 times less than the EC50 of the NMDA receptor (10).  
 In general, NSS are concentrated on the plasma membrane of presynaptic terminals 
which synthesize the cognate neurotransmitter, although expression in dendrites and along the  
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Figure 1. Role and location of neurotransmitter transporters in the synapse. Using the Na+ 
gradient established by the Na+/K+ ATPase, these transporters catalyze neurotransmitter re-
uptake, terminating synaptic transmission. Adopted from Ref 23. 
 
 
cell soma has been also observed (29). At the synapse, these transporters tend to cluster outside of 
the active zone in perisynaptic regions along axons (Figure 1). Substantial innervation by 
dopaminergic and serotonergic neurons have been observed in midbrain regions including the 
striatum and nucleus accumbens (32-34), brain regions associated with motor control, learning 
and behavior. Therefore, the DAT and SERT possess critical roles in modulating complex 
physiological processes such as reward, motivation and locomotion. The regulatory importance of 
the DAT is highlighted in experiments with mice that lack the DAT gene. Indeed these mice 
demonstrated hyperlocomotion, which was correlated with an extended lifetime (approximately 
100 times longer) of dopamine in the synapse (35). The persistence of dopamine in the synapse 
also triggered a downregulation of both pre- and postsynaptic receptors, a likely result of 
excessive receptor stimulation. Since presynaptic autoreceptors control dopamine synthesis and 
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release (36), a marked decrease in tissue dopamine content was also observed. Similarly, SERT- 
and NET-deficient mice also demonstrate decreased tissue neurotransmitter content and 
expression of associated receptors and significantly reduced neurotransmitter re-uptake (37-39), 
reinforcing the role of these transporters in neurotransmitter and receptor regulation.  
Role of NSS in drugs of abuse 
 Besides controlling fundamental neurochemical signaling events, the NSS are also the 
sites of illicit drug action.  The meperidine analog, 1-methyl-4-phenyl-4-propionoxy-piperidine 
(MPPP), is a synthetic opioid which produces similar analgesic effects to heroin and morphine 
(40). In the 1980s, drug addicts began intravenous injections of MPPP, which was unknowingly 
contaminated with a by-product, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP), formed 
during synthesis of the opioid. MPTP is a hydrophobic molecule that can easily pass through the 
blood-brain barrier. Once taken up by glia, MPTP is rapidly oxidized to the potent neurotoxin 1-
methyl-4-phenylpyridinium (MPP+) by the monoamine oxidase B enzyme (inhibition of this 
oxidase prevents production of the toxin) (40). MPP+ inhibits mitochondrial oxidative 
phosphorylation by interacting with complex I of the electron transport chain leading to ATP 
depletion and a buildup of reactive oxygen species, triggering apoptotic cell death. MPP+ 
specifically targets dopaminergic neurons of the substantia nigra, leading to an identical pattern of 
cell death observed in Parkinson's disease. Indeed, administration of MPTP resulted in a 
permanent parkinsonian-like state characterized by immobility and rigidity, which could be 
treated by therapeutic doses of L-dopa, the precursor of dopamine (41). Various studies have 
shown that the DAT facilitates entry of MPP+ into dopaminergic neurons (42). Blockade of the 
DAT with an antagonist protects these cells from MPP+ toxicity (40). Furthermore, mice that 
overexpress the DAT gene are more sensitive to MPP+, an opposite effect to that observed in 
DAT-deficient mice (40).  
 Although MPP+-induced toxicity may be considered the unintentional result of drug 
abuse, evidence overwhelmingly supports the notion that the rewarding effects of illicit 
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psychostimulants, such as cocaine and amphetamine, are mediated directly by NSS as well.  
Despite fundamentally different modes of interaction, both cocaine and amphetamine increase the 
extracellular concentration of neurotransmitter by inhibition of NSS, facilitating extended ligand-
receptor interactions which are thought to contribute to the reward potential of these 
psychostimulants, including acute euphoria (43,44). Furthermore, both cocaine and amphetamine 
induce alterations in transporter trafficking at the plasma membrane, consistent with a dynamic 
mode of transporter regulation by psychostimulants (45). Certainly changes in trafficking and, 
therefore, cell surface expression effect overall transport activity by modulating neurotransmitter 
uptake capacity.  
 Cocaine is an alkaloid stimulant derived from the coca plant indigenous to South 
America. According to the 2009 World Drug Report released by the United Nations Office on 
Drugs and Crime, North America remains the largest world-wide cocaine consumer with 
estimates of up to 700 metric tons of cocaine having been smuggled into the United States in 
2007 (46). Cocaine abuse has been linked to an extensive array of neurological and psychiatric 
disorders, including reduced cognitive function, psychosis and comorbidity with schizophrenia 
(44). Depression often occurs following a cocaine binge (47). Although amphetamine or related 
precursors have been found in several plant species, the drug can be manufactured synthetically 
(48). The amphetamine derivative methamphetamine can be easily obtained from a one-step 
reduction of ephedrine or pseudoephedrine, compounds that have been used as nasal 
decongestants in some over-the-counter drugs (48). Similar to cocaine, a 2008 global assessment 
indicated that North America remains one of the largest consumers of amphetamine-type 
substances (49). The stimulant activity of amphetamine has led to an effective treatment of 
narcolepsy (48). Amphetamine is also used paradoxically in the treatment of attention deficit 
disorder(50). However, cognitive impairment, hallucinations and psychosis indistinguishable 
from schizophrenia have been linked to amphetamine abuse (51). These negative effects of illicit 
drug use ultimately leads to deleterious socioeconomic burdens, such as altered work productivity 
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and an increased financial weight for proper medical treatment (52). 
 Cocaine has been shown to interact with the SERT and NET, but studies with genetically 
modified mice have implicated the DAT as the primary target of cocaine (35). Cocaine behaves 
as a classical uptake blocker by competitively inhibiting dopamine binding and transport by the 
DAT (53), resulting in increased dopaminergic neurotransmission. In wild type mice, cocaine 
administration leads to increased locomotor activity (35), which correlates with movement 
disorders observed in humans (44). As stated previously, DAT-deficient mice demonstrated a 
hyperlocomotion phenotype, yet these mice were unresponsive to high doses of cocaine (35). 
These observations were consistent with a cocaine-induced change in movement activity 
mediated by the DAT. Interestingly, these DAT-deficient mice exhibit two paradoxical behaviors: 
1.) they self-administer cocaine and 2.) demonstrate cocaine-induced conditioned place 
preference, both of which are classical methods of determining if a drug-exposed animal displays 
sensitivity to the drug (54,55). These observations suggest that DAT-deficient mice still 
experience the rewarding effects of cocaine and that the DAT alone does not completely mediate 
these effects. 
 Indeed, cocaine was found to bind the SERT in mice lacking the DAT (54), suggesting 
that serotonergic circuits may be involved in the positive reinforcement of cocaine effects. In 
support of this, cocaine-induced conditioned place preference is abolished in mice lacking both 
DAT and SERT (56). Therefore, the neurophysiological effects of cocaine may be topologically 
diffuse requiring multiple neural pathways. However, the dopaminergic system is likely the chief 
mediator of cocaine reward since cocaine still increases extracellular dopamine in the nucleus 
accumbens of DAT-deficient mice (57). The mechanism of increased extracellular dopamine of 
DAT-deficient mice appears to be dependent on enhanced serotonin sensitivity in the ventral 
tegmental area, which is not observed in wild type mice (57). While these observations are 
consistent with the polygenic nature of cocaine reward, they suggest that reward pathways may 
be modified in genetically altered mice. One study sought to circumvent this potentially 
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confounding issue by introducing mutations in the DAT that significantly reduced cocaine 
sensitivity yet retained transport activity (58). These mice that possessed a cocaine-insensitive 
DAT did not display anatomical changes or altered DAT expression levels compared to wild type 
mice. Whereas cocaine was found to increase the extracellular dopamine concentration of both 
wild type and DAT-deficient mice, cocaine did not elevate the dopamine concentration in 
cocaine-insensitive mice (58). Furthermore, these mice did not develop conditioned place 
preference for cocaine, but did demonstrate cocaine-dependent hypolocomotion. Since cocaine 
induces hyperlocomotion in wild type animals (35), the authors suggested that, in the absence of 
cocaine inhibition of the DAT, cocaine may interact with other members of the NSS family 
(including the SERT) to reduce locomotion (58). Consistent with this hypothesis, cocaine has 
been found to decrease locomotion in C. elegans, a response that required both serotonin and the 
SERT (59). The results with mice possessing a cocaine-insensitive DAT clearly demonstrate that 
the cocaine reward pathway is mediated by the dopaminergic system and requires blockade of the 
DAT. 
 In contrast to cocaine, voltage-clamp electrophysiology has demonstrated that the 
presence of extracellular amphetamine or amphetamine-like stimulants (i.e. methamphetamine) 
elicits a transport-related inward current similar to dopamine mediated by the DAT in Xenopus 
laevis oocytes or HEK-293 cells (8,21,60,61). In addition, this amphetamine-induced current 
could be blocked with cocaine (8). Biochemical and electrophysiological measurements have 
clearly shown that apparent amphetamine transport is saturable and dependent on ion gradients 
(8,62). Collectively, both electrophysiology and biochemical flux assays indicate that 
amphetamine is a DAT substrate. Therefore, competition of amphetamine with dopamine for 
binding and transport by the DAT is a likely means of inhibiting dopamine re-uptake. Other 
experiments have indicated that amphetamine also induces neurotransmitter release, or efflux, via 
the cognate transporters, thereby providing an additional mechanism of increased extracellular 
neurotransmitter concentrations (35,63-65). For instance, dopamine was readily released from 
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striatal slices of wild type mice following incubation with amphetamine (35). In contrast, 
amphetamine-induced dopamine release was absent in DAT-deficient mice, demonstrating that 
DAT is a required component for enhancing dopaminergic signaling via amphetamine stimulation 
(35). The exact mechanism by which amphetamine induces a transporter-mediated 
neurotransmitter efflux is a matter of controversy. Indeed multiple models of reverse transport of 
the DAT have been proposed, but these models are not necessarily mutually exclusive.  
 One model envisions the counter transport of dopamine from the cytoplasm with the 
uptake of extracellular amphetamine. This model, known as facilitated exchange diffusion, 
predicts that the transport of amphetamine would increase the accessibility of intracellular 
dopamine binding sites, thereby increasing the probability of intracellular catecholamine binding 
and subsequent reverse transport (48,66). The model also predicts that, under normal 
circumstances in the absence of amphetamine, extracellular dopamine could also induce efflux of 
cytoplasmic dopamine. However, the low concentration of intracellular Na+ under these 
conditions decreases the probability of dopamine binding to the intracellular binding sites so that 
the rate of dopamine uptake is much larger than dopamine release. Indeed, Vmax for outward 
transport is less than 20% of Vmax for inward transport (67). Because amphetamine transport is 
Na+ dependent, amphetamine may not only increase the access to intracellular dopamine binding 
sites, but also significantly increase the local concentration of intracellular Na+ so as to promote 
high affinity binding of cytoplasmic dopamine. An amphetamine-dependent increase in 
cytoplasmic Na+ concentration has been found to stimulate reverse transport (68). 
 In contrast to this model, amphetamine does not have to be actively transported to elicit 
dopamine release. A particular study showed that addition of either dopamine or amphetamine 
directly to the cytosol, i.e. in the absence of DAT-mediated transport, of the giant dopamine 
neuron from a pond snail induces dopamine efflux through the DAT (69). This observation 
suggests that facilitated exchange diffusion cannot explain all aspects of amphetamine-driven 
dopamine efflux. In 2005, Kahlig and colleagues reported that, under controlled intracellular Na+ 
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concentrations, amphetamine causes reverse dopamine transport by a slow, transporter-like mode 
and a fast (millisecond), channel-like mode (70). Although the slow process is consistent with the 
facilitated exchange diffusion model, the channel-like mode released a "burst" of dopamine 
similar to that observed with normal vesicular release during an action potential. Even though 
dopamine has also been shown to elicit efflux (67,71), the channel-like mode of the DAT is 
inhibited in the presence of dopamine or cocaine, suggesting that dopamine-induced efflux 
proceeds through the transporter-like mode of the DAT (70). The intrinsic difference between the 
DAT substrates to induce different modes of dopamine release is not known, but may be related 
to altered intracellular signaling events and protein-protein interactions discussed later in the 
chapter. 
 The effects of amphetamine on the activity of the DAT may be further exacerbated by the 
intracellular action of amphetamine on vesicular stores of dopamine. Dopamine and other 
catecholamines are actively removed from the cytosol into acidic storage compartments by the 
vesicular monoamine transporters (VMATs) (3). The VMATs utilize an outwardly-directed 
proton gradient to concentrate monoamines into the vesicles up to 100,000 fold relative to the 
cytosol (48). Two modes of amphetamine interaction with these vesicular pools have been shown 
to increase cytosolic neurotransmitter concentrations. The membrane-permeable nature of 
amphetamine allows it to penetrate these synaptic vesicles. Once inside the acidic compartment, 
the weak base potential of amphetamine collapses the pH gradient required for monoamine 
transport (72). The presence of amphetamine has been shown to decrease the quantal size 
vesicular dopamine release in PC12 cells by more than 50%, consistent with a decreased number 
of stored dopamine molecules (69). However, the stereospecificity of the amphetamine effect at 
the vesicles suggests a more direct interaction with specific vesicular components, such as the 
VMATs. Indeed, the S(+) –isomer of amphetamine is more effective at releasing monoamine 
stores than the R(-) –isomer, and the S(+) –isomer binds preferentially to the VMAT (73). This 
may suggest that amphetamine is a substrate for VMAT and may induce exchange diffusion, 
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ultimately increasing the concentration of cytosolic neurotransmitter concentrations and the efflux 
potential.  
 
 
 
Figure 2. Illicit drug regulation of cell surface expression. (A) Normal physiological expression 
of the DAT. (B) Amphetamine causes acute internalization of the DAT, decreasing transport 
capacity. (C) Cocaine, a potent uptake blocker, elicits an upregulation of surface expression. The 
illustration was inspired from Ref 75.  
 
 
 The normal constitutive internalization and recycling of transporters to the plasma 
membrane are also altered in the presence of either cocaine or amphetamine (Figure 2). Cocaine 
has been found to increase the number of functional DATs at the cell membrane. For instance, 
after incubation with cocaine and subsequent washout, dopamine uptake (Vmax) increased without 
a change in Km (74). These changes correlated with an increase in cell surface expression of the 
DAT measured by biotinylation, which facilitated an increased uptake. In contrast to cocaine, 
amphetamine has been shown to have the opposite effect on members of NSS, i.e. a decrease in 
cell surface expression. A decrease in Vmax has been observed for both DAT and SERT, consistent 
with a decrease in the number of functional transporters at the cell surface (61,75,76). A 
combination of electrophysiology and confocal microscopy has shown that amphetamine-induced 
internalization of functional DATs is likely to be a clathrin-dependent mechanism that is inhibited 
by DAT blockers such as cocaine (77). Analysis of a transport deficient DAT mutant indicates 
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that this process of transporter redistribution appears to be dependent on the increase of the 
cytosolic amphetamine (78). The means by which these psychostimulants mediate such a 
dynamic mode of transporter regulation is not entirely clear, but may be tied to extensive 
autoreceptor stimulation and/or intracellular signaling events and protein-protein interactions 
addressed in subsequent sections of this chapter.  
Pharmacological inhibitors 
 The neuropsychological effects of cocaine and amphetamine abuse briefly mentioned 
above, including induced depression, indicates that dysfunction of the associated neurotransmitter 
systems may underlie the development of severe psychiatric disorders. Indeed, symptoms of 
major depression such as alterations in mood, appetite, sleep behaviors and suicidal thoughts 
appear to be linked to dopaminergic, serotonergic and noradrenergic circuits (79). Positron 
emission tomography of individuals with major depression (not drug induced) has indicated a 
reduced number of DAT and SERT binding sites (80,81). Coinciding with this observation is a 
decrease in both serotonin and tryptophan (the serotonin precursor) concentrations, suggesting 
vast physiological changes associated with major depression (82). SERT knockout mice 
demonstrate increased anxiety and stress under basal conditions (83). 
 It is now accepted that both environmental and genetic factors contribute to the 
development of major depression. In contrast to SERT knockout mice, NET deficient mice have 
been shown to be resistant to depressive-like behaviors as a result of chronic physical stressors, 
perhaps through enhanced serotonergic signaling mediated by norepinephrine stimulation of α1-
adrenoreceptors (84). Interestingly, this particular study suggested that noradrenergic pathways 
are connected to changes in downstream biochemical events such as the regulated expression of 
brain neurotrophins. Under chronic stress conditions, a downregulation of neurotrophins occur 
and may be linked to the onset of stress-induced depression. The propensity for genetic factors to 
influence depressive symptoms is highlighted by functional polymorphisms of the human SERT 
gene that reduce transcriptional efficiency and increase susceptibility to depression (85).  
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 In addition, the neural connections made between the midbrain and other brain regions 
often result in the onset of other psychosomatic symptoms. For instance, these neurons project 
from the midbrain by frontostriatal circuits to the medial prefrontal cortex, the region of advanced 
cognitive processes such as decision making, where they converge with noradrenergic projections 
arising from the locus coeruleus of the brain stem (81,86). Patients with major depression or other 
disorders, such as Huntington's disease (characterized by atrophy of the striatum), demonstrate 
deficits in executive functions such as attention and planning (81). Furthermore, due to the strong 
correlation of cognitive impairment with reduced blood flow in the medial prefrontal cortex, low 
blood perfusion has been suggested to be a hallmark of individuals with major depression (81).  
 Perhaps the most convincing evidence of the involvement of dopamine, norepinephrine 
and serotonin in the pathophysiology of major depression is the pharmacology of antidepressants. 
Similar to NET knockout mice, wild type mice treated with antidepressants prevent depressive-
like behaviors and blocked the downregulation of neurotrophic factors (84). Although the modes 
of action of some antidepressants are not known, several classes of antidepressant drugs have 
been developed that target specific proteins, including tricyclic antidepressants (TCAs), selective 
serotonin re-uptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs). Free 
cytosolic monoamine transmitters are either transported by VMATs into synaptic vesicles (as 
described previously) or metabolized by a monoamine oxidase (82). The net effect of MAOIs is 
an increased concentration of cytosolic serotonin and a shift in the flux of serotonin toward 
vesicular repackaging. TCAs, such as clomipramine, imipramine and desipramine, act by 
competitively binding with nanomolar affinity to NSS (87), thereby increasing synaptic 
neurotransmitter concentrations and postsynaptic receptor stimulation. Interestingly, 
administration of TCAs to depressed individuals was found to increase blood perfusion in the 
medial prefrontal cortex, an area in which the NET is fundamental to removing both 
norepinephrine and dopamine from the synaptic cleft (81,86). However, potent side effects of 
both MAOIs and TCAs including sedation and orthostatic hypotension provided a driving force 
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for the development of novel efficacious drugs, such as the SSRIs (79,88,89).  
 Whereas TCAs are indiscriminate towards inhibition of transporters, the SSRIs such as 
fluoxetine—marketed as Prozac—more specifically target the SERT, but will bind to the DAT 
and NET with lower affinity (90). Unfortunately, these inhibitors take several weeks in vivo to 
produce an antidepressant effect, which may be related to the process of serotonin autoreceptor 
desensitization (83). That is, autoreceptor stimulation provides negative feedback towards 
inhibiting further neurotransmitter release. The autoreceptor inhibitory effect was found to be 
attenuated after 14 days of SSRI treatment. This suggests that an adaptive response facilitates the 
mechanism of SSRI antidepressant action. Furthermore, a significant fraction (~30%) of 
depressed individuals do not respond to SSRIs and those that do respond deal with multiple side 
effects such as nausea and sexual dysfunction (79). Due to these observations, one approach may 
be to employ the synergistic activity of a combination of a specific transport inhibitor and 
autoreceptor antagonist to facilitate therapeutic inhibition on a shorter temporal scale (79). The 
promiscuity of SSRIs at higher dosages is also a clear indicator that more work is required to 
develop faster acting, highly specific drugs to combat major depression and associated 
debilitating symptoms. Indeed, an SSRI can become a higher affinity inhibitor of the NET with 
changes to one or two functional groups (91).  
To accomplish this task, a fundamental understanding of transporter structure and the 
relationship of structure to functional activity is required. A detailed structural analysis provides 
essential information regarding the organization of the polypeptide chain within the context of a 
lipid bilayer and the orientation of specific components, such as loops, N- and C-termini. How are 
these components utilized in the functional cycle? A number of studies suggest that 
posttranslational modifications and protein-protein interactions that involve loop segments or 
both N- and C-termini are critical for transporter activity and membrane targeting. Furthermore, 
where are the ligand binding sites relative to inhibitor binding sites? What are the molecular 
determinates of substrate and inhibitor binding specificity? How does the binding of inhibitors 
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impact the structure of the transporter? The answers to these questions and others are crucial to 
the development of models that capture the structure/function relationship as well as to the 
rational design of specific, highly efficacious inhibitors (91). As discussed below, it is clear that 
the structure of these transporters not only plays a pivotal role in NSS membrane targeting and 
transport efficiency, but also regulates efflux and facilitates autoreceptor interaction.  
 
Molecular structure and organization 
 The GABA transporter from rat brain was the first NSS family member to be cloned (92). 
The primary sequence suggested a protein of 599 amino acids. Subsequent cloning of the NET, 
DAT and SERT revealed proteins of similar lengths (617, 620 and 630 amino acids, respectively) 
(93-95). BLAST analysis of the human GAT primary sequence against those of the NET, SERT 
and DAT reveals a substantial amount of sequence conservation (42-45% identity). Sequence 
identity approaches 50% between the SERT and DAT proteins. In particular, the highest degree 
of conservation occurs in the transmembrane (TM) region, but the most divergence is observed at 
the variable length N- and C-termini (5). Hydrophobicity analysis has predicted that these 
polytopic membrane proteins possess 12 TM segments with cytoplasmic N- and C-termini (94). 
For example, the hydropathy profile of the human DAT primary sequence generated from the 
Kyte-Doolittle method (96) is plotted in Figure 3A, suggesting the presence of 12 membrane-
spanning segments. It has been shown by von Heijne that the distribution of positively charged 
residues also impacts the topological orientation of the polypeptide chain in the bilayer (97). The 
results from another topology predicting program that incorporates hydrophobicity, charge bias 
and other variables, the transmembrane hidden Markov model (TMHMM) (98), is also shown in 
Figure 3B that illustrates the probable location of TM segments, loop regions and orientation. In 
addition to the TM segments, a large extracellular loop is predicted between TM3 and TM4 that 
contains a variable number of N-glycosylation sites. Given significant sequence similarity, all 
NSS are predicted to share a similar topology in which the TM segments form α-helices as 
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illustrated by the model in Figure 3C.  
 
 
 
Figure 3. Topology of NSS. Kyte-Doolittle (A) and TMHMM (B) sequence analysis of the 
human DAT suggests 12 membrane spanning regions. Predicted transmembrane segments (red) 
are separated by extracellular (green line) and intracellular (blue line) loops shown in (B). Thus, 
NSS family members are expected to display a membrane topology similar to that shown in (C). 
 
 
 Experimental validation of this predicted model is necessary for proper assignment of 
functionally relevant residues. In the absence of crystallographic evidence, indirect methods have 
been used to investigate the topological organization at low resolution. All data collected to date 
support a 12 TM topology with intracellular termini. Immunofluorescence of the NET was 
observed for polyclonal antibodies of the N- and C-termini only in permeabilized COS-7 cells 
expressing the NET, consistent with a cytoplasmic location for these termini (99). Using 
monoclonal DAT antibodies, immunogold electron microscopy indicated that the N-terminus was 
found in the cytoplasm (100). Bennett and Kanner found that all three naturally occurring N-
glycosylation sites in the GAT are utilized in the predicted loop between TM3 and TM4, which 
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argues for an extracellular location (101). Similarly, limited trypsin proteolysis and photolabeled 
fragments suggested that the N-glycosylation sites of the DAT are located between TM3 and 
TM4 (102). Furthermore, enzymatic treatment of the glycosylated DAT with N-glycanase and 
neuraminidase indicated that N-linked oligosaccharides and sialic acids are attached to these sites.  
 Despite this agreement, the specific location of some loops and transmembrane segments 
has been controversial. Two groups investigating the topology of either the GAT or GlyT 
(glycine transporter) using introduced N-glycosylation sites suggested that the topology of the 
first one third of the protein is different from theoretical predictions (101,103). Based on 
glycosylation of the first predicted intracellular loop (IL) and lack of glycosylation of the first 
predicted extracellular loop (EL), alternative models were proposed. In this model, EL1 was 
placed intracellularly and IL1 was placed extracellularly and the first predicted TM segment does 
not completely cross the membrane. In addition, TM3 either transverses the membrane twice or 
forces a string of hydrophobic amino acids into the extracellular milieu. However, the 
introduction of new glycosylation sites may significantly alter the natural structure of the 
transporters. Consistent with this notion, the insertion mutations in IL1 of either the GlyT or the 
GAT greatly reduced or eliminated functional activity. Furthermore, it was suggested that the 
lack of glycosylation in EL1 in the GlyT may be due to steric factors.  
 A number of studies contradict this alternative model and support the original topological 
model. Small cysteine-modifying reagents have been used to increase the sensitivity of 
measurements designed to probe potentially restricted areas without significant structural 
perturbation. For example highly conserved cysteine residues in the DAT displayed reactivity 
with small polar derivatives of methanethiosulfonate (MTS) (104). The endogenous Cys-90 found 
in the first predicted extracellular loop demonstrated fast reactivity similar to the extracellular 
loop residue Cys-306 between TM5 and TM6 in both membrane preparations and intact cells. In 
contrast with the glycosylation studies mentioned above, similar results have been obtained at the 
site analogous to Cys-90 in the GAT (105). Moreover, the reactivity of the conserved Cys-135, 
19 
 
predicted to be found in IL1, was reduced in cells compared with membranes (104). These results 
did not agree with the alternative topology proposed for the GAT and GlyT based on inserted 
glycosylation sites. In addition, reactivity studies with the SERT indicated that Cys-109 predicted 
to be in EL1 could be biotinylated with MTS derivatives, although alanine mutagenesis prevented 
biotinylation (106). Collectively, these data suggest that the topology of both the DAT and SERT, 
and likely all NSS, agree with the original model of TM organization.  
Impact of structural elements on NSS regulation 
 Specific sites within structural elements of the NSS appear to influence the regulated 
trafficking of transporter to the plasma membrane, as well as impact functional activity. Although 
the DAT possesses 13 cysteine residues, a pair of cysteines (Cys-180 and Cys-189) in the large 
extracellular loop between TM3 and TM4 impacts plasma membrane expression (107). Mutation 
of these cysteines to alanine prevented the DAT from reaching the membrane surface, eliminating 
all functional activity. These two highly conserved residues map to Cys-200 and Cys-209 in the 
SERT. Mutagenesis studies of these two cysteines increased the Km and decreased the Vmax (75-
85% relative to wild type), reflecting a substantial reduction transport capacity (106). By 
comparison, mutation of another cysteine in EL1 did not alter transport activity. The altered 
activity of the EL2 mutants was found to be due to reduced cell surface expression and a lower 
intrinsic activity of the mutant SERT. Interestingly, mutation of Cys-200 to serine increased the 
reactivity of SERT to MTS reagents, which is reversed in the double mutant C200S/C209S (106). 
These observations suggested that these two cysteine residues form a disulfide bond in EL2, and 
may play a role in the Na+-dependent activity of SERT transport.  The conservation of these 
cysteines in other transporters implicates a role of disulfide bond formation in the DAT and NET 
as well. 
 The attachment of sugar moieties to proteins have been shown to affect protein folding, 
targeting, and functional activity (108). The N-glycosylation sites found in the NSS appear to 
have a pivotal role on the overall activity of the transporters. Studies with the GlyT, DAT and 
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SERT emphasize the effect of enzymatically removing oligosaccharides or preventing the 
posttranslational modification via site directed mutagenesis. Approximately 30% of the molecular 
mass of the GlyT can be attributed to sugar chains, which may be the result of modification of all 
four asparagine sites in EL2 (109). Mutagenesis of all four sites results in a 65% decrease in 
transport activity characterized by a decrease in Vmax, although Km appeared unchanged. A 
combination of cell surface biotinylation and immunofluorescence suggested that the reduction in 
transport velocity can be attributed to a decrease in cell surface expression (110). Therefore, 
glycosylation appears to be required for efficient targeting of the GlyT, although not absolutely 
required for function. Interestingly, a previous study of the GlyT reconstituted into 
proteoliposomes demonstrated a ~75% decrease in transport after a five hour incubation with 
peptide-N-glycosidase F, but no changes were observed with other glycosylation enzymes (109). 
Although the experiments could not identify if sugar modification altered the structure of the 
protein or if the sugar moiety interacted with the binding site, this result seems to suggest that 
glycosylation may impact intrinsic functional activity and not just plasma membrane expression.  
 A similar observation with the SERT has been reported when insect cells were treated 
enzymatically to remove the endogenous sugars or in a Asn/Gln mutant that eliminates 
modification at both glycosylation sites (111). Addition of tunicamycin to Sf9 cells expressing 
wild type SERT decreased the total ligand binding without changing the KD.  In addition, site 
directed mutagenesis of both glycosylation sites did not change the KD relative to wild type, but a 
decrease in ligand binding mirrored a decrease in total protein expression at the membrane. 
Transport kinetics also reflected a net decrease in transport velocity without a change in the 
apparent dissociation constant. In case of the DAT, cell surface biotinylation and confocal 
microscopy indicated a reduced surface expression of unglycosylated DAT resulting in a reduced 
Vmax, but also reduced total protein content (112). More immunofluorescence was also found in 
the cytosol of mutant DAT than at the plasma membrane, which was correlated with enhanced 
internalization. Collectively, N-glycosylation is not an absolute requirement for either catalytic 
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activity or plasma membrane expression since unglycosylated forms of the NSS are present to 
some degree at the membrane and transport substrate. In fact, removal of one glycosylation site in 
the SERT reduces plasma membrane expression, but not to the same extent as removal of both 
sites (111).  Therefore, the emerging theme is that catalytic activity is impaired relative to fully 
glycosylated wild type, likely due to a reduced stability at the membrane surface.   
 Activity at the N-terminus of these transporters may also play a role in transporter 
regulation through second messengers. The N-terminus of NSS possesses several consensus 
phosphorylation sites for different protein kinases, including PKA, PKC and Ca2+/calmodulin-
dependent protein kinase (113). Pharmacological stimulation of DAT activity through activation 
of adenylate cyclase has been shown to be reduced to basal levels by the presence of a specific 
PKA inhibitor (114). In this study, PKA stimulated an increase in uptake velocity without altering 
the affinity for substrate, and led to the hypothesis that an increase of DAT density at the plasma 
membrane may mediate these affects. However, it was not clear from this study if PKA 
stimulation of the DAT was directly due to DAT phosphorylation. Although PKA activation 
increased the phosphorylation of the SERT, it has been shown that the DAT phosphorylation state 
is not affected by PKA (113).  
 In contrast, phosphorylation of the DAT N-terminus has been shown to be PKC 
dependent. Foster and colleagues recently demonstrated through peptide mapping and epitope-
specific immunoprecipitation that the N-terminus of DAT is phosphorylated by PKC at serine 
residues in the rat striatum (115). Basal phosphorylation was increased in a dose-dependent 
manner with treatment of PKC activators. This effect was also blocked in the presence of PKC 
inhibitors. In contrast to PKA, activation of PKC reduces transport Vmax, although Km is 
unaffected, and therefore may have an opposite effect on cell surface expression (113). Indeed, 
PKC activation also leads to a decrease in uptake velocity of the SERT, but 
biotinylation/immunoblot analysis suggested that the reduction in Vmax was due to a redistribution 
of SERT away from the cell surface (116). Daniels and Amara have shown that the PKC-driven 
22 
 
process of DAT internalization is mediated by clathrin and the GTPase dynamin (117). However, 
site directed mutagenesis of the consensus PKC phosphorylation sites which prevented PKC 
phosphorylation did not inhibit PKC-induced internalization (118), suggesting that N-terminal 
phosphorylation is not required for transporter trafficking and that other mechanism(s) are 
employed.  
 It has been suggested that the phosphorylation-dependent regulation of the DAT may be 
coupled with D2 pre-synaptic autoreceptor activity (113). Activation of these dopamine 
autoreceptors has been shown to inhibit PKC activity (119). Thus, the de-activation of the PKC 
pathway would have stimulatory effect on dopamine transport. Under normal physiological 
conditions, these pre-synaptic receptors are activated by dopamine in the synapse followed by 
vesicular release to inhibit further synthesis and release of neurotransmitter (36). The application 
of a D2 autoreceptor agonist or antagonist has been shown to either increase or reduce, 
respectively, DAT activity (29). The mechanism of D2 autoreceptor regulation has been proposed 
to involve either changes in membrane polarization or Gi/o protein-coupled pathways (21,120). 
Inwardly rectifying K+ channels, which hyperpolarize the neuron, are coupled to D2 autoreceptors 
(120), which may lead to an increase in DAT activity (see page 4).  However, under voltage 
clamp conditions, dopamine stimulation of the D2 autoreceptor increased DAT activity by ~70%, 
which is inconsistent with a voltage-dependent process (120). Instead, the increase in transporter 
uptake velocity was attributed to an increase in DAT cell surface expression which was sensitive 
to pertussis toxin treatment, implicating a role for G protein activation and second messenger 
signaling. These results have been confirmed using a fluorescent MPP+ analog, ASP+, as a DAT 
substrate together with a D2 autoreceptor agonist (121,122). Furthermore, flow cytometry was 
used to show that D2 autoreceptor activation increases DAT surface expression.  
 The relationship of the D2 autoreceptor with the DAT was explored further by co-
immunoprecipitation and in vitro binding assays elegantly demonstrating that the DAT N-
terminus directly interacted with the D2 autoreceptor (123). This physical interaction facilitated 
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the increased surface expression of the DAT (~20%) and disruption of the interaction resulted in 
hyperlocomotion in mice similar to the DAT knockout. The D2 autoreceptor regulation of the 
DAT may provide a mechanism whereby cocaine increases DAT surface expression. Addition of 
a D2 receptor antagonist prevented cocaine-induced DAT up-regulation (29). As a classic uptake 
blocker, cocaine would not only enhance post-synaptic receptor stimulation, but also D2 
autoreceptor stimulation which leads to an increase in cell surface expression and an increase in 
transport capacity (see page 12).  
 The neurotransmitter stimulation of pre-synaptic receptors appears to extend beyond the 
D2 autoreceptor. Indeed, D3 autoreceptors have been shown to modulate dopamine uptake. 
Because of this observation, autoreceptor regulation of the DAT is confounded by the effects of 
the mutual response of different pre-synaptic autoreceptors. This requires experimentation in the 
absence of one or the other autoreceptor to directly determine the specific modulating effects of 
an individual receptor. Recently, Zapata and colleagues examined the effect of a D2/D3 receptor 
agonist in the absence of intrinsic D2 receptors and found that D3 receptor stimulation increased 
the uptake of the DAT substrate ASP+ (124). This effect was sensitive to pertussis toxin, again 
implicating a G protein pathway that proceeded through the MAPK and PI3K pathway. 
Furthermore, stimulation of the D3 autoreceptor led to an increase in DAT surface expression. 
The similarity of these results with those of the D2 autoreceptors described above may suggest 
that the observations accompanying supposed D2 autoreceptor stimulation actually result from D3 
autoreceptor activation. In fact, the D2 autoreceptor studies used dopamine as a substrate and the 
effect of D3 stimulation was not investigated (120). Furthermore, the observation that the D2 
receptor directly interacts with the DAT N-terminus to facilitate increased uptake velocity is 
fundamentally different from that observed with the D3 receptor. Indeed, the DAT N-terminus is 
not required for D3 receptor modulation of the DAT transport activity (124).  
 The N-terminus of the NSS is also the site of other protein-protein interactions that alters 
functional activity. The soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
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(SNARE) syntaxin 1A has been shown to interact with the N-terminus of the GAT, SERT and 
NET (125-127). Importantly, the binding of syntaxin to the DAT N-terminus is a critical 
component of amphetamine-induced dopamine efflux (128). Interestingly, this interaction is 
facilitated by Ca2+/calmodulin kinase II (CaMKII) activity, an observation also reported for the 
SERT (129).  In fact, it has been shown that CaMKII directly binds to the DAT C-terminus which 
facilitates N-terminal phosphorylation of serines in order for amphetamine to induce reverse 
transport of the DAT (130). Mutation of the DAT C-terminus or the N-terminal serine residues 
significantly impaired dopamine efflux. N-terminal phosphorylation was suggested to shift the 
DAT from a "reluctant" state to a "willing" state for dopamine efflux (131), indicating that 
phosphorylation may alter the conformation of the DAT. The effect of CaMKII suggests that 
increased intracellular Ca2+ concentrations play a role in amphetamine action. Indeed, 
amphetamine treatment led to an increase in cytoplasmic Ca2+ concentrations and efflux was 
dependent on this change (132). Because amphetamine transport increases the intracellular Na+ 
concentration, the associated membrane depolarization may open voltage gated Ca2+ channels 
leading to an influx of Ca2+ and subsequent activation of CaMKII.  
 The C-terminus is not only important in amphetamine-induced efflux, but is also a vital 
component of export from the endoplasmic reticulum (ER). Fluorescence microscopy and cell 
surface biotinylation experiments have suggested that tafficking to the plasma membrane is 
impaired in a DAT mutant in which the last five C-terminal residues were deleted (133). In more 
rigorous experiments, site directed mutagenesis of three critical residues in the C-terminus 
resulted in significant retention in the ER, including mutation of a highly conserved Gly residue 
that completely abrogated plasma membrane expression (134). Specific residues in the C-
terminus of the GAT appear to influence ER export to the cell surface (135). Thus, the data 
suggests that an intact C-terminus is required for export from the ER and targeting to the plasma 
membrane. Interestingly, when wild type DAT is co-expressed with trafficking-deficient DAT 
mutants, plasma membrane expression is still impaired (133). This observation suggests that these 
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transporters may form oligomeric structures during biogenesis, which may be maintained during 
export to the membrane.  
Oligomeric architecture of NSS 
 The propensity of NSS to form oligomeric structures has been investigated by both 
biochemical and spectroscopic approaches. Expression of two SERT constructs each containing a 
different epitope tag have subsequently been co-immunoprecipitated using an antibody for one 
construct (136). Although both constructs were functionally active, reactivity with a Cys-sensitive 
MTS reagent de-activated only one of the constructs, suggesting the presence of at least a SERT 
dimer. This oligomeric association was observed at the plasma membrane as well as in cytosolic 
compartments. In support of these results, fluorescence resonance energy transfer (FRET), which 
measures distance-dependent interaction between fluorophores, was observed in the plasma 
membrane of cells co-expressing functional SERTs or GATs fused with either cyan or yellow 
fluorescent protein (137,138). In contrast, no FRET was observed in cells expressing only a 
single construct.  
 The nature of the FRET experiment in cells does not allow for unambiguous 
determination of interfaces due to the large range of distances FRET can be observed (typically 
<100Å), as well as the large size of the fused domains. Furthermore, the interpretation of FRET is 
complicated by the expression of the acceptor construct, which may lead to errors in assessing 
direct interaction between donor/acceptor pairs (139). Due to transporter overexpression, it is 
unlikely that FRET observed between the constructs is the result of non-interacting monomers 
over a large distance (<100Å), although it is theoretically possible that overexpression leads to 
non-specific FRET (138).  Ideally, calculation of the FRET efficiency, which displays r-6 
sensitivity (where r is the distance), in dilute solution would be used to determine a unique 
distance between the fluorophores, assuming the relative orientation of the fluorophores is known 
(140). This would require a homogeneous purification of the transporter to remove other 
associated proteins and non-specific interactions that may confound results, assuming that the 
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purification process does not disrupt the interface or native structure of individual monomers 
(136). However, the structural components that form the interface(s) may be approximated, albeit 
at low resolution, by assessing FRET under conditions that may alter the oligomeric state of the 
transporter.  
 For example, the primary sequence of the GAT suggested the possibility of a Leu heptad 
repeat in TM2, possibly forming a hydrophobic "Leu zipper" similar to that observed by dimeric 
soluble proteins (138). Site directed mutagenesis of this repeat resulted in a loss of FRET and 
reduced cell surface expression. Because the mutations only modestly affected the kinetics of 
transport, the transporter was not likely to be grossly misfolded. The data suggested that the GAT 
naturally forms at least a dimer at the interface of TM2. By measuring donor photobleaching 
lifetimes between CFP and YFP, Just et al determined that the C-termini of oligomeric SERT 
were closer together than the N-termini, suggesting that the C-terminal domain may form part of 
an interface between SERT monomers (141). This is consistent with the data discussed above for 
the DAT in which an intact C-terminus is required for export from the ER. Furthermore, a peptide 
fragment consisting of TM11 and TM12 demonstrated a strong association with itself and, when 
expressed in the presence of full-length transporter, prevented cell surface expression (141). The 
data implied that an oligomeric interface was formed between TM11, TM12 and the C-terminus 
of SERT monomers. Although the SERT does not have the same potential to form a perfect "Leu 
zipper", the association of a peptide fragment constructed of TM1 and TM2 suggested the 
formation of an interface near the N-terminus similar to that observed with TM2 of the GAT 
(141). Collectively, the FRET analysis suggested the presence of two interfaces arising from 
structural components at the N- and C-termini of the SERT.  
 Besides FRET, cysteine crosslinking experiments have suggested possible locations for 
symmetric interfaces in an oligomeric assembly. A dimerization motif GXXXG, originally 
identified in glycophorin A, was found in TM6 of the DAT (142). Treatment with copper 
phenanthroline induced crosslinking at Cys-306, which was prevented by site directed alanine 
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mutagenesis. Co-immunoprecipitation of differently epitope-tagged, crosslinked DAT suggested 
that the DAT forms at least a dimer. In contrast, an interface was not observed at TM6 in the 
SERT although it possesses this same motif (141). Subsequent crosslinking analysis of DAT with 
CuSO4 indicated that TM4 may also reside at a dimer interface distinct from TM6, indicating that 
DAT forms higher order oligomers at the plasma membrane (143). Recently, a combination of 
cysteine crosslinking and FRET microscopy was used to show that the GlyT forms a dimer at the 
plasma membrane and that mutation of a Trp residue at the interface results in intracellular 
retention of the transporter (144).  
 Although it is difficult to interpret these results in the absence of atomic resolution 
structures, taken together the observations clearly indicate that these transporters possess a 
propensity for oligomer formation even during biogenesis at the ER and that oligomer formation 
plays a role in plasma membrane targeting. The apparent role of an intact C-terminus in ER 
egress and the finding that the C-termini are likely to be close together in the oligomer suggest 
the possibility that export signals are employed in membrane targeting. PICK1, a protein 
containing a PDZ domain which may be important in plasma membrane targeting, interacts with 
the DAT C-terminus (145,146). Deletion of five amino acids in the C-terminus of the DAT 
removed a PDZ interaction domain and resulted in cytoplasmic retention (133). Oligomerization 
may also hide selective retention signals, such as in the case of the NR-1 subunit of the NMDA 
receptor (147). The interface formed by the C-terminus may also bring ER export signals 
together, as proposed for the GAT, which would recruit proteins involved in COPII-dependent 
vesicle budding from the ER (147). It is also likely that other structural elements are required to 
promote oligomeric assembly and subsequent ER export. Sialylated N-glycans have been shown 
to promote oligomeric interactions of the SERT and impact functional activity (148).  
 Recently, it has been proposed that the oligomeric structure of these transporters may 
facilitate amphetamine-induced efflux (149). A major pitfall of the facilitated exchange diffusion 
model (described on page 10) is that any substrate, including the biogenic monoamines, is 
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predicted to induce efflux, creating the potential for a futile transport cycle (67). That is, the 
increase in local Na+ concentration would increase the potential that substrates would be 
"trapped" in an exchange state resulting in no net flux, yet this phenomenon has not been 
observed in vivo. Furthermore, Zn2+ binding noncompetitively inhibits dopamine transport, but 
stimulates amphetamine-induced dopamine efflux (150), an observation difficult to reconcile with 
a coupled inward/outward substrate transport mechanism. In an oligomeric complex, 
amphetamine transport by one monomeric unit would trigger the release of cytosolic substrate 
through the other unit. This mechanism may be consistent with the observed "burst" of dopamine 
released by the DAT in a channel mode following treatment with amphetamine (70). This 
mechanism has also been used to explain the observation that the SERT-specific para-
chloroamphetamine induced GABA efflux in a SERT-GAT concatemer (149).  
 
The mechanism of transport 
 From the preceding section, it is clear that structural elements of the NSS are critical 
components to the overall functionality and regulation of the transporters. However, it is not clear 
how structural elements are coordinated in a transport mechanism. These transporters form 
oligomeric complexes as indicated above, but it is not known if or how these interactions affect 
crosstalk or the activity of pharmacological ligands on individual monomers. Besides membrane 
targeting, oligomeric interactions may provide a means by which the density of transporters at the 
synapse can be achieved through ordered arrays leading to efficient spatial and temporal control 
of synaptic signaling (23). At an even more fundamental level, the absence of three dimensional 
structural information precludes clear mechanistic treatment of how the structure of transporters 
facilitate ion/substrate coupling. In addition, the presence of thermodynamically uncoupled 
currents (see page 3) adds an additional level of difficulty in determining a unique mechanism of 
transporter functionality. As will be described in the subsequent section, attempting to merge 
limited structural information with an enormous pool of functional data into a uniform 
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mechanism is a daunting task. Nevertheless, two models of transporter function have been 
proposed, single file diffusion and alternating access, which capture specific aspects of known 
activity. Although it cannot explain all aspects of transport activity, most functional and indirect 
structural data are interpreted in the context of the alternating access mechanism. However, it 
must be emphasized that only a superficial treatment of these models should be considered until 
high resolution tertiary and quaternary structural information is obtained.  
Single file diffusion 
 The movement of ions and substrate into the cell via the NSS has been observed through 
both biochemical flux assays and measurements of transporter-mediated currents (8,15). The 
origin of the electrical current is presumably associated with the charge flux of the transported 
species. Assuming that strict coupling between ions and substrate gives rise to stoichiometric 
transport, one can estimate the size of the electrical current expected for each transport cycle. 
However, the size of the observed currents can be several times larger than calculated (151). This 
is clearly the case in the SERT in which transport is predicted to be electroneutral (no net current 
flow), but the charge:serotonin ratio is approximately eight on average (20). Increasing the 
substrate concentration also increases the conductance, suggesting that more ions flow through 
the transporter per substrate (152). These observations and others led to the proposal that the NSS 
proteins have the propensity to function as channels.  
 A generalized single file diffusion model mechanism borrows from the theory of ion 
channel activity (12,153). In this mechanism, ions and substrate traverse a pore opened to both 
the cytoplasm and extracellular solution in which ion/substrate interactions within the pore result 
in coupling. The inwardly-directed Na+ gradient is primarily responsible for "pushing" substrate 
into the cytoplasm against a substrate gradient. One version of this model developed by Su and 
colleagues focused on the coupling interactions attributed to attraction and repulsion of ions and 
substrates hopping at specific rates between distinct binding sites within the transporter lumen 
(154). This theoretical treatment could recapitulate some experimental observations (such as the 
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increase in charge:serotonin flux ratio with increasing membrane polarization), but could not 
explain blunt channel activity. A slightly different model based on the Hodgkin and Keynes 
model of K+ channels proposed that stochastic diffusion of ions and substrate can account for 
coupling as well as channel-like activity (153).  
 Some simple observations of the SERT activity can be readily explained by this model. If 
ions and substrate were strictly coupled in a fixed stoichiometry and the ion concentration 
gradient maintained, an increase in extracellular substrate concentration would predict a 
proportional increase in cytoplasmic concentration at equilibrium. However, this was not 
observed with the SERT at extracellular substrate concentrations above 3µM, suggesting that ions 
and substrate are not strictly coupled (18). In fact, a time-dependent decrease in the uptake rate 
was observed with increasing intracellular serotonin concentrations. It was suggested that a 
channel mode of the SERT would suffice to efficiently remove serotonin from the synapse 
following an action potential due to the transient inwardly-directed substrate gradient. It was 
posited that strict ion/substrate coupling would occur only when the driving force supplied by the 
ion gradients would be utilized to move substrate against its concentration gradient.  
Alternating access 
 Regardless of the intriguing transport-associated currents, these currents are much 
smaller than those generated by ion channels (67) and channel-like states have been predicted to 
be brief (~1ms), low probability events (17,19). The dominant transporter mode has been 
hypothesized to reflect alternating access of a centralized ion/substrate binding compartment 
formed by the presence of physical "gates" (16). Coupling is realized by the direct interaction of 
ion and substrate at the binding site. Furthermore, the coordinated movement of the gates during 
distinct steps of transport maintains the coupled interaction by alternately exposing the binding 
site to either the extracellular or intracellular milieu. Channel-like behavior may be attributed to 
aberrations of the gating mechanism such that both gates are briefly opened simultaneously 
allowing indiscriminant flux of ions/substrate through the transporter (25). Thus, the fundamental 
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difference between the single file diffusion model and the alternating access model are the 
conformational changes in the structure of the transporter that is required of the latter mechanism.  
 A simplistic version of this model was originally proposed by Jardetzky, described as a 
pump, in which three structural criteria were met: a substrate permeable cavity, the ability of the 
pump to interconvert between two configurations, and a binding site within the cavity in which 
the affinity for the substrate is different between the two configurations (155). The original 
proposal was given in the context of an ion pump moving Na+ up the concentration gradient with 
energy supplied by a phosphorylation event that triggered a conformational change in structure. 
In this case, the process of gating is implied by the chemical-induced change in the configuration 
of the pump which alters the exposure of the binding site. This model has since been extended to 
describe the mechanism of secondary active transporters with explicit gating machinery (23). As 
shown in Figure 4, a thermodynamic cycle of four intermediate states can describe the process of 
substrate translocation with energy supplied by an ion gradient.  
 
 
 
Figure 4. Thermodynamic cycle of ion-coupled transport. Substrates bind in an outward-facing 
conformation (Tout) and proceed through a doubly-occluded conformation (Toccluded) to achieve the 
inward-facing, substrate-releasing state (Tin). Transporter re-facing to Tout requires an doubly-
occluded state in the absence of substrate (Tempty). In the SERT, the Tempty may be actually be a 
K+-bound state. 
 
32 
 
In the initial conformation, the intracellular gate is closed while the extracellular gate is open to 
receive ion and substrate. The energy of ion/substrate binding at the centralized location triggers 
the closure of the extracellular gate and the subsequent opening of the intracellular gate. If the 
intracellular concentration of ion is lower than the KD for ion binding, the ion will release into the 
cytoplasm. Since substrate binding and transport is contingent upon coupling to the ion, the 
substrate will also release into the cytoplasm due to a change in binding site affinity. Following 
release, the intracellular gate closes and the pump returns to the initial conformation for 
subsequent cycles. Jardetzky demonstrated that this process of substrate release will occur even 
against a concentration gradient provided the chemical energy that drives the pump is available.  
 The transition between the intermediate states may account for the slow turnover rates 
observed for the transporters relative to ion channels (23). For instance, the turnover rate for the 
DAT is on the order of one to two seconds per cycle, necessitating high concentrations of 
transporter at the plasma membrane for efficient signal termination according to this mechanism 
(23). In particular, the rate of structural transitions is different between the intermediates. 
Recently, Erreger et al demonstrated that the reorientation of the DAT from the inward-facing 
conformation to the outward-facing conformation is the rate-limiting step (8). However, 
reorientation of the SERT can be potentiated by the presence of intracellular K+, suggesting that 
the outwardly-directed K+ gradient influences the structure of the transporter (16). The resulting 
increase in rate of serotonin transport is consistent with the exchange or countertransport of K+ 
during the SERT cycle, an observation that cannot be adequately explained by the single file 
diffusion model. Furthermore, this model links the effects of other ligands or modulators to the 
conformational state of the transporter. 
 
The leucine transporter (LeuT) as a prokaryotic model of NSS 
 As previously stated, the practical application of these models to the transport of substrate 
is limited without high resolution structural information. The single file diffusion model of K+ 
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channels was substantiated by crystal structures of various ion channels from both prokaryotes 
and eukaryotes (156,157). In the absence of such structural information for the NSS, the form of 
the cavity, the binding site and gating machinery leaves mere speculation of how these models 
can be applied to the transport mechanism. At this time, native structure determination is 
inhibited by the lack of heterologous expression systems yielding sufficient quantities (mg) of 
material for crystallographic analysis (158). The size of these transporters also precludes 
structural analysis by current protocols of nuclear magnetic resonance spectroscopy (159). Even 
if the expression systems were available, there is no guarantee that the membrane proteins would 
be functional (158). 
 Due to the conspicuous absence of these methodologies, the scientific community is 
forced to rely on biochemical approaches yielding insufficient mechanistic details with low 
structural resolution. Measurements of transport activity following site directed mutagenesis, 
cysteine crosslinking or cysteine reactivity with MTS reagents can only supply a premise for 
structural changes in the system. Such experiments have been used to imply that cocaine binding 
stabilizes the outward-facing conformation, thus preventing the conformational changes required 
for transport (160). The substituted cysteine accessibility method, which employs site directed 
cysteine mutagenesis to assess the sensitivity of transport in the presence of covalent modifiers 
(MTS reagents), has suggested that the putative extracellular regions of TM7 and TM8 in the 
DAT undergo conformational changes in the presence of substrates or inhibitors (161). Cysteine 
reactivity studies with MTSET identified specific residues in TM3 that may be involved with 
substrate permeation and gating in both the SERT and NET (162). Other studies have generated 
chimeras of transporters to investigate the mechanism of substrate specificity. Chimeras of SERT 
and NET have suggested that EL2 and EL4 play a role in conformational changes, but do not 
affect substrate and inhibitor binding specificity (163,164). Many other studies can be mentioned 
and have been reviewed (16,165). Whereas these results cannot efficiently and explicitly map the 
structure of these transporters, the data are important for the generation of testable hypotheses.  
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 One avenue whereby structural information can be obtained more easily is through the 
analysis of evolutionarily related prokaryotic membrane proteins. These homologs can be readily 
overexpressed and functionally purified. The utility of this approach is exemplified by crystal 
structures of the KcsA K+ channel, the E. coli lactose permease and the structure of a glutamate 
transporter homolog (156,166,167).  These structures not only provide a context for the 
interpretation of both structural and functional data, but they also facilitate the development of 
highly specific hypotheses regarding their mechanisms at atomic resolution. Subsequent 
structural analysis in the presence or absence of ligands and/or inhibitors provides essential 
details into the modes of interaction and specificity. This approach has recently been applied to a 
bacterial homolog of NSS. 
The structure of LeuT 
 Crystallographic and functional analysis of a leucine transporter (LeuT) from Aquifex 
aeolicus, a thermophilic bacterium found near underwater volcanoes and hot springs, has revealed 
a tractable structural model for the NSS family (168). The primary sequence of LeuT displays 20-
25% sequence identity to eukaryotic members of the NSS family, although conservative 
substitutions approximate a 45% similarity (169). Even though the sequence identity is rather 
low, protein segments that are thought to be involved with forming the ion/substrate binding sites 
in the eukaryotic proteins are conserved in LeuT (5). The structure of LeuT, solved in β-octyl 
glucoside detergent (OG), reveals a novel fold of 12 TM α-helices, the first ten of which are 
related by a pseudo two-fold symmetry and forms the protein core (Figure 5). The presence of 12 
TM segments is different from the vast majority of prokaryotic homologs in this family, but 
similar to that predicted for the NSS (170). The co-transported substrates Na+ and Leu (2 Na+:1 
Leu) are centrally bound in a site devoid of water. Extensive hydrogen bonding and hydrophobic 
interactions with the Leu substrate are provided by unwound regions within TM1 and TM6 with 
additional contributions from residues in surrounding helices. The bound Na+ and Leu are closely 
associated in space and the carboxylate moiety of the Leu participates in the direct coordination 
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of one of the Na+ (designated Na1). LeuT crystallizes as a dimer with an interface formed by 
TM9 and TM12. In comparison with the predicted topology of the NSS, long N- and C-terminal 
tails are notably absent and EL2 appears truncated (identified in Figure 5) relative to EL2 of NSS. 
 
 
 
Figure 5. Location of conserved residues in the LeuT structure. The view is captured along the 
membrane plane (transparent orange box). Positions highlighted in red are strictly conserved, 
while those in blue represent sites of conservative mutations. Leu and Na+ are depicted in yellow 
and green space filling models. The table identifies sites that participate in Leu and Na+ binding. 
LeuT PDB code 2A65 is shown. TM10-12 have been removed for clarity. 
 
 
 LeuT is functionally dependent on Na+ since substitution with K+ did not support 
transport (168). In contrast to NSS, LeuT is not dependent on the presence of Cl-. Prokaryotic 
transporters like LeuT share a highly conserved acidic residue (Asp or Glu) near the Na1 binding 
site that is a highly conserved Ser residue in the Cl--dependent eukaryotic transporters. 
Introduction of an acidic residue at this position renders SERT, DAT and rat GABA transporters 
Cl--independent and neutralization of the Asp/Glu in LeuT and the tyrosine transporter Tyt1 
renders binding and/or transport Cl—dependent (171,172). Identified by two separate groups, this 
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Cl- binding site is approximately 5Å away from Na1, supporting an interaction energy of -11 
kcal/mol and suggests how Na+ and substrate could interact with Cl- at the binding site (171).    
Proposed transport mechanisms of LeuT 
 How does the crystal structure of LeuT inform the mechanism of Na+-coupled transport?  
 
 
 
Figure 6. Proposed alternating access mechanism of LeuT based on the initial crystal structure. 
The transition between outward-facing and inward-facing states is facilitated by the intrinsic 
flexibility of TM1 and TM6. Adopted from Ref 168. 
 
 
First, the centralized binding site is occluded from both the cytoplasmic and extracellular sides. 
Thus, there is no clear entry way for ions and substrate to permeate to the binding site, or for 
them to exit out the other side. The structure appears to support the alternating access model 
(168) in that it is likely occupying the intermediate state between the outward-facing and inward-
facing conformations characterized by closed extracellular and intracellular gates (Figure 6). 
Binding site occlusion from the extracellular side is primarily achieved by the helical hairpin turn 
of EL4, as well as F253 in TM6, D404 and R30 in TM10 and TM1, respectively. The two 
charged residues, D404 and R30, are located near a vestibule and are predicted to serve as an 
ionic extracellular gate. The pathway leading from the binding site to the cytoplasm is much more 
37 
 
extensive and compact. 
Subsequent crystal structures revealed that LeuT is rather promiscuous, binding several 
other amino acids including Ala, Val and Met. In these structures (173), the packing of the helices 
and loops were identical to the Leu-bound structure (Figure 7A). Interestingly, crystal structures 
 
 
 
Figure 7. LeuT forms similar crystal structures with different substrates or in the presence of 
TCA inhibitors. (A) The Ala crystal structure (transparent green helix, PDB 3F48) is nearly 
identical (<0.15Å rmsd) to the Leu-bound LeuT structure (gray loop). Leu (yellow) and Ala 
(magenta) occupy a similar space at the primary binding site. (B) A TCA, clomipramine (purple 
stick, PDB 2Q6H), binds in a vestibule ~10Å above the Leu binding site. The ionic pair, Asp404 
and Arg30 (inset) postulated to form the extracellular gate, forms a direct interaction in the TCA-
bound structure. In the original LeuT structure, this interaction is mediate by a single water 
molecule. 
 
 
of LeuT with bound TCAs (169,174) or SSRIs (91) in the extracellular vestibule also reported a 
nearly identical structure with Na+ and Leu also bound in the central binding site (Figure 7B). 
Alignment of the original LeuT structure with the TCA clomipramine-bound structure using the 
molecular visualization tool Pymol revealed an rmsd of less than 0.1Å for all atoms. One subtle 
difference was identified involving the ionic interaction between D404 and R30. In the original 
structure, this interaction was bridged by a water molecule (168). In contrast, this water is missing 
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in the TCA-bound structure (174). Combined with noncompetitive inhibition kinetics, the authors 
suggested that the TCAs stabilized the occluded conformation, by sterically restricting 
conformational movement and by “locking” the ionic extracellular gate. However, it is not clear 
how this TCA binding site relates to that found in the NSS, since the mechanism of TCA 
inhibition in the NSS is competitive, suggesting a binding site that overlaps with the native 
substrate binding site (87,89). Mutagenesis studies of the SERT based on this TCA binding site in 
LeuT has suggested that the inhibitory site is conserved in the SERT (169); yet, these affects may 
be mediated indirectly.  
 
 
 
Figure 8. Stabilizing interactions of the primary binding site. Side and main chain atoms 
contribute to forming the substrate binding site. Note the interactions provided by the 
discontinuous helix of TM6. PDB code 2A65 is shown. 
 
 
 The geometric organization of the binding site not only provides for specific interactions, 
but also insight into how the transporter may expose the binding sites. TM1 and TM6 reveal a 
break in the α-helical pattern of the polypeptide chain at the binding site (Figure 8). This appears 
to confer specific functions (168). Residue side chains as well as backbone atoms contribute to 
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the formation of the binding site. Furthermore, the discontinuity of the helices exposes the 
intrinsic dipole moment which contributes to the coordination of charges. Lastly, the loss of 
periodicity may confer flexibility at the binding site to allow alternating exposure to the 
extracellular or intracellular media. The pattern of discontinuous helices in LeuT also appears in 
other transport proteins, including the glutamate transporter and the ClC H+/Cl- exchanger, in 
similar topological arrangement or as helical re-entry loops involved with binding of substrates 
(175).   
 While the crystal structure of LeuT provides a structural context for functional activity, it 
must be emphasized that more structural analysis is required to elucidate all aspects of transporter 
functionality. That is, there are questions that still remain to be answered. Foremost, the doubly-
occluded nature of the structure demands investigation into what structural changes occur to 
accomplish Na+-coupled transport. Yet another, what is the structural basis of functional 
inhibition by other compounds, such as cocaine? A number of intensive efforts have been 
undertaken to integrate the structural information of LeuT with the structure/function data of the 
NSS. For example, the alignment of LeuT with the SERT sequence suggested that residues along 
TM5 near the cytoplasm may form part of the intracellular permeation pathway (160). The 
reactivity pattern of substituted cysteines with MTSEA in the presence of either substrates or 
inhibitors seems to substantiate this hypothesis. Based on the LeuT crystal structure alone, this is 
not an obvious result due to the densely packed nature of the intracellular domain (168). A 
number of studies have used the LeuT structure as a basis to fold the sequence of the NSS to 
generate homology models (176-180). These computational models can help to align the 
molecular details of prior and novel indirect structural measurements of the NSS, as well as 
conjure new hypotheses. A recent study featuring computational modeling and functional analysis 
of the DAT implicates a conserved intracellular interaction network that may control cytoplasmic 
gating (181). Another study using a molecular model of the DAT found that the binding site for 
cocaine overlaps with the dopamine binding site, which was found to be consistent with previous 
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mutagenesis studies in the DAT (181,182).   
 Subsequent reports of other prokaryotic Na+-coupled transporters crystallized in different 
conformations suggested that structural information regarding the mechanism of transport could 
be gathered from analysis of the unique arrangement of structural elements coupled to the 
conditions of crystallization. This approach, which attempts to align these different structures 
with the thermodynamic cycle shown in Figure 9, appears to have some merit as these 
transporters are dependent on Na+ and possess a similar topological organization to LeuT (183).  
 
 
 
Figure 9. Thermodynamic cycle of transport based on available crystal structures. The structure 
of Mhp1 (PDB 2JLN), which was suggested to be in an outward-facing state, is an example of the 
Tout configuration. The original LeuT structure (PDB 2A65) has been suggested to be in an 
outward-facing occluded state (Tout-occluded), whereas the structure of vSGLT (PDB 3DH4) may 
represent an inward-facing occluded (Tin-occluded) conformation. The crystal structure (PDB 2X79) 
of an inward-facing Mhp1 with an empty binding site may represent the Tin state. The figure was 
inspired from Ref 183.  
 
 
Three crystal structures of the NCS1 benzyl-hydantoin transporter, Mhp1, have been reported in 
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different conformations (184,185). Although the specific details of substrate occlusion are 
different in Mph1 (mainly the inward bending of TM10 toward the binding site), in the presence 
of substrate it resembles a doubly-occluded structure similar to LeuT (185). In the absence of 
substrate, the Mph1 adopts a more outward-facing configuration facilitated by the outward 
movement of TM10. Recently, an inward-facing conformation of Mhp1 was reported with an 
empty binding site, illustrating much larger structural changes from the occluded intermediate 
(184). Relative to the occluded conformation, this cytoplasmic open state is facilitated by 
movement of a four-helix bundle (TMs 3, 4, 8 and 9). The Na+/galactose transporter vSGLT 
adopts a more inward-facing conformation, yet substrate remains bound and occluded (Figure 9) 
(186). This model emphasizes the presence of residues and/or structural elements forming gates at 
the extracellular and intracellular sides of the binding site and that the doubly-occluded structure 
is an obligatory intermediate in the conformational cycle. Obviously, the most complete 
conformational cycle is represented by the structures of Mhp1. However, to combine the crystal 
structures of multiple unrelated transporters assumes that the structures represent native 
conformations, the transport mechanism is uniform and that individual transporter idiosyncrasies 
do not affect the details of the overall transport process. This is not necessarily the case.  
 Ideally, efforts to identify the structural intermediates of LeuT are advantageous to the 
elucidation of specific properties of transport in the family of NSS. Although crystallographic 
analysis of LeuT with other amino acids revealed a similar structure, Trp will also displace Leu, 
but leads to a significant expansion of the extracellular vestibule (Figure 10) (173). Trp was also 
found to inhibit transport, leading the authors to suggest that Trp stabilizes an outward-facing 
conformation. The structure was solved in the presence of 50mM Trp, which is three orders of 
magnitude above the Ki (~25µM). The high Trp concentration may have contributed to what 
appears to be non-specific binding. Four Trp molecules were resolved in the structure but only 
two were bound in close proximity to the Leu binding site. Nevertheless, it is difficult to interpret 
the relationship of this inhibited structure in the context of a functional cycle of transport.  
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Figure 10. Crystal structure of LeuT in the presence of 50mM Trp. (A) Leu is competitively 
displaced by Trp in the primary binding site. (B) A second Trp molecule disrupts the interaction 
between Asp404 and Arg 30. PDB code 3F3A is shown. 
 
 
 In order to generate a LeuT model of the inward-facing conformation, Forrest et al 
exploited the internal pseudosymmetry of the inverted topological repeats formed by the first 10 
TM segments (187). By computationally tilting a four-helix bundle composed of TM1, 2, 6 and 7, 
they were able to essentially swap the conformation of the repeats revealing a potential pathway 
for substrate exit into the cytoplasm. This model was used to predict cytoplasmic exposure of 
specific residues in the SERT upon substrate binding (Figure 11). Thus, this “rocker switch” type 
model predicts two prominent conformational intermediates, outward- and inward-facing, and the 
transition between these two states may not necessarily depend on the formation of a doubly-
occluded intermediate. Fundamental to the generation of this model is the assumption that the 
original LeuT structure essentially represents an outward-facing conformation. Presumably, this 
assumption is based on the presence of an extracellular vestibule and a binding site this is 
occluded by only a few residues, whereas no vestibule is visually present on the cytoplasmic side 
of the binding site (168). Although some differences were identified, the inward-facing structure 
of Mhp1 suggests that similar rigid body movement may be associated with isomerization from 
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an outward-facing intermediate (184). 
 
 
 
Figure 11. The rocking bundle mechanism. Inward tilting of a four helix bundle is proposed to 
close the extracellular permeation pathway and establish a conformation open to the cytoplasm. 
The model exploits the pseudo-two fold symmetry of internal structural repeats formed by TM1-5 
and TM6-10. The figure was adopted from Ref 187.  
 
 
 A more detailed functional model of the transport cycle of LeuT was recently 
investigated by a combination of steered molecular dynamics (SMD) simulations and 
radiolabeled flux assays (Figure 12) (188). By “pulling” the Leu substrate out of the primary 
binding site (denoted the S1 site) toward the extracellular milieu, the SMD calculations identified 
a potential second substrate binding site (denoted the S2 site) in the extracellular vestibule similar 
to the location of the TCA and SSRI binding site. Subsequent functional analysis in both n-
dodecyl-β-D-maltopyranoside (DDM) detergent and proteoliposomes indicated that Leu can bind 
with nM affinity to both sites simultaneously (2Leu:1LeuT, stoichiometry). Furthermore, 
mutation of residues involved in the formation of the S2 site or the presence of a TCA inhibitor 
eliminated Na+-coupled transport. The authors postulated a mechanism whereby substrate binding 
to the S2 site allosterically triggers the cytoplasmic release of Na+ and substrate in the S1 site. 
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Hence the formation of the inward-facing conformation may be contingent on substrate 
occupation of the S2 site. Furthermore, the presence of the TCA inhibitor appears not only to 
stabilize the occluded conformation, but also functions as a “symport uncoupler” by preventing 
substrate binding to the S2 site.  
 
 
 
Figure 12. A functional model of transport. Based on steered molecular dynamics, Na+ binding 
facilitates opening of LeuT so that Leu can bind in the primary (S1) site. From radiolabel ligand 
binding experiments, Leu binding in the S2 site triggers release of Na1 and Leu in the S1 site, a 
mechanism disrupted by TCAs (or OG or SSRIs) binding in the S2 site. Adopted from Ref 188. 
 
 
Significance of further LeuT investigations 
 The foundation of a functional transport mechanism relies on the identification of 
multiple intermediate states. However, all crystal structures of LeuT, except one (Trp-bound), 
adopt a similar conformation (91,168,169,173,174). Prompted by the observation that LeuT can 
only bind one Leu when purified in OG detergent in contrast to that purified in DDM detergent, 
Quick and colleagues recently determined by X-ray crystallography that a molecule of OG 
occupies the extracellular vestibule similar to a TCA inhibitor (189). Functional analysis also 
confirmed that OG inhibits Na+-coupled transport similar to the TCAs. In contrast to all published 
functional data obtained from LeuT purified in DDM micelles, all crystal structures were 
obtained in OG detergent. Indeed, re-examination of the electron density map of the original 
LeuT structure revealed a residual density consistent with the presence of OG (189). The apparent 
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disparity led the authors to conclude that the current library of LeuT crystal structures represent 
inhibited intermediates. Therefore, models of conformational changes based on these structures as 
described above are fundamentally flawed since these models assume that the original LeuT 
structure represented a legitimate, uninhibited intermediate in the functional cycle.  
 This critical observation demands further examination of the LeuT structure and its 
relationship to a functional cycle. Furthermore, how different intermediate states are connected 
through dynamic fluctuations in structure is an important consideration for the proper 
characterization of Na+-coupled transport. This is most appropriately described by Karpowich and 
Wang in their editorial comments on the inward-facing crystal structure of the Na+/galactose 
transporter (190): 
Isolation of secondary transporters in specific conformational states remains a 
major technical obstacle for structural studies. However, with structural 
information for some conformational states in hand, spectroscopic techniques 
can provide precise information about the nature and magnitude of the 
conformational states during the transport cycle. 
 
Using a spectroscopic approach, experiments can be designed to identify the structural 
characteristics of intermediate states as well as capture the dynamics associated with specific 
protein conformations. These dynamic properties cannot be observed properly in the confines of 
the crystal lattice, which may even lead to structural distortions (191,192). The body of work 
presented in this manuscript describes the investigation of the LeuT conformational cycle by 
electron paramagnetic resonance (EPR) spectroscopy, a technique highly sensitive to both local 
and global conformational rearrangements in protein structure. Chapter 2 features a formal 
introduction to EPR spectroscopy and the application of the technique to protein structure and 
mechanism. Subsequent chapters report the results of the analysis, outlining the structural 
transitions of LeuT that occur during the first two steps of the transport cycle in the region of the 
extracellular vestibule and in the context of both DDM micelles and proteoliposomes. 
Furthermore, the results clearly demonstrate the differential effect of inhibitors on the structure of 
LeuT relative to natural substrates. 
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CHAPTER II 
 
ELECTRON PARAMAGNETIC RESONANCE SPECTROSCOPY 
 
Origin of the EPR signal 
 The spectroscopic basis of the EPR experiment is contingent on the transition of electron 
spin states between discrete energy levels induced by the oscillating magnetic dipole component 
of microwave radiation. The process is quantum mechanically similar to nuclear magnetic 
resonance (NMR) which observes transitions between energy states of nuclei. As will be 
discussed below, the fundamental requirement for observing these transitions in EPR is having an 
unpaired electron (193). Detection of these signals furthermore requires an external magnetic 
field. Free radical species and transition metals that possess an unpaired electron, such as Cu2+ 
and Mn2+, demonstrate unique EPR signals. In a biological context, the incorporation of stable 
free radicals, such as a nitroxide spin label, is often necessary to introduce an unpaired electron. 
The sensitivity of the free electron to the molecular environment allows the spectroscopist to 
interpret EPR spectra as reporting specific interactions that may include neighboring nuclei and 
molecular structure. The following description briefly elaborates on the processes that give rise to 
electronic transitions, as well as those that influence the lineshape of absorption signals.  
Electron spin state transitions in a magnetic field 
 The physical property of charge in addition to quantized spin angular momentum confers 
the electron with a permanent magnetic moment. As illustrated below, this magnetic moment is 
the basis for the behavior of an electron in an external magnetic field (Ho) and, therefore, the 
spectroscopic investigation of electron spin dynamics. The energy of interaction between the 
electron and Ho along the z-direction can be described by the Hamiltonian 
  H  =  −𝜇𝑧𝐻𝑜 (1) 
in which µz is the electron magnetic moment. This mathematical statement can be rewritten to  
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  H = 𝑔𝐵𝐻𝑜𝑆𝑍 (2) 
which emphasizes the direct dependence of the interaction energy on the electron spin quantum 
operator, Sz. In Equation 2, g is the dimensionless electron g factor and B is the electron Bohr 
magneton, both of which are known constants. For the electron, the Sz operator yields spin 
eigenvalues (MS) that are ±½. From the Pauli Exclusion Principle, no two electrons can possess 
the same value of MS if occupying the same orbital. Thus, if an electron is paired with another 
electron, the spin angular momentum is canceled and cannot contribute to the magnetic moment 
(193,194). Therefore, paired electron spins are said to be diamagnetic or EPR "silent". For 
unpaired electrons, the values of Ms lead to Zeeman interaction energies of either -½gBHo (α 
state) or ½gBHo (β state) according to Equation 2. In an ensemble of unpaired electrons, the spins 
will either occupy the α (lower energy) state or the β (higher energy) state. Those spins which 
occupy the α state are said to be parallel to (or align with) the magnetic field, whereas those in the 
β state are antiparallel. The difference in energy (∆E) between these two states is given by 
  ∆𝐸 = 𝑔𝐵𝐻𝑜 = ℎν (3) 
where h is the Planck constant and ν is the frequency of electromagnetic radiation. Importantly, 
this equation indicates that these two energy states are degenerate outside of a magnetic field. 
That is, there is no measurable difference between the two energy states in the absence of Ho. In 
addition, the separation between the two states will increase proportionally to the strength of the 
magnetic field. Furthermore, when the magnetic moment of an impinging oscillating field of 
electromagnetic radiation (hν) matches the separation of the energy levels, known as the 
resonance condition, the spins from one state will absorb this energy leading to a transition to the 
other state (193,194). A diagram depicting this behavior of electron spins in a magnetic field is 
shown in Figure 13. 
 This stimulated transition can be accomplished in one of two ways. As in a NMR 
experiment, the frequency of electromagnetic radiation to induce a transition can be interrogated  
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Figure 13. Behavior of an electron spin ensemble in a magnetic field. In the absence of a 
magnetic field, electron spins will orient randomly (bottom left) and their energies are similar. 
When a field is applied, the spins will align with (α) or against (β) the field, resolving energetic 
differences between spin states. The α state is only slightly more populated than the β state. 
 
 
at a constant magnetic field strength (159). Alternatively, an EPR experiment typically holds the 
frequency of radiation constant while scanning the magnetic field (193). From the resonance 
condition described in Equation 3 above, the electronic transition will occur with an 
electromagnetic radiation frequency of 9.5 GHz at a magnetic field strength of 0.34 Tesla (or 
3400 Gauss). This frequency, known as X-band, corresponds to the microwave region of the 
electromagnetic spectrum and is the predominate regime applied in EPR spectroscopy (193). 
 The stimulated transitions have an equal probability of resulting from an electron moving 
from the α state to the β state, or from the β state to the α state. This elicits the fundamental 
question of how an absorption signal is detected. At thermal equilibrium, relaxation processes 
(that will be discussed in detail in a subsequent section) dictate that an excess of spins occupy the 
α state (Figure 13). The population of spins in each energy level can be described by the 
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Boltzmann distribution in which the spin population ratio of the states is a temperature-dependent 
exponential function of ∆E 
   
𝑁𝛼
𝑁𝛽
= 𝑒(∆𝐸/𝑘𝑇) (4) 
where Nα and Nβ represent the populations of state α and state β, k is the Boltzmann constant and 
T is the absolute temperature (193,194). Using this expression, it can be calculated that Nα/Nβ for 
electron spins is ~1.0046 at a temperature of 293K and a 1 Tesla magnetic field, indicating that 
the lower energy α state is only slightly more populated than the higher energy β state. Therefore 
a net excitation of spins from the α state to the β state results in the appearance of a single 
absorption line. Equation 4 establishes the sensitivity of the EPR measurement as only those spins 
that contribute to the population difference between the states give rise to the signal. However, 
Equation 4 also indicates that the signal intensity, which is directly proportional to the induced 
polarization of spins, can be increased by either lowering the temperature or increasing the 
magnetic field strength, or a combination of both.  
Hyperfine interactions 
 The preceding discussion focused on the interaction of a "naked" electron in a magnetic 
field that could be sufficiently described by the Hamiltonian in Equation 2. However, some 
atomic nuclei also possess a permanent magnetic moment arising from nuclear spins with 
nonzero angular momentum. The presence of two (or more) particles with magnetic moments 
gives rise to specific interplays between spins that alter the energetic interaction of the electron 
with the magnetic field (193,194). In the case of nitroxide spin labels, the unpaired electron is 
located in a π-like orbital between the nitrogen and oxygen bond, predominately residing near the 
nitrogen nucleus. The spin quantum operator, Iz for the 14N nucleus results in eigenvalues (MI) of 
±1 and 0, leading to three spin states characterized by nuclear Zeeman interaction energies 
±1gnBnHo and 0gnBnHo (i.e., the associated interaction energy for the MI=0 state is zero). Here, 
the subscript n refers to the nuclear g factor and nuclear Bohr magneton. These spin states couple 
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to the spin states of the free electron introducing hyperfine interactions into the spin Hamiltonian 
and re-defines the resonance condition. To a first approximation (193,194), the complete spin 
Hamiltonian is: 
  H = 𝑔𝐵𝐻𝑜𝑆𝑧 − 𝑔𝑛𝐵𝑛𝐻𝑜𝐼𝑧 + 𝐴𝑜𝑆𝑧𝐼𝑧 (5) 
In this equation, Ao is the isotropic hyperfine coupling constant which defines the interaction 
energy between the unpaired electron and the 14N nucleus. The result of Equation 5 is that the 
energy levels sampled by the electron are further split, which gives rise to the approximate energy 
level diagram depicted in Figure 14.  
 
 
 
Figure 14. Resonance condition including hyperfine interactions. The presence of a permanent 
magnetic moment from the 14N of a nitroxide spin label increases the number of available spin 
states. Quantum selection rules dictate three electronic transitions, as shown with the associated 
energies, resulting in three absorption lines in the EPR spectrum. 
 
 
 From the diagram above, it is apparent that the electron can occupy one of six spin states 
as opposed to two spin states of the "naked" electron: three in the α state (MS = -½, MI = ±1, 0) 
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and three in the β state (MS = ½, MI = ±1, 0). Likewise, this leads to six potential electronic 
transitions. However, the conservation of angular momentum during the interaction of microwave 
radiation with the electron demands selection rules for induced transitions, ∆MS = ±1 and ∆MI = 
0, which means that sufficient energy leading to absorption can only change the spin state of the 
electron and not the nucleus (193,194). Therefore, there are only three quantum mechanically 
"allowed" transitions, as illustrated in Figure 14 with the associated energies derived from 
Equation 5. These transitions correspond to three absorption lines of equal intensity separated by 
the hyperfine coupling constant Ao in the EPR spectrum.  
The orientation dependence of the g and A tensors 
 In the preceding treatment, it has been assumed that the g factor in the spin Hamiltonian 
of Equation 5 takes on the unique value of the free electron g factor (2.0023) and the hyperfine 
coupling constant arises from purely isotropic interactions with the 14N nucleus. In many cases, 
the g factor does not take on this value resulting in a shift in the resonance position. In a nitroxide 
spin label, an additional component to the electron magnetic moment arises from the coupling 
interaction between the electron spin angular momentum and orbital angular momentum. This 
interaction must be considered for unpaired electrons that occupy non-spherical orbitals where the 
electron and nuclear g factors and Ao are not purely isotropic (193). The spin-orbit interaction is 
facilitated by a local magnetic field induced by the interaction of the orbital angular momentum 
with the external magnetic field, which alters the overall field experienced by the electron such 
that  
  𝐻𝑒𝑓𝑓  =  𝐻𝑜  + 𝐻𝑙𝑜𝑐𝑎𝑙  (6) 
where Heff represents the effective magnetic field at the electron. The presence of local magnetic 
fields (Hlocal) affect the electron Zeeman energies analogous to that observed in NMR with the 
appearance of chemical shift for atomic nuclei in non-identical chemical environments (159). 
Therefore, deviations in both the g factor and Ao can be expected. It is helpful to consider a 
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coordinate axis system that describes Heff relative to the electron (Figure 15). In this system, the 
z-axis is taken along the direction of the localized electron and θ/φ are the angles between the Heff 
vector and z-axis and x-axis, respectively (193).  
 Both the g factor and Ao are best represented as symmetric tensors that demonstrate the 
relationship between the magnetic field vector and the electron spin vector and between the 
electron spin vector and the nuclear spin vector that includes components from all directions 
along the Cartesian system set up in Figure 15. For instance, the principle value gxx of the g tensor 
 
 
 
Figure 15. Coordinate axis defined for the nitroxide. The z-axis direction is taken along the 
unpaired electron (colored orbitals). The Ho vector is defined relative to the z axis (A) and x-y 
plane (B) by angles θ and ϕ, respectively. 
 
 
describes the g factor of the electron along the x-axis of the magnetic field. In a purely isotropic 
system, the principle values of these tensors (i.e., the diagonal of the matrix) are identical: gxx = 
gyy = gzz and Axx = Ayy = Azz. However, in a nitroxide spin label these values are different 
(anisotropic), emphasizing the dependence of these values on the orientation of the nitroxide in a 
magnetic field (193). As a result, an orientation-dependent function of the observed g factor and 
Ao can be shown to be  
  𝑔𝑒𝑓𝑓 = 𝑔𝑥𝑥𝑠𝑖𝑛2𝜃𝑐𝑜𝑠2𝜑 + 𝑔𝑦𝑦𝑠𝑖𝑛2𝜃𝑠𝑖𝑛2𝜑 + 𝑔𝑧𝑧𝑐𝑜𝑠2𝜃  (7) 
  𝐴𝑒𝑓𝑓 = [𝐴𝑥𝑥2 𝑠𝑖𝑛2𝜃𝑐𝑜𝑠2𝜑 + 𝐴𝑦𝑦2 𝑠𝑖𝑛2𝜃𝑠𝑖𝑛2𝜑 + 𝐴𝑧𝑧2 𝑐𝑜𝑠2𝜃]1/2 (8) 
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where geff and Aeff represents the effective g factor and hyperfine coupling constant. Therefore, 
the observed EPR spectrum is a function of the orientation of the nitroxide spin label in the 
magnetic field.  
 
 
 
Figure 16. First derivative EPR spectra of motional extremes. (A) The fast motion limit due to 
rapid reorientation of a nitroxide in solution. (B) The EPR spectrum approaching the "rigid" limit 
resolving components along all directions in the magnetic field. Both spectra were simulated 
using standard g and A tensor values in the program MatLab. 
 
 
 In an ensemble of randomly oriented (and static) spin labels, such as in a crystalline 
powder, the absorption of microwaves while scanning the magnetic field will yield an EPR 
spectrum that is the sum of all possible orientations (194). Because the nitroxide is held 
motionless, this EPR spectrum represents the "rigid" limit or no motion EPR spectrum (Figure 
16B). However, in dilute solution the principle values of both the g and Ao tensors are time-
averaged due to rapid reorientation of the label relative to the magnetic field. In this case, geff and 
Aeff is equal to 
   𝑔 = 𝑔𝑥+𝑔𝑦+𝑔𝑧 
3
 (9) 
  𝐴𝑜 = 𝐴𝑥+𝐴𝑦+𝐴𝑧 3  (10) 
which yields three evenly-spaced narrow lines centered about the average g factor that is 
orientation independent (194). This EPR spectrum is classified as the "fast motion" limit (Figure 
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16A). Importantly, this indicates that the rate of reorientation influences the EPR spectrum. As 
will be seen later in this chapter, spectra that sample a range of lineshapes are informative about 
the local molecular structure that may restrict the reorientation rate of the spin label. 
Relaxation processes and lineshape 
 As previously stated, the slightly larger population of spins occupying the lower energy α 
state at equilibrium is the basis for net absorption of microwave radiation (193,194). However, 
the electron spin states are energetically equivalent in the absence of a magnetic field. This elicits 
the question of how the net polarization is achieved once an ensemble of electron spins is placed 
in a magnetic field. In a bulk ensemble of electron spins, some spins will occupy the α state and 
some will occupy the β state collectively contributing to a bulk magnetic moment vector, M. In 
the absence of a magnetic field, the degeneracy of both spin states drives M to zero (i.e., M is 
proportional to the population difference of spin states). However, an applied uniform magnetic 
field along the z-direction results in a time-dependent shift in M due to an alteration of the 
population of spin states and is described by the Bloch equation:   
  
𝑑𝑀𝑍
𝑑𝑡
= 𝑀𝑜−𝑀𝑧
𝑇1
 (11) 
In Equation 11, Mz is the initial bulk magnetization along the z-direction in the absence of a 
magnetic field and Mo is the bulk magnetization at thermal equilibrium achieved after a time T1 in 
the presence of an applied magnetic field (193,194). After the time T1, the population of spin 
states is described by the Boltzmann distribution and the net magnetization vector aligns with the 
direction of the applied magnetic field. Therefore, T1 describes how fast M aligns with the 
magnetic field direction. 
 The processes involved in the T1 mechanism induce an exponential decay of non-
radiative energy transfer from excited spin states to the surroundings (lattice), which is known as 
spin-lattice relaxation or longitudinal relaxation (193,194). The value of T1 reflects the degree of 
coupling between all electron spins (or nuclei) in the field to the surrounding environment. The 
55 
 
shorter the T1 time, the stronger the coupling that leads to faster relaxation. This pathway, which 
for instance exchanges excited spin states into molecular rotations and vibrations within the 
lattice (193), is also a critical component of achieving a ground energy state following microwave 
absorption. In the absence of spin-lattice relaxation, the populations of the spin states would 
equalize when excited by microwaves. The resulting saturation of spin states eliminates the net 
polarization required for absorption; thus, the EPR signal disappears. However, if T1 is 
sufficiently long, population saturation can still be achieved by high microwave powers which 
enhance α→β transitions  (193). This is the fundamental basis of power saturation experiments 
that will be discussed later in this chapter. 
 Equation 11 defines the interdependence between the net magnetization in a magnetic 
field to the spin-lattice relaxation. Therefore, thermodynamic equilibrium characterized by the 
Boltzmann distribution of spin states cannot be obtained in the absence of relaxation. That is, the 
bulk magnetization will decay to zero in the absence of relaxation processes even in the presence 
of a magnetic field. If T1 were not present, the change in Mz with respect to time would be zero 
(193). However, M is a vector quantity and is fully described by components along the x and y-
axis (Mx and My). In addition, M also possesses a bulk angular momentum originating from the 
ensemble of electron spin angular momenta. Thus, the applied magnetic field exerts a torque on 
the bulk spins causing M to precess about the magnetic field direction like a gyroscope (Figure 
17) (159,193,194). In contrast to Mz in the absence of relaxation, this precession is defined by 
time-dependent changes in the Mx and My magnetization components and the frequency of 
precession is referred to as the Larmor frequency. The following Bloch equations describe the 
behavior of the transverse components Mx and My in the presence of relaxation: 
  
𝑑𝑀𝑥
𝑑𝑡
= 𝛾𝐻𝑜𝑀𝑦 − 𝑀𝑥𝑇2  (12) 
  
𝑑𝑀𝑦
𝑑𝑡
= −𝛾𝐻𝑜𝑀𝑥 − 𝑀𝑦𝑇2  (13) 
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where γ is the electron gyromagnetic ratio (=2πgB/h). Whereas relaxation induces a T1-dependent 
transition of Mz→Mo (Equation 11), relaxation causes the Mx and My components to go to zero. 
However, this relaxation process is different from T1 due to different mechanisms characterized 
by a T2 relaxation time (159,193). The T2 time describes the rate of signal decay in the transverse 
(x-y) plane. 
 Unlike T1 relaxation, the T2, or transverse, relaxation mechanism does not alter the 
population of spin states because it does not operate on the Mz component of the bulk magnetic  
 
 
 
Figure 17. Precession of electron spins in a magnet. An external magnetic field interacts with the 
bulk angular momentum from a spin ensemble causing the spins to rotate about the magnetic field 
direction. The precession of spins causes the x and y components of the vector M to cancel, 
leaving only the z component. The net magnetization (Mo) along the z-axis results from having a 
greater population of spins in the lower energy α state aligned with the direction of Ho.  
 
 
moment. Typically, T2 relaxation is referred to as spin-spin relaxation, which qualitatively 
describes either dipolar interaction or collision with neighboring spins (159,193). These 
interactions facilitate mutual spin "flips" or reorientation of the spin magnetic moments, which 
transfers energy to the individual spins and not the lattice. Therefore, there is no net exchange of 
energy to the lattice. Both relaxation mechanisms contribute to the observed EPR lineshape.  
 Continuous irradiation of microwaves, such as in continuous wave (CW) EPR, along the 
axis perpendicular to the magnetic field Ho generates a steady-state magnetization behavior in the 
57 
 
spin ensemble. The solution to the Bloch equations, which takes into account the perturbing 
interaction of the oscillating microwave field, reveals an absorption line that has the form of a 
Lorentzian function (193,194). The full width at half height of the lineshape is inversely 
proportional to 1/T2. Therefore, faster T2 times lead to broader lineshapes. However, the T1 
relaxation pathway prevents infinitely narrow absorption lines by establishing finite lifetimes for 
excited states. Both relaxation mechanisms are critical to signal generation as only a portion of 
the ensemble of spins contributes to the absorption of microwaves per unit of time. Outside of 
these processes, few technical applications can be employed to enhance the EPR signal. Among 
these, decreasing the absolute temperature or increasing the magnetic field strength has already 
been mentioned. In the absence of narrowband microwave signal detectors, a common EPR 
scheme to enhance sensitivity employs magnetic field modulation in combination with phase-
sensitive detection which effectively filters out noise (193). The result of this detection scheme is 
an EPR lineshape that is the first derivative of the absorption signal.  
 
Strategy of site directed spin labeling 
 A chief focus in structural biology is the identification of the molecular determinants 
governing the construction of complex assemblies, ligand/inhibitor interactions and enzymatic 
reactions. A fundamental understanding of how these and other elements are linked together to 
drive critical biological processes demands focused investigation to probe the structure/function 
relationship. Obtaining a picture, preferably one at atomic resolution, often represents a milestone 
in this endeavor. Yet the challenge is to not only define the spatial relationship of structural 
elements, but to elucidate their relative contributions to a functional process. Importantly, the 
experimental means by which molecular machinery are interrogated sets boundaries on the 
answers to an ever-deepening well of relevant questions. For instance, at its very best x-ray 
crystallography can define molecular architecture under a given set of conditions. However, this 
structural "snapshot" can only stimulate hypotheses regarding a mechanism of action.  
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 The information gap between a protein of known structure and a mechanism is the 
dynamic fluctuations in the structure that facilitate functional activity. Structural dynamics may 
lead to the formation of stable intermediate states related to a conformational cycle. One approach 
to address this issue is to crystallize the protein in a different set of conditions that putatively 
favor a different conformational intermediate. Whereas the identification of the exact conditions 
may be an experimental bottleneck, some dynamic features may remain unresolved due to a non-
unique spatial position of loop regions or by constraining crystal lattice forces. Trapping specific 
conformations with inhibitors may yield an altered conformation, but it is difficult to interpret this 
data in the context of a functional cycle.  
 Spectroscopic techniques are a viable alternative to deciphering the role of both structure 
and dynamics in protein activity. Specifically, EPR spectroscopy offers many advantages over 
more popular techniques such as crystallography and NMR spectroscopy. Crystallography 
typically demands high protein concentrations (mg quantities) and conditions conducive for the 
formation of an ordered crystal lattice (192). These conditions most likely will not resemble the 
normal biological medium sampled by the protein. Although NMR is sensitive to dynamic 
processes, the ability to observe sharp resonance lines decreases with increasing molecular size 
due to slower rotational correlation times and enhanced T2 relaxation rates (159). However, 
sophisticated pulse sequences and magnetic resonance techniques, such as transverse relaxation 
optimized spectroscopy (TROSY) and paramagnetic relaxation enhancement, provide a means of 
determining structural restraints of macromolecules approximating 100 kDa. This is illustrated by 
the recent solution NMR structure of diacylglycerol kinase (195). In EPR, proteins of arbitrary 
size can be investigated in more native-like environments with structural resolution at the level of 
the backbone fold (196,197). In addition, EPR does not demand large sample preparations, 
requiring as little as ~100 pmol of labeled protein. As mentioned in the previous section, the 
fundamental requirement of EPR spectroscopy is having an unpaired electron. The presence of 
unpaired electrons in a biological system represent a potent redox hazard in the cell (superoxide, 
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for instance). Thus, free radicals are a transient species in a healthy biological system. Nitroxide 
spin labels are stable free radicals that are commonly introduced into a protein sequence and used 
to report specific parameters that characterize the microenvironment of the spin label side chain 
(198-200). Changes in these parameters are often correlated to the intrinsic protein dynamics 
related to functional activity. The following discussion highlights methods in EPR used to extract 
fine structural detail.  
Incorporation of nitroxide radicals 
 Most commonly, a site for introduction of a nitroxide spin label in a protein sequence is 
created by site directed cysteine mutagenesis (200). The sulfur moiety of the cysteine is 
subsequently used as the site of nitroxide attachment with a sulfhydryl-specific spin label probe. 
This reaction scheme is often achieved by methanethiosulfonate derivatives as depicted in Figure 
18. In theory, spin labels can be incorporated at any site along a peptide chain using this method, 
although labeling sites with restricted access (buried sites) may require modifications of the 
protocol. This procedure typically requires initial mutations to remove native cysteine residues to 
control for label placement (200). Recently, Fleissner and colleagues described a method of 
incorporating a genetically encoded unnatural amino acid which is subsequently reacted with 
hydroxylamine reagent to generate the nitroxide moiety (201). This would seem to eliminate the 
need of cysteine mutagenesis and potentially expand the application of EPR to those molecules 
that possess cysteine residues required for function. Experimentally, labels are introduced one at a 
time in a protein sequence. As a result, the EPR method is labor intensive requiring many spin 
labeled mutants to fully characterize structure and dynamics. Although most EPR methods call 
for only a single site for incorporation, it is appropriate under certain circumstances to incorporate 
a second site to measure the strength of dipolar coupling between labels (discussed in a 
subsequent section). Because site directed spin labeling requires the incorporation of extrinsic 
labels, it is important to ascertain the structural and functional integrity of mutant proteins. This 
analysis should occur at two stages: following mutagenesis and after subsequent nitroxide  
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Figure 18. Site-directed spin labeling. Targeted Cys mutagenesis introduces a sulfhydryl moiety 
for the attachment of a nitroxide spin label, R1. This procedure requires the conversion of native 
Cys residues to non-reactive residues. 
 
 
modification. Assessing the activity of the protein in this manner deconvolutes the specific 
contribution of cysteine mutagenesis and/or labeling to alterations in function. Nevertheless, a 
systematic study of T4 lysozyme structure and function after labeling indicated that core locations 
or sites directly involved in function significantly alter the activity (202). Furthermore, labeling of 
core residues was found to be the most perturbing as measured by thermal denaturation studies. 
However the induced thermodynamic perturbations were at the level of those found for natural 
amino acid substitutions. Protein surface sites not directly related to the binding site of T4L 
tolerated the spin label with little thermodynamic and functional perturbation. Another 
consideration is the labeling efficiency which may influence the interpretation of both structural 
and functional data. As will be discussed, labeling efficiency is a crucial element in the 
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interpretation of broadened EPR spectra due to dipolar coupled spin labels. Furthermore, the 
correlation between labeling efficiency and functional activity may provide insight into the 
perturbing effects of spin labeling.  
EPR parameters: spin label mobility 
 The applicability of the nitroxide probe to the determination of local structure originates 
with the sensitivity of the spin label to its orientation in a magnetic field. In brief, a sweep of the 
magnetic field under constant microwave irradiation will induce absorption at three resonance 
positions determined by the electron g factor and is reported in the first derivative lineshape of the 
EPR signal. The intrinsic anisotropy of the g and Ao tensors allows for a range of lineshapes to be 
observed with boundaries characterized by two motional extremes. Hence the rate of motion of 
the nitroxide in the magnetic field impacts the observed lineshape. This is illustrated in Figure 19 
for an array of rotational correlation times (τc), assuming isotropic rotational diffusion along all 
the principle axes of the magnetic field frame of reference (i.e. the nitroxide tumbles in all 
directions without preference). The fast motion limit is achieved when τc ≅ 0.01 ns. As τc 
increases, the rotation of the nitroxide decreases and the time averaging of the g and Ao tensors is 
reduced which broadens the EPR spectrum (bottom right spectrum of Figure 19).  
 This principle of nitroxide motional averaging is generally applicable to spin labels that 
are attached to a polypeptide chain. However, the motional degrees of freedom are complicated 
by the modification. An attached spin label no longer tumbles freely in solution as it is now 
coupled to the motion of the protein. Therefore, the EPR lineshape is reflective of the available 
degrees of motional freedom of the attached spin label as well as the dynamic properties of the 
tumbling macromolecule (203). Specifically, the overall tumbling rate of the protein, local 
dynamic fluctuations of the backbone to which the nitroxide is attached and the intrinsic rotation 
of the spin label about the bonds that tether the probe to the protein contribute to the spin label 
dynamics observed in the EPR lineshape. For large macromolecules (>50 kDa), such as 
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membrane proteins, the overall rate of protein tumbling is too slow (τc ≅ 10-8 s or slower 
depending on solution viscosity) to have an effect on the EPR spectrum (10-11-10-9 s timescale, 
Figure 19) (196,202). Therefore, the motion of the spin label side chain is largely dictated by 
bond rotations and backbone dynamics. Separation of these two variables requires a full 
simulation of the EPR lineshape (203,204).  
 
 
 
Figure 19. The EPR lineshape depends on the spin label rate of rotation. Slower reorienation 
rates of a nitroxide causes broadening of the resonance lines, which increases the breadth of the 
EPR spectrum. Lineshapes were simulated using standard g and A tensor values in the program 
MatLab. Special thanks to Dr. Richard Stein for help with generating the simulations. 
 
 
 The spin label R1 in Figure 18 is the most commonly used in EPR studies of proteins due 
to the high reaction selectivity for cysteine sulfhydryls and its relatively small size (on the order 
of a Trp side chain) (200). A detailed analysis of this particular nitroxide side chain suggested 
that intrinsic spin label rotation is largely limited to Cε—Cζ and the Cε—Sδ bonds (202). Rotation 
about the disulfide linkage is restricted by a sufficiently large energy barrier ( ≥ 7 kcal/mol). Also, 
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rotation about the Sγ—Cβ is negated by interaction of the Sγ atom with the Cα hydrogen, which 
was subsequently supported by crystallographic analysis of spin labeled T4 lysozyme. 
Importantly, these observations suggest that the chemical structure of the nitroxide side chain will 
impact the EPR lineshape. Mchaourab et al demonstrated several cases where the lineshape is 
modulated by different side chain structures that alter specific interactions with the backbone and 
nearest neighbor residues (205).  
 
 
 
Figure 20. Correlation of spin label mobility with site of attachment. Spin labels attached to the 
backbone of flexible loops (pink dots) demonstrate high mobility characterized by a narrow 
central line and second moment. In the other extreme, buried spin labels (yellow dots) exhibit 
slow motion as described by larger values of both parameters. Intermediate values typically 
reflect contact interactions (green dots). The figure was adopted from Ref 196. 
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 Besides the structure of the side chain, Mchaourab and coworkers showed that spin label 
dynamics are contingent on the local molecular structure of the protein (202). In studies using the 
R1 spin label and T4 lysozyme as a model, attachment to different structural elements led to 
distinct lineshapes. The results suggested that a phenomenological analysis of the EPR central 
line width (∆H) or the spectral second moment ( ˂H2˃ , represents the breadth of the spectrum) 
could qualitatively differentiate between spin labels attached to buried, surface or loop sites as  
well as those in tertiary interaction with structural elements. These terms established a general 
correspondence between the local structure of the protein and the "mobility" of the spin label. As 
the mobility (which refers to the collective motions of the label) of the probe increases, both the 
∆H and the ˂ H 2˃ decreases as reflected by an increase in signal amplitude and narrowing of the 
three resonance lines. Plotting the inverse ˂H2˃ as a function of the inverse ∆H demonstrated a 
linear increase in spin label mobility from buried to loop sites (Figure 20) (202). The mobility of 
the spin label can thus be used to report structural characteristics of the immediate surroundings. 
Furthermore, the exquisite sensitivity of the probe to the environment allows detection of 
conformational changes that may be associated with function through changes in lineshape. 
EPR parameters: spin label solvent accessibility 
 The placement of a spin label in a protein not only leads to a "fingerprint" of the local 
structure manifested in the EPR spectrum, but may also result in differential accessibility of the 
spin label to solvent (197,200). This adds a new dimension to the spectroscopic analysis and 
effectively increases the structural resolution of the EPR technique. Recently, a pulsed EPR 
method has been utilized to determine the accessibility of a nitroxide probe to water within a 
membrane protein (206). This method relies on proton modulation of the time-dependent echo 
decay of the EPR signal to estimate the number of water molecules in close (3-6Å) vicinity. 
However, the most common method of determining spin label solvent accessibility is by 
measurement of the collision frequency of the spin label with a diffusing paramagnetic reagent 
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using a conventional CW-EPR method (207). This method is based on Heisenberg exchange 
where a bimolecular reaction between two unpaired electron species results in a swapping of spin 
orientations. That is, if an unpaired electron possessing the β state energy (eβ
1) collides with 
another unpaired electron in the α (eα
2) state, the electron spin exchange process dictates that 
(eβ1)→ (eα1) and (eα2)→ (eβ2).  
 The protocol yields a dimensionless parameter, Π, which is directly proportional to the 
Heisenberg exchange rate (Wex). This exchange rate is also directly proportional to the 
concentration of the collisional reagent and a rate constant which is coupled to the diffusion rate 
of the paramagnetic species: 
  Π = 𝛼𝑊𝑒𝑥 = 𝑘𝑒𝑥𝐶𝑟~𝐷𝑟 (14) 
where α is a proportionality constant, kex is the exchange rate constant, Cr and Dr is the 
concentration and diffusion rate constant of the paramagnetic collisional reagent, respectively 
(207). Equation 14 indicates that in the absence of diffusion Wex cannot be measured and, 
therefore, Π is undetermined. Ideally then, the collisional reagent should be a small, water soluble 
compound with a high diffusion rate to ensure a strong exchange interaction (207). Both 
Ni(II)ethylenediamine diacetic acid (NiEDDA) and molecular oxygen (O2) possess these 
properties and are commonly used collisional reagents. Because Wex is related to changes in T1, 
experiments that exploit the coupling of the spin label to the surrounding environment (lattice) 
will provide insight to the exchange interaction. In practice, Π is usually determined from power 
saturation of the EPR signal (207). Because nitroxides have slow relaxation times (T1 ≈ 1µs), 
increasing the microwave power will lead to saturation of the α/β spin states (i.e. the spin 
populations are equalized) and the EPR signal will disappear (Figure 21). The chosen collisional 
reagent will possess a fast T1 time relative to the spin label and, upon collision, an excited 
nitroxide electron will transfer its energy to the fast-relaxing compound. The net effect of this 
process is that T1 for the nitroxide appears to get shorter and saturation of the EPR signal is 
impaired. Plotting the central line amplitude of the EPR spectrum as a function of the square root  
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Figure 21. Correlation of power saturation curves with spin label environment. (A) Increasing the 
microwave power increases the transitions from the α state to the β state, which increases the 
signal amplitude (gray box). In the absence of relaxing agents, high microwave powers will 
equalize the spin states resulting in a power-dependent decrease in signal intensity (also shown in 
N2 controls in (C-D). (B) The differential solubility of fast-relaxing paramagnetic reagents 
(NiEDDA and O2) allows the unique determination of spin label environment. (C) The high 
NiEDDA accessibility at site 480 in LeuT relative to O2 and N2 control determined from power 
saturation curves suggests a water exposed position of the spin label. (D) In contrast, the high O2 
accessibility at site 488 indicates that the spin label samples the lipid phase. An approximate 
membrane-water interface for LeuT is outlined by an orange box in (B). Power saturation curves 
are fit using a non-linear least squares algorithm as described in the Experimental Methods of 
Appendix B. The LeuT PDB code 2A65 is shown in (B). 
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of the microwave power results in a saturation curve which describes the EPR signal behavior in 
absence and presence of a fast-relaxing reagent. 
 The power saturation curve is described by the parameter P1/2, which is obtained from a 
non-linear least squares fit of the data. P1/2 is the microwave power required to achieve half of the 
unsaturated EPR signal amplitude and this number is used to calculate the value of Π (207). The 
value of P1/2 is determined in the absence and presence of a fast-relaxing species, which are then 
used to determine ∆P1/2. Furthermore, three factors influence P1/2: the T1 time (see above), the T2 
(spin-spin relaxation) time and a variable (Λ) that describes the efficiency of the EPR resonator 
(207). Essentially, Λ describes the variability of instrument response and can be properly 
accounted for by determining the P1/2 of a known standard. Wex is also related to changes in the T2 
time and, because T2 impacts the EPR signal line width, the presence of a fast-relaxing agent can 
lead to Lorentzian line broadening (208). As shown in Equation 15, isolation of the T1 component 
of the power saturation curve is achieved by dividing ∆P1/2 by the peak-to-peak central line width  
(∆Hpp) of the EPR spectrum to remove contributions of T2 relaxation. This value is subsequently 
normalized by a standard to remove instrument bias (207).  
  Π = � ∆𝑃12∆𝐻𝑝𝑝�
�
𝑃1
2
∆𝐻𝑝𝑝
�
𝑟𝑒𝑓
 (15) 
In general, there is a direct correlation between the mobility and accessibility of the spin label. 
That is, high spin label accessibility is often degenerate with high spin label mobility, such as 
observed in exposed loop regions. Importantly, the absolute value of Π, as shown in Equation 14, 
is a function of the concentration of the collisional reagent. Therefore, the structural interpretation 
of the accessibility values from multiple sites can only be realized from experiments using 
identical concentrations of the collisional reagent.  
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 A power of the accessibility measurement lies within its ability to identify secondary 
structural elements. If a structural element is asymmetrically solvated, the pattern of 
accessibilities revealed by a nitroxide scan along that element will be consistent with the 
periodicity (3.6 for α-helices; 2.0 for β-sheets) and phase of the polypeptide chain reflecting the 
three dimensional organization (197). Furthermore, the topological organization of membrane 
proteins can be investigated due to the differential solubility of NiEDDA and O2 in the lipid 
bilayer (209). A concentration gradient of O2 exists toward the center of the bilayer, while the 
concentration of NiEDDA in the lipid phase is very low. Hence, the pattern of NiEDDA and O2 
accessibilities will reveal the location of transmembrane segments as well as any solvent exposed 
connecting loops (Figure 21). In addition, the concentration gradient of O2 in the bilayer allows 
for the detection of tilt angles of transmembrane segments. Changes in the pattern of 
accessibilities have been correlated with structural dynamics (210,211). Other techniques based 
on chemical reactivity have also been shown to be informative about dynamic changes in protein 
structure, albeit with lower resolution. The information Π divulges about conformational changes 
initially may be considered analogous to that obtained by MTS reactivity experiments with native 
or engineered cysteines. "Accessibilities" from these experiments typically are inferred indirectly 
by changes in the MTS-induced protein inactivation rate in the presence of ligands (160,187). In 
contrast, spin label accessibility is determined directly because the value of P1/2 is a direct 
consequence of a physical interaction with a diffusing reagent usually without compromising 
structural or functional integrity. 
EPR parameters: distance-dependent dipolar coupling 
 The preceding discussion highlighted two spectroscopic parameters that define the local 
structural environment of the spin label. The sensitivity of these parameters confers the ability to 
measure distinct conformational changes within a protein, effectively discerning differences 
between specific environments. In addition to these site specific measurements, global structural 
constraints can be generated by measuring the energetic interaction between two spin labels. In 
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contrast to crystallography, distance-dependent spin-spin coupling establishes the spatial 
relationship of structural elements in solution. The value of this information is highlighted by 
recent computational studies demonstrating significant improvement of structural models 
generated by the de novo folding algorithm Rosetta by reducing the conformational search space 
(212). Furthermore, the information obtained from spin label mobility, solvent accessibility and 
dipolar coupling will uniquely define the three dimensional structure at the level of the backbone 
fold that can be directly compared to crystal structures (210,213).  
 Spin-spin interaction occurs at two levels distinguished by the specific coupling 
mechanism and each of these two mechanisms dominate in different distance regimes. As a result 
of the presence of two electron spins, the effective spin Hamiltonian must be modified to reflect 
changes in the energetic transitions.  
  H = 𝛽𝐻𝑜 ∙ 𝑔1 ∙ 𝑆1 + 𝛽𝐻𝑜 ∙ 𝑔2 ∙ 𝑆2 − 𝜔𝑛(𝐼𝑧1 + 𝐼𝑧2) + 𝛾𝐼1 ∙ 𝐴1 ∙ 𝑆1 
  +𝛾𝐼2 ∙ 𝐴2 ∙ 𝑆2 + 𝑆1 ∙ 𝐷 ∙ 𝑆2 + 𝐽𝑆1 ∙ 𝑆2 (16) 
In Equation 16, ωn is the Larmor frequency of the nitrogen nucleus, γ is the electron 
gyromagnetic ratio, D is the dipolar coupling tensor and J is a spin-spin exchange factor (193). 
The numerical superscripts designate the two electron spins. Spin-spin interaction via scalar J 
coupling occurs through chemical bonds, as probed in NMR spectroscopy, or through very close 
spatial interactions facilitated by orbital overlaps, such as in Heisenberg exchange described 
above (159,193). However, J coupling decreases exponentially with increasing distance and 
contributes little to the overall interaction beyond ~8Å (214,215). For spin labels, the length of 
the tether (~7Å) linking the nitroxide to the protein backbone precludes through-bond 
interactions. In the absence of direct orbital interaction, J coupling is generally disregarded.  
 The dipolar interaction term of Equation 16 represents through-space spin coupling 
between probes that can be measured from 8-70Å. In the absence of both dipolar and J coupling, 
Equation 16 reduces to a Hamiltonian that describes the sum of two non-interacting spins. The 
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energy of the dipolar interaction is inversely proportional to the cube of the distance (r3) and is 
dependent on θ which describes the angle between the external magnetic field and a line that 
joins the two spins (193,200,214). Equation 17 states the energetic relationship between two 
interacting dipoles (µ) and the distance between them. 
  𝐸 = 𝜇1𝜇2
𝑟3
(3𝑐𝑜𝑠2𝜃 − 1) (17) 
The sum of all orientations of both spin labels from parallel (θ=0°) to perpendicular (θ=90°) 
between the two dipole moments results in a composite Pake pattern in which the frequency of 
separation between the two peaks is proportional to r-3. A sum of Pake patterns is typically used  
as a broadening function in the analysis of EPR spectra demonstrating dipolar coupling (Figure 
22 and described below) (215). The dipolar interaction between nuclei is averaged to zero by 
isotropic motion in solution NMR, and is effectively removed by spinning the sample at the 
"magic angle" of 54.7° in solid state NMR (159). The angular dependence creates an inherent 
anisotropy of the dipole-dipole interaction. For freely moving spin labels, on a protein surface for 
instance, an isotropic distribution of θ is generally assumed which leads to simple models of 
analysis (215). 
 When the dipolar interaction is sufficiently strong (<20Å), spin-spin coupling 
significantly alters the EPR lineshape by broadening the spectrum (Figure 23). As a result the 
strength of the interaction can be assessed qualitatively from the degree of line broadening or 
measured directly by a variety of lineshape analysis techniques. If the two spin labels adopt a 
unique orientation, a full simulation of the EPR lineshape can extract the distance information 
(216). However, this is not normally the case. Approximations of the spin-spin distance can be 
made if the protein tumbles sufficiently slowly so as not to reduce contribution of the dipolar 
coupling to the EPR spectrum through rotational averaging of the interspin vector (196,217). 
Furthermore, approximations by Fourier convolution/de-convolution analysis of the spectral 
lineshapes assume that the dipolar interaction spectrum is a convolution of a non-interacting  
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Figure 22. Relationship between the angular-dependent dipolar interaction and the distance. (A) 
The energetic interaction between two magnetic dipoles is dependent on the distance r and angle 
θ. (B) The frequency of separation between the two peaks of the Pake pattern is inversely 
proportional to the distance at θ = 90°. The Pake patterns in (B) give rise to the distance 
distributions in (C). The broader, black-line Pake in (B) is associated with a shorter distance, 
indicating a stronger dipolar interaction. 
 
 
spectrum (obtained from the spectral sum of corresponding single mutants) with a Pake 
broadening function (215,218). The inherent flexibility of the nitroxide, and dynamics from the 
protein backbone, generally leads to a distribution of distances, which is plotted as a probability 
of a distance (P(r)) as a function of a given distance (r), as opposed to a singular distance. 
However, a "tether-in-a-cone" model has been developed that simulates the EPR spectrum of 
nitroxides and is beneficial for deciphering distance distributions that include specific label 
orientations from nitroxides that demonstrate a more ordered (slower τc) lineshape (216). Both of 
these approaches impose a Gaussian model upon the resulting distance distributions.  
 For distances above 20Å, the line broadening due to dipolar interactions (3-5 Gauss) can 
no longer be resolved because of the intrinsic width of the EPR lineshape (6-8 Gauss) (214). Yet 
spin-spin coupling can be probed with pulse EPR methods to extract distance information. This 
technique relies on the time-dependent spin echo decay in the transverse plane of the magnetic  
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Figure 23. Dipolar broadening of the EPR spectrum. Spin-spin interaction will broaden the EPR 
spectrum (red trace) if two spin labels are within 20Å of each other (arrows). The amount of 
broadening depends on the distance between the probes. The red trace has been multiplied by a 
factor of 20 to emphasize the outer intensities arising from the dipolar interaction relative to the 
sum of non-interacting spin labels (black trace). Data adopted from Ref 208. 
 
 
field following a series of microwave pulses designed to selectively excite two separate 
populations of spin labels (219). Double electron electron resonance (DEER) spectroscopy 
follows a four-pulse protocol shown in Figure 24A and the observe and pump pulses are 
qualitatively defined in Figure 24B. Recall that the magnetic moment of electron spins results in a 
bulk magnetization along the direction (traditionally taken along the z-axis) of the external 
magnetic field and these spins rotate about the field characterized by the Larmor precession 
frequency. To observe dipolar coupling requires perturbation of these spins at thermal 
equilibrium. This is achieved by a π/2 (90°) pulse of microwaves along the x-axis at a specific 
frequency to tip the bulk magnetization of the observe spins in the x-y plane. The decay of this 
magnetization back to thermal equilibrium (spin alignment along the z-direction) will contain the 
information regarding dipolar coupling and is a function of T1 (alignment along the z-axis) and T2 
(decay along x-y plane) relaxation. Following the π/2 pulse, the excited spins are briefly coherent 
along the x-axis; however, each spin experiences a slightly different magnetic field depending on 
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their coupling interactions which results in a slightly different precession frequency subsequently 
resulting in dephasing of the spins in the x-y plane (i.e. the spins fan out in either direction in the 
transverse plane away from each other). The spin echo, which contains the dipolar information, is 
formed by a π (180°) pulse which has the net effect of reversing the direction of the dephasing in 
the x-y plane (i.e. spins are moving toward each other instead of away from each other). The 
point at which the spins are transiently coherent corresponds to the peak of the first spin echo. 
However, we do not observe this echo. 
 
 
 
Figure 24. DEER pulse protocol and spin echo decay. (A) Standard four-pulse protocol for 
DEER spectroscopy. (B) The EPR absorption signal illustrating the positions of the pump and 
observe pulses. The pump pulse specifically excites an ensemble of spins that absorbs radiation at 
the central part of the spectrum. The effect of the pump pulse on the dipolar interaction is 
observed by the time-dependent behavior of the spin echo formed by a low field ensemble of 
spins (C). 
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 After the observe spin π pulse, a π pulse of microwaves is applied corresponding to the 
frequency of the pump spins (Figure 24). This has the effect of flipping the bulk magnetization of 
this spin ensemble (initially along +z-axis) in the -z direction, and this effect alters the magnetic 
field experienced by the observe spins that are dipolar coupled and, therefore, their behavior as  
they return back to thermal equilibrium. A final π pulse at the observe spin frequency re-focuses 
the perturbed spins into the observed spin echo. In the experiment, the position of the pump π 
pulse is moved incrementally defined by τ to determine how this pulse modulates the final 
observe spin echo. The data from the experiment is collected by plotting the amplitude of the 
observe spin echo as a function of τ. If the interaction is sufficiently strong, oscillations will 
appear in the DEER signal. The frequency (or frequencies) that characterize this time-dependent 
decay is related by r-3. The rate of signal decay to baseline is related to the width of the distance 
distribution. Importantly, the phase memory time, Tm, for the observe spins following 
perturbation limits the length of detection in the experiment. Tm is primarily a function of T2 
relaxation and can be extended by decreasing the absolute temperature. Because Tm is short for 
large proteins, a complete characterization of the echo decay requires lowering the temperature 
substantially, typically near liquid N2 temperatures (~80 K). Obviously at these temperatures the 
sample is frozen and the resulting distance distributions are considered to be a static 
representation of isotropically averaged distances between the probes (215,220). 
 To extract distance information, the DEER signal can be Fourier transformed into the 
frequency domain to obtain the corresponding dipolar (Pake) spectrum. However, the DEER 
signal can be directly analyzed by fitting routines, such as through a parameterized Gaussian 
model. In the absence of parameterization, it must be noted that obtaining distance distributions 
from the DEER signal is inherently complicated because the Fredholm relation (Equation 18) 
connecting the distance distribution P(r) to the experimental data V(t) is an ill-posed problem:  
  ∫𝐾(𝑟, 𝑡)𝑃(𝑟)𝑑𝑟 = 𝑉(𝑡) (18) 
75 
 
where K(r,t) is the ensemble average of dipolar coupling.  This means that a unique solution to 
the equation is not mathematically attainable. Tikhonov regularization, which directly simulates 
the time-domain data, has been shown to be a suitable method for approximating a unique 
solution to the Fredholm equation (221). This method is contingent on identifying an appropriate 
regularization parameter which stabilizes the Fredholm equation and balances the uniqueness of 
the fit with the smoothness of the distance distributions. Therefore, critical to the analysis are data 
sets that possess a good signal to noise ratio, else the regularization will introduce artificial peaks 
in the distance distribution.  
 The information obtained from measuring the distance-dependent dipolar coupling may 
be considered complementary to fluorescence resonance energy transfer in which the FRET 
efficiency demonstrates an r6 distance dependence. With the major caveat from both techniques 
that the distance measured is between probe centers and not the Cα or Cβ carbons, there are 
several advantages to the EPR technique. First, FRET is complicated in application due to 
problems with light scattering, especially in the context of lipid phases (215). Second, EPR only 
requires labeling at two sites with the same probe. Traditional FRET experiments require two 
different labels, a donor and an acceptor, whose optical properties are properly tuned for 
sufficient overlap of the donor emission and acceptor absorbance envelopes. Labeling efficiency 
of the acceptor probe is the major source of error in FRET because low acceptor labeling will 
lead to a decreased energy transfer efficiency which would translate to an artificially longer 
distance (139). To circumvent labeling problems, homotransfer FRET, which occurs between 
identical fluorophores, has been shown to be an accurate alternative (222). Similar to 
heterotransfer FRET, CW-EPR analysis of broadened lineshapes can be complicated by 
insufficient labeling. Because broadened lineshapes yield lower absolute intensities, the presence 
of singly-labeled sites can dominate the EPR spectrum through the larger amplitude lines. 
Because of this, lineshape analysis procedures must include additional parameters to account for 
the presence of non-interacting spins. In contrast, DEER spectroscopy is only sensitive to those 
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spins which are dipolar coupled and proteins that are underlabeled do not contribute to the 
intramolecular time-dependent echo decay.  
 Thirdly, FRET reports a single distance that assumes an average dipole orientation of the 
two probes (139). This can lead to substantial deviations in the accuracy of the FRET 
measurement (140). Although distance distributions, especially broad ones, from the EPR 
experiments emphasize the intrinsic difficulty of identifying a unique distance between probes, 
these distributions may be informative as to the dynamic nature of a particular conformational 
intermediate, a concept that is apparently well justified as discussed in the subsequent section. 
However, the local dynamics of the probe may also contribute to the width of the distribution 
depending on their relative orientation to each other (213,223). A qualitative assessment of 
changes in spin label dynamics with a given condition through changes in the EPR spectrum may 
indicate possible contributions to the width of the distribution. In some cases, it may be required 
to determine all possible rotameric configurations of the spin label to separate the contribution of 
probe dynamics from backbone fluctuations (224). In the following section, a brief summary of 
EPR applications to specific membrane proteins establish the power of the technique to define the 
nature, magnitude and direction of conformational changes in protein structure.  
Practical application of EPR spectroscopy to a primary active membrane transporter 
 EPR spectroscopy has been applied to a variety of protein systems to investigate 
outstanding questions regarding molecular structure and mechanism. Specifically, this method 
has been particularly insightful toward the structural dynamic basis of membrane protein 
functionality. Notable examples include studies of the photoactivation of bacteriorhodopsin, 
conformational changes in K+ channel homologs and structural transitions in the sugar transport 
mechanism of E. coli lactose permease (LacY) (191,225,226). An extensive experimental dataset 
including spin label mobility, solvent accessibility and DEER analysis has characterized the 
structure of MsbA in various intermediate states. MsbA is an E. coli membrane transporter that 
couples the movement of lipid A to ATP hydrolysis and belongs to a subgroup of ABC (ATP 
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binding cassette) transporters, which include human P-glycoprotein (210). Investigation of the 
structure and mechanism of membrane proteins in this class by multiple laboratories is driven in 
part their implicated role in multi-drug resistance.  
 Crystal structures of MsbA, which functions as a homodimer, have previously suggested 
the existence of different conformational states putatively associated with a thermodynamic cycle 
of substrate transport (227). In the absence of nucleotide, apo MsbA has been found to crystallize 
in a cytoplasmic open and closed conformation, suggesting large domain movements in the 
cytoplasm. In the presence of nucleotide, extensive interactions between the cytoplasmic 
nucleotide binding domains (NBD), the intracellular domains (ICD) and transmembrane domains 
(TMD) from each monomer closed off cytoplasmic access to the V-shaped cavity formed in the 
open apo structure. These movements also facilitated increased access from the extracellular side 
suggesting that this conformation represented an outward-facing state.  
 The first EPR analysis of MsbA by Dong and colleagues investigated the solution 
structure in four biochemical intermediate states (210). Extensive mapping of the spin label 
mobility and solvent accessibility along helix 2, 5 and 6 that span the ICD and TMD revealed the 
topological location and orientation of these segments in proteoliposomes (Figure 25). In the apo  
state, the pattern of NiEDDA accessibilities along the ICD suggested a predominately open 
conformation toward the cytoplasm. The addition of either AMP-PNP (a non-hydrolyzable ATP 
analog), ADP-Vi or ATP-Vi (stabilization of the high energy post-hydrolysis transition state) 
revealed similar changes in the EPR parameters consistent with a reversal of the transporter 
orientation from inward-facing to outward-facing. The similarity of the results with the nucleotide 
binding studies suggested that ATP binding provides the power stroke for cytoplasmic closure. 
 The spin label mobility and accessibility analysis was extended to other helices in the 
TMD and connecting loops (211). Together with the previous findings, the EPR studies 
established that nucleotide-dependent conformational changes take place to facilitate alternating 
access of the putative substrate binding chamber. However, the magnitude of these changes had  
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Figure 25. Accessibility of Apo-MsbA. The pattern NiEDDA and O2 accessibility across three 
TM segments and the ICD domain (top panel) illustrates the topological arrangement of these 
helices in proteoliposomes. Mapping of solvent accessibility onto the open Apo crystal structure 
identifies boundaries of the membrane-water interface. Figure adopted from Ref 210.  
 
 
not been investigated. DEER spectroscopy of MsbA, as well as homotransfer FRET, has 
suggested that large conformational motions occur upon ATP binding to bring the NBDs and 
ICDs together from the apo state (213,223). Striking evidence of these distance changes are 
illustrated for certain sites such as 121 at the N-terminus of helix 3. Here, the distance change is 
at least 30Å, since in the apo state 121 is separated by 50Å and upon ATP binding are close 
enough (≤15Å) to exhibit strong dipolar coupling in the EPR lineshape (Figure 26B).  
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Figure 26. Mapping of conformational changes by spin label dipolar coupling. (A) Crystal 
structure of open Apo-MsbA (gray) and the closed, ATP bound state (cyan) highlighting the 
location of specific sites interrogated by EPR distance analysis. (B) EPR spectra of spin labels at 
these positions in both states. (C) The Tikhonov fits of the time-dependent spin echo decays and 
resulting distance distributions (D) for both states. Positions 561 and 162 show opposite changes 
distance between states, consistent with rigid body movement of helices in an alternating access 
mechanism. Symmetry-related spin labels at site 121 in the ICD is separated by ~50Å in the Apo 
state (D), but is close enough for dipolar broadening of the EPR spectrum in the ATP-bound state 
(B). Data adopted from Ref 223. 
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Furthermore, substrate binding studies with lipopolysaccharide (LPS) suggested that distances 
between these domains increased with LPS binding and that subsequent ATP binding could 
mostly reverse this effect and establish an ATP-bound configuration. Importantly, closing the 
chamber with ATP binding prior to LPS addition prevented substrate effects on the apo state 
structure and argues for a direct, functional interaction of LPS with MsbA. 
 One of the more interesting spectroscopic observations stemming from these studies is 
the sensitivity of the distance-dependent dipolar coupling to backbone dynamics. Site 561 is 
located in the cytoplasmic NBDs and analysis of spin-spin dipolar coupling indicates that these 
two symmetry-related sites are separated by a distance longer (>70Å) than is resolvable by DEER 
methods. ATP binding brings these two sites within 40Å of each other (Figure 26). A salient 
feature of the two states is the widths of the distance distributions. In the apo state, a broad 
envelope of distances is reported, whereas a very narrow distribution is found in the nucleotide-
bound state. The changes in the distributions are directly related to the fast signal decay of the apo  
state, which precludes a modulation of the time domain signal leading to a broad distance 
distribution. Because the spin label mobility is not sensitive to changes between these two states, 
the distributions likely reflect changes in the degree of order in the backbone (223). Therefore, 
the apo state reflects a high degree of conformational flexibility and the binding of ATP 
establishes a unique conformation. Interestingly, dynamics of the spin label at site 162 on the 
extracellular side is also not sensitive to ATP-induced distance changes. However, the changes in 
the distance distribution are opposite to those observed at 561 (Figure 26). Collectively, these 
results indicate that the shape of the distance distributions is due to backbone fluctuations. 
 The extensive analysis of MsbA establishes a precedent for monitoring conformational 
changes in membrane transport proteins with EPR spectroscopy. In combination with all three 
methods, site-specific changes in the local environment of the spin label can be correlated with 
global changes in structure. Chapters 3 and 4 illustrate how this approach can define the structural 
basis of ion-coupled transport using the leucine transporter, LeuT, as a model.   
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CHAPTER III 
 
NA+/LEU-DEPENDENT CONFORMATIONAL CHANGES IN THE LEUCINE 
TRANSPORTER 
 
Rationale 
 The crystal structure of the Na+-dependent leucine transporter, LeuT, revealed an 
occluded, centralized binding site containing two Na+ and one Leu (168). From this structure 
alone, it is not clear what structural changes occur to accommodate ion/substrate permeation to 
the binding site. Although both Na+ atoms are bound close to the Leu substrate, and Leu 
participates in coordination of Na1, it is not known if Na+ binding elicits conformational changes 
that facilitate substrate binding. Furthermore, the fact that all crystal structures of LeuT are likely 
to be in functionally inhibited conformations precludes a mechanistic interpretation of the 
structural dynamics that may occur to support ion/substrate coupling (189). However, this 
structure may be exploited as a high resolution molecular map to guide a spectroscopic analysis 
of LeuT function. In the work presented here, spin labels were introduced into the sequence of 
LeuT corresponding to sites located in the extracellular region in order to determine the structural 
features of conformational intermediates sampled by LeuT under conditions that mimic distinct 
steps of a transport cycle. 
 The specific sites of nitroxide incorporation were based initially on the results of steered 
molecular dynamics simulations (188). In these simulations, the Leu molecule was "pulled" out 
of the primary (S1) binding site toward the extracellular milieu to identify an extracellular 
permeation pathway. During the computation, Leu made preferential binding contacts in a 
vestibule (the S2 site) ~10Å above the S1 site. Based on these results, spin labels were introduced 
at or near this site in transmembrane and extracellular loop segments to monitor changes in local 
dynamics and solvent accessibility in three biochemically-induced intermediates: 1. Apo (absence 
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of Na+/Leu), 2. NaCl alone and 3. Na+/Leu. In addition, the magnitude and direction of global 
conformational changes in these states were investigated through distance-dependent dipolar 
coupling between two strategically placed spin probes at surface locations. The structural 
characteristics of these intermediates were assessed in both n-dodecyl-β-D-maltopyranoside 
(DDM) detergent micelles and proteoliposomes, the solvent environments employed for all prior 
and current functional studies. In a collaborative effort, these studies combined with functional 
analysis (Jonathan A Javitch and Matthias Quick, Columbia University) and molecular dynamics 
simulations (Harel Weinstein and Lei Shi) identify the structural dynamics of LeuT enabling 
substrate permeation to internal binding sites and the subsequent formation of an occluded 
intermediate.  
 
Functional analysis 
 To assess the impact of site directed cysteine mutagenesis and spin labeling, all mutants 
were subjected to a [3H]-Leu binding assay and/or [3H]-Ala uptake assay. Although more 
thoroughly described in the Experimental Methods (see Appendix B), direct [3H]-Leu binding 
was evaluated for Ni2+ affinity purified LeuT mutants in DDM micelles by the scintillation 
proximity assay (SPA) (228). In this assay, the N-terminal His10-tag binds to a Cu2+ chelate 
scintillation bead which releases light upon radiolabeled ligand binding to LeuT. Specific Na+-
dependent binding for cysteine mutants before and after labeling with 1-oxyl-2,2,5,5-
tetramethylpyrroline-3-methyl methanethiosulfonate (MTSSL)  were compared to the specific 
binding activity of wild type LeuT, which is devoid of endogenous cysteines.  
 The functional analysis of the mutants for EPR studies is summarized in Figure 27, 
Figure 28 and Table 1. The binding parameters of sites labeled with a (*) in Figure 27 are found 
in Table 1. According to Figure 27, the vast majority of single cysteine mutants demonstrate at 
least 50% binding of 100nM [3H]-Leu relative to wild type and the presence of the spin label does 
not change the binding profile. It is likely that the variation in the amount of Leu bound in  
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the mutants reflects a shift in the KDLeu. To illustrate this point, wild type LeuT binds two Leu and 
exhibits an EC50Leu= 70nM according to Table 1. Although the G249C mutant reports wild type 
Leu binding stoichiometry, the EC50Leu is approximately nine fold greater than wild type, 
consistent with a decrease in binding affinity. This is also indicated for the double mutants in 
Figure 28 where all display wild type stoichiometry but vary in the total amount of Leu bound 
according to the pattern of changes in the EC50 Leu. 
 Only two sites in Figure 27, L29 in TM1 and D404 in TM10, show significantly lower 
(~10%) total Leu binding relative to wild type when the native residue was changed to cysteine. 
L29 is a buried residue near the S1 site and, therefore, mutation may perturb the local helix 
packing and indirectly effect binding at the S1 site (168). Mutation at L29 may also disrupt the 
ionic interaction between neighboring R30 and D404. The Asp at site 404 is a highly conserved 
and critical residue shown to form a salt bridge with R30 which has been proposed to serve as 
part of the extracellular gate (5,168). Therefore, it is not unexpected that mutation of this residue 
drastically influences binding behavior. Subsequent spin labeling at these sites does not change 
the binding profile. 
There are also a few sites that show decreased Leu binding when the spin label is 
attached (P137C and D138C in EL2; G307C and A311C in EL4). The cysteine mutation at P137 
and D138 decreases binding relative to wild type, but the amount of binding exceeds 50% of the 
total. Given the peripheral location of these positions in the crystal structure, it is difficult to 
envision the source of additional perturbation due to spin labeling. It is also quite interesting that 
spin labeling at the C-terminal residue positions 145-150 in EL2 potentiates substrate binding. 
This may suggest a slight repacking of the loop against other structural elements that may 
increase access to either the S1 or S2 site. Mutation and labeling at sites 307 and 311 are likely to 
disturb the tight packing of the helix-turn-helix from TM7 to EL4. Figure 29 illustrates the 
location of  
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Figure 27. [3H]-Leu binding analysis of LeuT single Cys mutants determined from SPA in the 
presence (red bar) and absence of spin label. Data are shown as the mean ± SEM.   
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Figure 28. [3H]-Leu binding analysis of select LeuT double Cys mutants determined from SPA 
analysis in the presence and absence of spin label. Data are reported as mean ± S.E.M. The total 
amount of 100nM Leu bound (A) varies with the EC50 (B). All double mutants possess wild type 
stoichiometry (C). The triple mutant, H480C/A309C/L400S eliminates binding to the S2 site, as 
described in the text.  
 
 
 
 
Table 1: Binding parameters of purified LeuT mutants determined from SPA analysis. Data are 
reported as mean ± S.E.M. See Experimental Methods in Appendix B for protocol.  
Mutant LeuT- Unlabeled LeuT- MTSSL 
 EC50 (nM) Leu-to-LeuT 
stoichiometry 
EC50 (nM) Leu-to-LeuT 
stoichiometry 
LeuT-V33C 616 ± 46 (n=3) 1.83 ± 0.10 690 ± 8 (n=3) 1.80 ± 0.02 
LeuT-I111C 105 ± 18(188) 1.00 ± 0.10 116 ± 4 (n=3) 1.00 ± 0.03 
LeuT-L400C 68 ± 11(188) 0.90 ± 0.01 69 ± 6 (n=2) 0.96 ± 0.03 
LeuT-A315C 105 ± 1 (n=2) 1.99 ± 0.02 101 ± 1 (n=2) 1.99 ± 0.01 
LeuT-F320C 28 ± 2 (n=4) 1.96 ± 0.06 31 ± 3 (n=2) 1.98 ± 0.01 
LeuT-F253C 101± 5 (n=4) 0.98 ± 0.06 83 ± 9 (n=2) 1.02 ± 0.06 
LeuT-G249C 647 ± 33 (n=2) 1.92 ± 0.02 552 ± 7 (n=2) 1.80 ± 0.13 
LeuT-WT 70 ± 7(188) 1.80 ± 0.10 N/A N/A 
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these particular sites where mutation and/or labeling reduces Leu binding in the SPA. 
Nevertheless, all spin labeled mutants were informative with site specific changes in EPR 
parameters according to the conditions tested.  
   
 
 
Figure 29. Location of positions that significantly alter Leu binding. (A) Mutation of Asp404 or 
the buried site Leu29 significantly decreases Leu binding. Asp404 participates in a salt bridge 
with Arg30 mediated by a water molecule (blue sphere). (B) Sites in EL2 and EL4 that decrease 
Leu binding after labeling with MTSSL.  
 
 
Na+ binding induces a dynamic outward-facing conformation 
 Although the LeuT crystal structure clearly shows a Leu molecule bound in the S1 site, 
Leu was never added during the purification or to the crystallization soup (168,188). Therefore, 
the Leu bound in the S1 site must have come from the expression medium which survived the 
purification process reflecting the intrinsic high affinity of the transporter for Leu. As indicated 
by the Experimental Methods, after LeuT mutants were expressed in E. coli and the membrane 
fraction isolated, the membranes were subjected to extensive washing in Na+ free buffer to 
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remove endogenously bound Leu. According to a previous study, this preparative procedure 
doubled the amount of Leu binding relative to unwashed membranes as measured by the SPA, 
which is consistent with the two binding site model (188). Following Ni2+ affinity purification, the 
mutants were gel filtered and subsequently desalted in a Na+ free buffer. This protocol effectively 
removes both Na+ and residual Leu from the transporter to generate the Apo state in DDM 
micelles. EPR spectra of single and double mutants were collected in DDM. However, for 
analysis of spin label mobility and solvent accessibility in proteoliposomes, all LeuT mutants 
were initially reconstituted in the Apo state and the other biochemical intermediates were formed 
by the addition of either Na+ or Na+/Leu to the liposome preparation. Double electron electron 
resonance spectroscopy between doubly labeled mutants was performed mostly in DDM. 
Oligomeric structure of LeuT in solution 
 Although doubly labeled mutants were designed to investigate intramolecular dipolar 
couplings, an important consideration for the DEER analysis is the oligomeric structure of LeuT 
in solution. In the crystal structure of LeuT, a dimeric interface is formed by TM9 and TM12 
(168). If LeuT forms a dimer in solution, the DEER signal will be a composite of both 
intramolecular and intermolecular dipolar couplings. To investigate the propensity of LeuT to 
form a dimer at this interface in solution, spin labels were placed along TM12 and analyzed by 
conventional CW-EPR and pulse EPR for evidence of spin-spin interaction. Based on the 
organization of this helix in the crystal, strong dipolar coupling will be manifested by extensive 
spectral line broadening between symmetry-related spin labels. However, this is not observed in 
either DDM or proteoliposomes regardless of the biochemical conditions (Figure 30). Likewise, 
DEER spectroscopy of the singly labeled TM12 mutants display a weak signal consistent with 
background decay. Furthermore, the high mobility lineshapes of those sites predicted to be in 
tertiary contact also suggests that this dimer interface does not exist in DDM micelles or 
proteoliposomes (Supplemental Figure 1). Therefore, the distances measured between sites in the 
extracellular vestibule exclusively arise from the intramolecular dipolar interactions.  
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Figure 30. LeuT is a monomer in solution. (A) Crystallographic dimer interface highlighting the 
close proximity (10Å) of position 488 in symmetry related monomers. (B-C) EPR spectra at site 
488 in DDM and proteoliposomes do not demonstrate the expected spin-spin interaction. The 
dashed red trace in (B) is a simulation of the EPR spectrum expected for two spin labels separated 
by 10Å. The red trace has been multiplied by 3 to emphasize the outer intensities arising from 
dipolar coupling. (D). The time-dependent echo decay (black line) does not show evidence of 
long-range interactions. The red and blue lines in (D) are the baseline and imaginary component, 
respectively. Besides lineshape and DEER analysis, the high O2 accessibility suggests that the 
spin label at site 488 is exposed to the lipid environment and not packed against protein as in the 
crystal structure.   
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Na+ binding alters the conformation of EL4 
 DEER spectroscopy was used to map the global structural features of all three 
intermediates by measuring distances between spin label pairs placed in the loops that surround 
the extracellular vestibule. Specifically, a spin label was placed in EL6 (sites 478 and 480) and in 
either EL2 (sites 126 and 136), EL4 (site 309) or EL3 (sites 220 and 236) as shown in Figure 31. 
Other spin label pairs either investigated the tertiary fold of EL2 (126/150) or the spatial 
relationship between EL2 and EL4 (A309C/S139C and A335/S139C). In general, most of the 
distance distributions are either heterogeneous possessing multiple, unresolved peaks or broad, 
asymmetric envelopes consistent with a large range of distances sampled in the Apo state (Figure 
31). The broad, Gaussian-like appearance of some distributions are the result of featureless signal 
decays that quickly approach a baseline (Supplemental Figure 2 and 3). Depending on the 
position of the probe, these distributions may reflect rapid spin label reorientation in the magnetic 
field, dynamic backbone fluctuations or a combination thereof. However, the addition of Na+ or 
Na+/Leu either induce shifts in the average distance and/or alter the width of the distributions. 
Furthermore, the CW-EPR spectra of the double mutants do not change substantially, suggesting 
that apparent changes in the distance distributions likely reveal backbone movements (Figure 31).  
 For instance, H480C/A309C, which probes the distance between EL6 and EL4, 
demonstrates a prominent peak in the distribution at ~25Å and other lower probability 
populations sampling longer distances (30-40Å) in the Apo intermediate. The addition of Na+ 
induces a right shift in the average distance between the spin labels and increases the width of the 
distribution. In addition, the overall shape of the distribution changes as well, revealing two 
unresolved distance populations (arrows in Figure 31A2). Multi-Gaussian analysis of the distance 
distribution identifies two separate populations with equal intensities centered about 28.5 (±3.1)Å 
and 36.7 (±3.8)Å , whereas ~2/3 of the spin populations occupy a distance of 25.8 (±2.6)Å in the 
Apo intermediate (Table 2, Supplemental Figure 4).The lack of significant changes in the spin 
label mobility argues that the Na+-induced distance distribution originates with dynamic  
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Figure 31. Global structural rearrangements upon Na+ binding. Distance analysis of dipolar 
coupled spin labels shows that Na+ binding leads to increased dynamic behavior of LeuT in 
specific regions (A2, B3 and C1). Also, EL4 (A2) has a role in establishing an outward-facing 
state. No changes in spin label mobility suggest that changes in the distance distributions reflect 
backbone movements. Multi-Gaussian analysis of the distance distributions to model the changes 
in the average distance and distribution widths are shown in Table 2. 
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backbone movements between two conformers. Importantly, the distance distribution for 
E478C/E220C does not change in the presence of Na+, suggesting that EL6 (E478-H480) is 
relatively static (Figure 31B1). Therefore, dynamic backbone fluctuations of EL4 probably give 
rise to the distance distribution of H480C/A309C in the Na+ intermediate.  
 The overall right shift in the distance distribution of H480C/A309C suggests an increase 
in the average distance between EL6 and EL4. A comparison of the distributions for the Apo and 
Na+ states indicates that Na+ binding enriches the populations of spins sampling longer distances 
in the Apo intermediate. Thus, the shape of the distance distribution in the Apo state may reflect 
an equilibrium between closed and open conformers. This pattern of distance changes suggests 
that the binding of Na+ increases the population of transporters occupying a more open 
configuration. Furthermore, similar distance changes are observed in proteoliposomes, 
confirming these structural transitions in a more native-like environment (Supplemental Figure 
5). Negligible changes in the average distance are observed for the other spin label pairs in the 
presence of Na+ (Figure 31, Table 2), suggesting some conformational degeneracy in EL2 and 
EL3. Although the DEER analysis is not exhaustive with this limited set of dipolar coupled spins, 
the results suggest that movement of EL4 is central in the structural transition to the outward-
facing state. In addition, this movement likely leads to exposure of both substrate binding sites 
since EL4 contributes to the occlusion of the extracellular permeation pathway. This 
interpretation is supported by the site-specific changes in spin label mobility and solvent 
accessibility discussed below.  
Dynamic behavior of EL2 
 Although backbone movement of EL4 appears critical to the formation of an open state, 
dynamic features of EL2 also emerge from the analysis of both the Apo and Na+ intermediates. 
Multi-component distance distributions are observed in one or both of these states in the analysis 
of H480C/D136C (EL6/EL2), A335C/S150C (EL4/EL2) and L126C/S150C (EL2/EL2) shown in 
Figure 31. Three dominant populations are observed in the distance distribution of H480C/D136C  
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Table 2. Model Parameters from Multi-Gaussian Fits of Distance Distributions 
Mutant State Gaussian 1 Gaussian 2 Gaussian 3 
Amp r(Å) σ Amp r(Å) σ Amp r(Å) σ 
H480C/A309C Apo 
NaCl 
Na/Leu 
0.63 
0.50 
0.67 
25.8 
28.5 
24.4 
2.6 
3.1 
1.3 
0.37 
0.50 
0.33 
32.5 
36.7 
29.1 
5.4 
3.8 
3.6 
   
H480C/D136C Apo 
NaCl 
Na/Leu 
0.20 
0.28 
0.11 
24.3 
26.3 
30.0 
1.6 
2.3 
1.6 
0.38 
0.30 
0.86 
30.0 
31.4 
31.8 
2.9 
2.2 
4.3 
0.42 
0.42 
0.03 
36.9 
37.8 
37.1 
2.2 
2.6 
0.9 
E478C/E236C Apo 
NaCl 
Na/Leu 
1.0 
1.0 
1.0 
45.0 
44.0 
41.9 
7.0 
7.0 
8.0 
      
E478C/E220C Apo 
NaCl 
Na/Leu 
1.0 
1.0 
1.0 
40.8 
39.5 
39.8 
8.1 
7.2 
7.4 
      
E478C/L126C Apo 
NaCl 
Na/Leu 
1.0 
1.0 
1.0 
41.0 
40.8 
42.9 
7.5 
7.4 
7.8 
      
A335C/S150C Apo 
NaCl 
Na/Leu 
0.12 
0.44 
0.32 
30.0 
29.6 
28.7 
1.0 
3.8 
3.4 
0.88 
0.56 
0.68 
34.3 
36.2 
34.2 
2.9 
3.0 
2.7 
   
L126C/S150C Apo 
NaCl 
Na/Leu 
0.57 
0.96 
0.56 
18.5 
19.6 
17.8 
0.1 
4.3 
1.4 
0.43 
0.04 
0.44 
22.9 
38.4 
22.4 
2.3 
2.0 
2.3 
   
A309C/S139C Apo 
NaCl 
Na/Leu 
1.0 
1.0 
1.0 
22.6 
23.9 
23.6 
3.4 
4.1 
3.4 
      
A335C/S139C Apo 
NaCl 
Na/Leu 
1.0 
1.0 
1.0 
30.8 
31.4 
30.1 
3.6 
3.5 
3.7 
      
 
 
 
in the Apo and Na+ intermediates, which may be related to backbone movements in EL2 along 
the N-terminus (discussed later in more detail). Interestingly, one distance component is observed 
in the Apo state of A335C/S150C (Table 2), which probes the distance between the extreme C-
terminus of EL4 and the C-terminus of EL2. However, Na+ binding elicits the formation of a 
second population, consistent with increased dynamics along the C-terminus of EL2 even though 
the average distance does not change much. In accordance with this observation, the signal 
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modulation observed in the Apo state of the L126C/S150C pair, which fingerprints the tertiary 
fold of EL2, is dampened in the Na+ state, leading to a broadening of the distance distribution and 
a concomitant loss of distinct features in the Apo state (Figure 31C1). This pair is also close 
enough in space to see evidence of dipolar coupling in the EPR lineshape. However, the EPR 
spectra does not change under any biochemical condition, suggesting that the DEER analysis 
resolves a contribution of EL2 backbone dynamics induced by Na+ that is not apparent in the EPR 
lineshape. Regardless of these changes in dynamics, the spatial relationship between the N- and 
C-termini of EL4 and EL2 appears conserved based on the distance distributions of A335/S139C 
and A309C/S139C which show no significant changes in distance. 
Na+ binding increases dynamics and accessibility of the extracellular permeation pathway 
 The pattern of distance changes suggests that areas in the vicinity of EL4, i.e. the 
extracellular vestibule, may experience changes in local dynamics and solvent accessibility with 
the addition of Na+. Most sites located within the extracellular vestibule demonstrate restricted 
spin label motions in the Apo intermediate, indicative of a tightly packed structural organization. 
However, Na+ addition titrates a mobile component into the EPR lineshape. Figure 32A shows 
the EPR spectra in the Apo and Na+ states for a set of representative sites positioned in different 
areas of the vestibule. The increase in spin label mobility suggests that the extensive packing 
interactions of the Apo state are relaxed upon Na+ binding. These lineshapes are consistent with 
increased local dynamics, which mirrors the observations in the DEER analysis described above. 
The lineshape change at the S2-site mutant I111C is particularly informative on the nature of Na+-
induced changes in local packing. Monitoring the change in EPR lineshape in DDM micelles as a 
function of [Na+] reveals an EC50Na ≈ 15mM (Figure 33A-B), similar to that obtained for Na+ 
stimulated [3H]-Leu binding (19mM), suggesting that the changes in lineshape are solely due to 
Na+ binding.  
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Figure 32. Na+ binding induces changes in the local spin label environment within the 
extracellular vestibule. Increased spin label mobility (A) correlates with higher accessibility (B), 
suggesting that increased water penetration is facilitated by looser packing in the extracellular 
vestibule. (C) Mapping the changes in NiEDDA accessibility onto the structure of LeuT 
highlights increased access to the permeation pathway. The LeuT PDB code 2A65 is shown in 
(C). 
 
 
In support of this observation, K+ does not elicit the same change in the spectrum (Figure 33C). 
This is consistent with the functional dependence on Na+ and the lack of transport activity in the 
presence of K+. Consistent with the detergent EPR lineshape, the presence of the ionophore 
gramicidin that destroys Na+ gradients across lipid bilayers does not change the EPR spectrum of 
Na+-bound I111C, suggesting that a Na+ gradient is not required to produce this conformational 
change (Figure 33D).  
 Interestingly, not all sites report extensive tertiary interactions in the absence of Na+. 
Indeed, the spin label mobility at L400C, another S2 site mutant, in the Apo state is consistent 
with a higher rate of rotation relative to other sites in the vestibule, suggesting a much less tightly 
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packed local environment. This result parallels the pattern of solvent accessibility for this site, in 
which the accessibility to 50mM NiEDDA at L400C is 7-fold greater than for I111C (Figure 
32B) even though these sites reside at a similar depth in protein and their side chains project into 
the extracellular vestibule. Although the addition of Na+ increases the spin label mobility at 
L400C, the NiEDDA accessibility remains statistically unchanged. In contrast, I111C increases 
more than 3-fold in the presence of Na+, suggesting that an increase in water penetration 
accompanies looser packing within specific region(s) of the vestibule.  
 
 
 
Figure 33. Characterization of ion-dependent changes. (A) [Na+]-dependent changes in the EPR 
spectrum of I111C reveals a similar EC50Na as Na+-stimulated Leu binding (B). (C) K+ does not 
change the EPR spectrum of I111C relative to the Apo state. (D) Gramicidin does not change the 
Na+-induced EPR spectrum of I111C in proteoliposomes, suggesting that a Na+ gradient is not 
required for the conformational change. 
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Mapping the Na+-induced changes in NiEDDA accessibility of 41 sites in the 
extracellular region onto the LeuT crystal structure reveals an increase in water penetration within 
the vestibule and outlines the permeation pathway to the S1 substrate binding site (Figure 32C). 
Changes in oxygen accessibility, shown in Supplemental Figure 6, support the pattern of 
NiEDDA accessibility changes in Figure 32C. Specifically, those sites that appear to have 
restricted access to solvent in the crystal structure demonstrate increased NiEDDA accessibility in 
the presence of Na+. This is emphasized for buried sites in EL4, such as A315C. The highly 
restricted dynamics of the spin label suggests that the side chain of A315 projects into a buried 
environment, yet a concomitant increase in spin label mobility and accessibility is observed in the 
Na+ intermediate. V33C in TM1 projects into the nearby environment of A315C and shows a  
similar change in both EPR parameters (Figure 32A-B). Notably, surface sites show larger 
absolute values of accessibility, which are attributed to larger local concentrations and diffusion 
rates of NiEDDA (Table 3) than within the vestibule (207). These surface sites, such as those in 
EL4 (e.g. A309C, 314C and A317C) and most sites in EL2, do not show significant changes 
(within experimental error, i.e. <20%) in accessibility with Na+ binding. Similar to these sites, 
spin labels in TM10 and TM6 show limited Na+-dependent changes in accessibility. 
The pattern of accessibility changes shown in Figure 32 in conjunction with spin label 
mobility and the DEER analysis illuminate two structural aspects of LeuT. First, the analysis 
reveals structural features of the Apo state from the perspective of the extracellular region. The 
Apo state, which has not yet been crystallized, may represent a transient intermediate in the 
thermodynamic cycle of the alternating access model following intracellular release of ion and 
substrate. According to Erreger et al, this structural transition is the rate limiting step for 
dopamine transport (8). The low values of solvent accessibility and restricted spin label motion 
suggest that specific structural regions are buried by the conformation of EL4 in the Apo state, 
which is described by the prominent short distance component of the H480C/A309C (EL6/EL4) 
distance distribution. However, those areas that reside outside of EL4 contact, such as TM10 and  
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Table 3: NiEDDA accessibility of MTSSL-labeled LeuT single Cys mutants. 
Values are reported with confidence intervals for a single experiment. (*) 
indicates the mean ± S.D. obtained from three independently determined П 
values. Values for O2 accessibility are reported in Supplemental Table 1. 
Position П (Apo) П (NaCl) П (Na/Leu) 
TM1 25 0.11  ±  0.01 0.14  ±  0.02 0.14  ±  0.01 
 29 0.09  ±  0.02 0.09  ±  0.01 0.06  ±  0.02 
 33* 0.13  ±  0.03 0.42  ±  0.02 0.17  ±  0.01 
 34 1.08  ±  0.07 1.15  ±  0.06 1.13  ±  0.07 
TM3 111* 0.12  ±  0.01 0.37  ±  0.03 0.23  ±  0.01 
 114 0.12  ±  0.02 0.16  ±  0.02 0.11  ±  0.03 
EL2 136 7.39  ±  0.30 8.03  ±  0.35 8.38  ±  0.38 
 137 2.80  ±  0.09 2.40  ±  0.07 2.51  ±  0.11 
 138 4.71  ±  0.18 3.73  ±  0.26 4.85  ±  0.14 
 139 6.38  ±  0.33 6.06  ±  0.34 5.84  ±  0.40 
 140 1.05  ±  0.05 0.83  ±  0.05 0.50  ±  0.03 
 141 1.68  ±  0.07 1.78  ±  0.05 1.66  ±  0.07 
 142 7.02  ±  0.26 6.77  ±  0.26 6.58  ±  0.31 
 143 3.00  ±  0.08 2.54  ±  0.09 2.81  ±  0.13 
 144 0.28  ±  0.02 0.22  ±  0.01 0.31  ±  0.02 
 145 1.18  ±  0.06 1.09  ±  0.06 1.10  ±  0.07 
 146 4.15  ±  0.22 4.03  ±  0.18 3.79  ±  0.18 
 147 0.49  ±  0.12 0.22  ±  0.03 1.73  ±  0.11 
 148 0.56  ±  0.07 0.35  ±  0.06 0.49  ±  0.10 
 149 0.86  ±  0.02 0.96  ±  0.04 0.94  ±  0.04 
 150 5.40  ±  0.23 5.33  ±  0.22 5.24  ±  0.31 
TM6 243 0.46  ±  0.05 0.44  ±  0.06 0.29  ±  0.07 
 246 0.43  ±  0.02 0.38  ±  0.02 0.63  ±  0.03 
 249 0.13  ±  0.01 0.18  ±  0.01 0.23  ±  0.04 
 253* 0.14  ±  0.01 0.11  ±  0.01 0.12  ±  0.02 
EL4 305 2.05  ±  0.09 1.85  ±  0.06 2.12  ±  0.09 
 307 0.04  ±  0.01 0.04  ±  0.01 0.06  ±  0.01 
 309 7.11  ±  0.34 7.27  ±  0.38 6.98  ±  0.28 
 311 0.21  ±  0.01 0.35  ±  0.03 0.24  ±  0.02 
 314 2.38  ±  0.08 2.73  ±  0.11 2.55  ±  0.07 
 315* 0.14  ±  0.02 0.36  ±  0.04 0.09  ±  0.01 
 317 3.15  ±  0.16 3.19  ±  0.19 3.86  ±  0.31 
 320* 0.21  ±  0.02 0.29  ±  0.01 0.21  ±  0.02 
 324 0.11  ±  0.02 0.10  ±  0.03 0.17  ±  0.02 
 325 0.61  ±  0.06 0.83  ±  0.10 0.58  ±  0.08 
 333 2.79  ±  0.12 3.54  ±  0.16 3.57  ±  0.16 
TM10 397 1.35  ±  0.15 1.57  ±  0.12 1.27  ±  0.08 
 400* 0.85  ±  0.09 0.74  ±  0.06 0.19  ±  0.04 
 404 0.20  ±  0.03 0.17  ±  0.02 0.12  ±  0.02 
 405 1.05  ±  0.04 1.32  ±  0.05 0.62  ±  0.04 
EL6 480 4.16  ±  0.15 4.16  ±  0.16 4.06  ±  0.22 
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TM6, are exposed to the extracellular milieu and therefore do not demonstrate large changes in 
solvent accessibility in the presence of Na+. The distance distribution of E478C/E236C 
(EL6/EL3) in the Apo and Na+ states may also support this interpretation. E236 is four residues 
away from the N-terminus of TM6, and changes in distance between E478C/E236C may echo 
movement of TM6. A role for TM6 in the dynamics of transport was initially proposed based on 
the discontinuity of the TM segment at the S1 binding site, which may confer intrinsic flexibility 
(168). Notably, the presence of Na+ does not change this distance distribution, suggesting the lack 
of conformational changes in this area and rationalizing the lack of changes in the solvent 
accessibility profile of TM6. 
 Lastly, and perhaps most importantly, distinct changes in the local environment of the 
vestibule correlate with movement of EL4 captured by the DEER analysis. A movement of EL4 
also rationalizes the attenuation of NiEDDA accessibility at sites 147 and 148 in EL2 in the 
presence of Na+. Indeed, an increase in dipolar coupling between spin labels fingerprinting the 
spatial relationship of EL2 and EL4 indicates an effective decrease in distance between the two 
loops in this region (Figure 34, Supplemental Figure 7). Collectively, this dataset strongly 
suggests a pivotal role of EL4 in generating an outward-facing conformation that exposes the 
extracellular permeation pathway and internal binding sites to solvent and substrate.  
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Figure 34. Relative movement between EL2 and EL4. (A)The pattern of accessibilities to both 
NiEDDA and O2 suggests that EL2 is a tilted α-helix, consistent with the crystal structure. (B) 
The Na+-dependent increase in dipolar interaction between spin labels at positions 317 (EL4) and 
145 (EL2) is consistent with a decrease in distance between the two loops. The attenuation of spin 
label accessibility at positions 147 and 148 (gray box) is consistent with movement of EL4 
toward EL2 upon Na+ binding. The distance distributions in (B) were obtained from non-linear 
least squares analysis of the EPR spectrum assuming a two Gaussian model. The EPR spectra 
have been integrated to emphasize the ion/substrate-dependent changes in broadening.  
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Leu binding and the formation of an occluded intermediate 
 
Leu binding establishes a globally occluded conformation 
 DEER analysis also suggests that distinct conformational changes occur upon Leu 
binding to the Na+ intermediate. Figure 35 reports the DEER signal and resulting distance 
distributions of all three intermediates. Specifically, changes in the average distance between spin 
labels as well as an increase in structural order are observed in the presence of Leu. Both of these 
changes are manifested in the distance distribution of H480C/A309C in which the broad, two-
component Na+ intermediate becomes a narrow, single component with a significant shift to 
smaller distances (Figure 35A2). The narrower distribution of the Na+/Leu state is due to the 
appearance of oscillations in the time-dependent echo decay of the DEER signal (Supplemental 
Figure 2). The lack of changes in spin label dynamics again indicates that this movement is due to 
a change in the backbone conformation of EL4. Thus binding of Leu appears to reverse the effect 
of Na+ to the Apo intermediate. Yet the magnitude of the left shift in the distribution and the 
changes in width distinguish the Na+/Leu state from both the Na+ and Apo intermediates. Indeed 
the average distance between the spin labels is shorter than in either the Na+ or Apo 
conformations. The formation of a dominate single component indicates that the structural 
flexibility of the Na+ intermediate is exchanged for a more rigid, structurally homogeneous 
conformation upon Leu binding (Table 2).  
 A similar change in the shape of distance distributions occurs in the presence of Leu 
across other LeuT structural elements, suggesting an overall decrease in transporter dynamics. 
For instance, the multi-component distance distributions of H480C/D136C and A335C/S150C 
coalesce into a single population (Figure 35A1 and B3, Table 2). The distance distribution of 
H480C/D136C in the Apo and Na+ states can be reasonably estimated by simulating theoretical 
conformations of the spin label at both H480C and D136C (dashed trace) using an unpublished 
spin label rotamer library developed by Gunnar Jeschke, possibly indicating that the distributions 
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reflect only movement of the spin label (Figure 35A1). It must be noted that this rotamer library 
was developed in silico and needs to be validated under experimental conditions. The EPR 
spectrum of H480C/D136C is degenerate in all conditions, suggesting that the sampled spin label 
 
 
 
Figure 35. Leu binding establishes an occluded state. Changes in the distance and associated 
distributions suggests that Leu binding leads to a closed and more rigid structure relative to the 
Na+ intermediate. This is emphasized in the (A) panels, which also shows that a decrease in 
distance between EL4 and EL6 (A2). Little change in the average distance is observed outside of 
the extracellular vestibule in all states. 
  
102 
 
 
conformations possess similar mobilities. However, the formation of a single component induced 
by Leu binding may suggest that sampling of these predicted rotameric conformations is 
associated closely with the backbone dynamics of EL2. That is, the binding of Leu establishes a 
unique conformation of EL2 which selectively enhances a specific rotamer population of the spin 
label. As shown in Figure 35, not all spin label pairs demonstrate narrowing of the distance 
distribution. For instance, E478C/E236C does not show a decrease in the width of the 
distribution. This is likely due to the structural nature of the polypeptide chain, i.e. E236C resides 
in an unstructured loop (168). Therefore, the width of the distribution is tied to the dynamic 
motion of this loop. Regardless, a Leu-dependent decrease in the average distance between the 
spin labels in this double mutant is consistent with the formation of a globally occluded 
conformation that is distinct from the Apo and Na+ intermediates.  
Leu binding decreases dynamics and accessibility of the extracellular permeation pathway 
 The Leu-dependent changes in the distance distributions correlate with changes in local 
dynamics and solvent accessibility within the vestibule. Typically, a reduction in spin label 
mobility accompanies Leu binding at sites within the vestibule. In particular, the transition to an 
occluded state is highlighted for L400C where large amplitude motion of the spin label is 
substantially reduced in the Leu-bound form as illustrated in Figure 36A. Coinciding with 
decreased spin label dynamics is a significant decrease in spin label accessibility (Figure 36B). 
The changes in solvent accessibility upon Leu binding relative to the Na+ intermediate are 
mapped onto the crystal structure in Figure 36C. In contrast to the Na+ state, these results indicate 
that Leu binding effectively reverses the accessibility of the vestibule and establishes a tightly 
packed conformation. Furthermore, the blueprint of Leu-dependent accessibility suggests that 
these changes are facilitated, in part, by movement of EL4. In addition, the decrease in solvent 
accessibility at sites within TM10 also suggest an inward movement of this helix toward the  
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Figure 36. Leu binding decreases accessibility and increases order within the extracellular 
permeation pathway. A decrease in spin label mobility (A) correlates with a decrease in solvent 
accessibility within the vestibule (B). The pattern of accessibility changes (C) indicates that 
movement of EL4 modulates access to the permeation pathway. The LeuT PDB code 2A65 is 
shown. 
 
 
vestibule. In support of this, a similar pattern of substrate-dependent EPR lineshape changes 
emerge at sites in TM10 that describe the local environment from the vestibule toward the S1 site. 
Although this movement of TM10 is not apparent from the crystal structure, it may be 
reminiscent of the substrate-dependent inward movement of TM10 in the NCS1 benzyl-hydantoin 
transporter, Mhp1 (185). An overlay of both structures illustrates where TM10 in LeuT may bend 
toward the extracellular vestibule (Figure 37). Gly residues have been suggested to confer 
flexibility to transmembrane segments in K+ channels (192), and helix bending is most likely 
facilitated by a Gly at position 371 in Mhp1 (185). Likewise, Gly408 in TM10 of LeuT may 
provide similar flexibility. Therefore, the N-terminus of TM10 may play a role in blocking access 
of the extracellular permeation pathway to the solvent.  
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Figure 37. TM10 may bend toward the vestibule in the Na+/Leu intermediate. (A) LeuT crystal 
structure highlighting the location of N-terminal TM10 residues relative to the Leu binding site. 
The combination of decreased spin label mobility (C, gray dashed box) and solvent accessibility 
(Figure 10) suggests a Leu-dependent conformational change of TM10, similar to substrate-
bound Mhp1 (PDB 2JLO) (B).  
 
 
  
 
Figure 38. Promiscuity of LeuT. The Leu-dependent change in lineshape at L400C occurs with 
other known LeuT substrates. (B) The substrates that alter the EPR spectrum in (A) compete with 
Leu for binding to LeuT.  
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 Binding studies have shown that LeuT is rather promiscuous by binding a variety of 
amino acids. Specifically, these studies suggested that Ala, Val, Ile and other neutral amino acids 
are substrates of LeuT (173). Furthermore, crystallographic analysis of some of these complexes 
suggests that these substrates displace Leu in the S1 site and the overall architecture of LeuT is 
nearly identical to the Leu-bound LeuT structure. This may also suggest that similar 
conformational changes occur in LeuT when binding to these substrates. In support of this, the 
EPR spectrum of Ala-, Val- and Ile-bound LeuT at L400C is superimposable with the Leu-bound 
spectrum (Figure 38). In contrast, Glu does not induce these lineshape changes, indicating that 
Glu is not a substrate for LeuT.  
 
 
 
Figure 39. Na+-dependence of Leu binding. (A) Overlay of Na+/Leu-dependent changes in the 
EPR spectrum at I111C and L400C. (B) In the absence of Na+, stoichiometric Leu binding is not 
observed. (C) In contrast, some substrate binding is observed in the absence of Na+ if the [Leu] is 
large enough (mM) relative to the [LeuT], suggesting that Na+ binding enhances the binding 
affinity of Leu to LeuT. 
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 Importantly, the changes in EPR lineshape induced by Leu are dependent on the presence 
of Na+. As previously stated, L400C and I111C are critical residues in the extracellular vestibule 
that form part of the S2 site and mutation of these residues disrupts substrate binding there.  
Correspondingly, the molar stoichiometry of these mutants is 1:1 (Leu-to-LeuT), as indicated by 
binding analysis (Table 1). In the Apo state, the addition of a stoichiometric amount of Leu does 
not alter the EPR spectrum, suggesting that Leu does not bind in these conditions (Figure 39).  
 
 
 
Figure 40. A Na+ gradient is not required for Leu binding. (A) Changes in the EPR lineshapes of 
I111C and L400C in DDM micelles are similar to those changes in proteoliposomes (B). The 
thick red trace in (B) is the resulting EPR spectrum following reconstitution of LeuT in the 
presence of Na+ and Leu. The black line is the EPR spectrum resulting from the external addition 
of Na+ and Leu to reconstituted Apo-LeuT. (C) Accordingly, solvent accessibilities at these two 
sites show similar behaviors to that described in (B).  
 
 
Furthermore, the presence of K+ also does not support Leu-dependent changes in the EPR 
lineshape (Supplemental Figure 8). These results may reflect a Na+-dependent decrease in the 
KDLeu. Indeed, the EPR lineshapes show evidence of some binding in the absence of Na+ at Leu 
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concentrations in vast excess (mM) of the LeuT concentration (µM) (Figure 39C). A Na+-
dependent increase in substrate binding affinity has been observed for the benzyl-hydantoin 
transporter (185). Importantly, similar changes in EPR lineshape in both DDM micelles and 
proteoliposomes suggest that a directional Na+ gradient is not required to support the Leu-
dependent conformational changes (Supplemental Figures 9-16). Indeed, no differences in EPR 
lineshapes or solvent accessibilities were observed for I111C or L400C when these mutants were 
reconstituted in the presence of both Na+ and Leu (i.e. identical concentrations of Na+/Leu on 
both sides of the proteoliposome) as shown in Figure 40.  
Leu binding dehydrates the S1 site 
 Spin labels near the binding site (e.g. L25C, L29C and F253C) report low accessibilities 
and restricted motion in all states, although the spin label at L29C shows changes in mobility 
(Table 3, Supplemental Figure 9). According to the crystal structure, F253 occludes the 
extracellular side of the S1 site and participates in direct interaction with the Leu substrate (168). 
Even though site-directed cysteine mutagenesis of F253 only slightly perturbs the binding affinity 
relative to wild type, the mutation reduces the molar stoichiometry to 1:1, Leu-to-LeuT (Table 1). 
Furthermore, the mutation also abolishes transport activity, consistent with disruption of the 
proposed symport mechanism (Figure 41B) (188). Binding studies show that the tricyclic 
antidepressant (TCA) clomipramine (CMI), a potent inhibitor of uptake, reduces the total amount 
of Leu binding to wild type LeuT by ~50%, consistent with CMI blocking Leu binding to the S2 
site in the extracellular vestibule (Figure 41C). Notably, CMI binding nearly abolished all binding 
to the F253C mutant (Figure 41C). This observation suggests that Leu binds only to the S2 site in 
this mutant.  
 The spin label accessibility of F253C to 50mM NiEDDA averaged 0.12±0.01 (n=3) over 
all conditions tested, suggesting steric restriction of NiEDDA (which is ~13 times larger than 
water) and/or the lack of significant diffusion of paramagnetic reagents at the S1 site (Figure 
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41D)(207). This result suggests that water activity may be underdetermined and therefore 
prevents a structural interpretation of changes in water penetration near the binding site. However 
 
 
 
Figure 41. Evidence of water exclusion at the S1 site upon Leu binding. Mutation of F253C (A) 
eliminates transport activity and reduces binding (B). The presence of CMI eliminates nearly all 
Leu binding (C), suggesting that Leu only binds to the S2 site in the extracellular vestibule in this 
mutant. (D) The spin label solvent accessibilities are low in all states, consistent with a buried 
location in the crystal structure (A). Leu binding causes a decrease in spectral breadth (2Azz) at 
room temperature (E) and 220K (F), consistent with a dehydrated S1 binding site as observed in 
the crystal structure (A). 
 
 
the breadth (2Azz) of the EPR spectrum is different in all three conditions (Figure 41E). This 
observation can be attributed to either subtle changes in mobility or changes in the polarity of the 
environment of the spin label. In low dielectric environments, the splitting of hyperfine extrema 
(2Azz) decreases (229). Relative to the Apo state, the addition of Na+ increases the value of 2Azz, 
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consistent with increased hydration of the S1 site (Figure 41E). In contrast, Leu reduces the 
spectral breadth by 8 Gauss, which implies that water is excluded from the area of the binding 
site. To eliminate any contribution of spin label dynamics to the changes in the EPR spectrum, the 
experiment was repeated at low temperature (220 K). At this temperature, motional averaging is 
"frozen" and any changes to 2Azz will be a function of the local dielectric. Indeed, the breadth of 
the EPR spectrum decreases at this low temperature with Leu binding (Figure 41F). Thus, the 
decrease in solvent accessibility within the extracellular vestibule is characterized also by 
dehydration at the primary binding site, consistent with the absence of water molecules near the 
S1 site in the crystal structure (Figure 41A). The shedding of water is likely to facilitate highly 
specific interactions of Leu within the S1 site. Importantly, these results appear to highlight the 
connection between the S1 and S2 sites since substrate binding in the extracellular vestibule 
triggers a reduction in water activity at the primary binding site.  
Leu-dependent conformational changes: correlation with the binding sites 
 Collectively, the data reveal that Leu binding induces a conformational change that 
reduces access to the extracellular permeation pathway—a result opposite to that of Na+ binding 
to the Apo intermediate. In combination with the functional analysis (Table 1), it appears that 
binding to the S1 site alone is sufficient to drive formation of the Na+/Leu state. Since L400C 
eliminates binding to the S2 site (188), the structural rearrangement captured by the mobility and 
accessibility analysis of spin labeled L400C is a function of Leu binding to the S1 site. In fact, 
titration of L400C with Leu shows that the maximal change in the EPR lineshape occurs at a 
molar ratio of 1:1, Leu-to-LeuT (Figure 42B). However, qualitatively similar results are obtained 
from mutants that possess wild type binding stoichiometry, such as V33C and A315C (Figure 36, 
Table 1), suggesting that binding to the S2 site may not contribute to changes in the local spin 
label environment. However, global conformational changes also seem to demonstrate the same 
behavior. Leu titration of H478C/E236C and H480C/A309C, both of which bind two Leu per 
LeuT, indicates that the Leu-induced change in spin label distance is saturated at a 1:1  
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Figure 42. Leu binding in the S1 site drives conformational changes. (A) Position of spin labeled 
sites used to investigate the correlation of Leu-dependent conformational changes with binding 
stoichiometry. The Leu titration of L400C (B) and global distance changes (C-E) indicate that 
substrate binding to the S1 site alone will drive occlusion of the extracellular permeation 
pathway. (F) This is further supported by superimposable distance distributions of H480C/A309C 
with an S2 site disrupting mutation (L400S).  
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stoichiometric ratio (Figure 42C-E, Supplemental Figure 17). In addition, incorporation of an S2-
disrupting background mutation, L400S, into the H480C/A309C construct did not alter the 
distance distribution (Figure 42F).  
 In light of these results, it is interesting to consider the unique spectroscopic signatures 
reported by the F253C mutant that binds Leu only to the S2 site as demonstrated by functional 
analysis. This data seems to imply that binding to the S2 site will also trigger conformational 
changes that reduce water penetration, which may suggest that binding to either the S1 or S2 site 
produces a similar Na+/Leu intermediate. Alternatively, the concentration of both LeuT and Leu 
used in the EPR experiments may be above the KDLeu for the perturbed S1 site. This would imply 
that the decrease in spectral breadth is due to binding in the S1, and not necessarily the S2, site. 
From the perspective of the SPA binding analysis applied here, specific interactions are masked 
by high backgrounds at protein and substrate concentrations employed for EPR spectroscopy. In 
addition, it is not possible to perform EPR experiments in the sub-micromolar regime. Therefore, 
complete overlap with the binding and EPR data cannot be achieved with confidence.  
 Although not conclusive, two lines of EPR evidence discussed here may suggest that 
binding at either the S1 or S2 site produces a similar Leu-bound intermediate. First, a background 
mutation, L400S was introduced into the F253C construct. The SPA reveals no Leu binding to 
the double mutant (data not shown), consistent with disruption of both substrate binding sites. 
However, EPR studies show lineshape changes consistent with some substrate binding. Relative 
to the F253C mutant, the F253C/L400S double mutant shows attenuated Leu and Ala binding at 
all tested concentrations of LeuT (3, 5, 20 and 50µM) as indicated by the change in spectral 
breadth (Figure 43A-C). This result is suggestive of an attenuated Leu-induced conformational 
change driven by binding to the S2 site. An important caveat to this experiment is the appearance 
of a mobile component in the spectrum (arrow, Figure 43). This component is observed also in 
the Apo and Na+ states (Figure 43D), suggesting that the additional L400S mutation may have 
altered the protein conformation or packing interactions. Second, the result of a TCA inhibitor 
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binding study is consistent with attenuated Leu binding in the S2 site. This experiment and the 
result is described in the following section. 
 
 
 
Figure 43. Mutation of an S2-site residue disrupts S1 site dehydration. Leu binding, as measured 
by a decrease in 2Azz, appears attenuated by the L400S background mutation (A-B), suggesting 
that reduced binding is the result of a disturbed S2 site. (C) This result is also observed a low 
[LeuT]. However, the presence of a mobile component in the EPR spectrum of the double mutant 
(arrows, A, B and D) suggests that the additional background mutation may alter the packing 
interactions of LeuT.  
 
 
Inhibitors induce distinct conformations of LeuT 
 
Clomipramine and octyl-glucoside alter the structure of the Na+/Leu intermediate 
 The observation that octyl-glucoside (OG), the detergent used in all crystallization 
studies, inhibits Na+-coupled substrate symport by binding in the extracellular vestibule has led to 
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the conclusion that all structures represent inhibited conformations (189). This proposal is 
supported by other inhibitor binding experiments that show TCAs and selective serotonin 
reuptake inhibitors (SSRIs) occupy a similar location in the vestibule to generate nearly identical 
crystal structures (91,169,174). Therefore, a significant disparity exists between these structures 
 
 
 
Figure 44. A tricyclic antidepressant impairs Leu binding. (A) [CMI]-dependent changes in the 
EPR spectrum of F253C in the presence of Na+ alone. (B) 1mM CMI does not alter the lineshape 
of F253C relative to the Na+ state or prevent stoichiometric Leu binding (C). However, both 
10mM (D) and 20mM CMI (E) impairs Leu binding as shown by an attenuation of the decrease 
in spectral breadth (F). 
 
114 
 
 of LeuT and the functionally relevant Na+/Leu intermediate. The apparent sensitivity of the 
F253C mutant to binding in the S2 site provides an avenue to differentiate the effect of inhibitors 
relative to native substrates. As shown previously, the presence of CMI blocks most Leu binding 
activity of the F253C mutant (Figure 41C). Interestingly, a [CMI]-dependent change in the EPR 
lineshape is observed at this position in the presence of Na+. At 1mM, the EPR spectrum of 20µM 
LeuT-F253C remains essentially unaltered relative to the Na+ intermediate (Figure 44A-B). 
However, at higher concentrations (10 and 20mM), the low and high field resonance lines 
increase in width. At 20mM CMI, a slight decrease in the 2Azz value is observed, but does not 
approach the value of the Leu-bound form (Figure 44A,F). At this high concentration of CMI, a 
white precipitate is formed, suggesting protein aggregation, and a significant amount of free spin 
label is seen in the spectrum. Also, Leu binding is substantially reduced as measured by a change 
in the value of 2Azz (Figure 44E-F). In contrast, no precipitation is observed at 10mM CMI, the 
concentration used for previous crystallization trials, and the spectral breadth does not change 
relative to the Na+ state. Yet in the presence of both 20µM Leu (1:1, Leu-to-LeuT) and 10mM 
CMI, the EPR spectrum shows a modest increase in 2Azz, suggesting impaired Leu binding 
(Figure 44D). This result implies that binding of CMI to LeuT prevents dehydration of the S1 site 
and is also consistent with the functional analysis suggesting that Leu binds only to the S2 site in 
the F253C mutant.  
 From a global perspective, the presence of 1mM CMI induces a small but reproducible 
decrease in the distance between spin labels in the E478C/E236C mutant relative to the Na+/Leu 
state (Figure 45A-B, Supplemental Figure 18). This shift in the distance distribution appears to be 
due to a specific binding interaction, presumably in the extracellular vestibule, because it does not 
occur in the absence of Leu (Figure 45C). Given that Na+/Leu are present in the crystal structure 
of CMI-bound LeuT, this result may suggest that Leu binding in the S1 site establishes a 
preferential conformation for TCA binding. Consistent with this notion, 10mM CMI recapitulates 
the distance change in the presence of Na+ alone (Figure 45D). This may suggest that the  
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Figure 45. OG and CMI binding induce a distinct global structure. (A) LeuT structure 
highlighting the spin label pairs used to measure global changes in structure upon inhibitor 
binding. (B) CMI and OG induce similar magnitude left shifts in the distance distribution of 
E478C/E236C. (C) Although the 1mM CMI-induced shift was dependent on the presence of Leu, 
a similar left-shift was observed with 10mM CMI in the absence of Leu (D), suggesting that Leu 
binding in the S1 site may enhance the binding affinity of CMI to the extracellular vestibule. (E) 
The effects of these inhibitors may be localized to specific structural regions since the average 
distance between spin labels at H480C and A309C did not change in the presence of OG or CMI. 
 
 
structural change associated with Leu binding in the S1 site enhances the affinity of LeuT for 
CMI. This may also explain why 10mM CMI is required to observe impaired Leu binding to the 
F253C mutant described above (since Leu does not bind in the S1 site in this mutant). 
Interestingly, an identical shift in the distance distribution is observed in the presence of OG, 
consistent with the observation that this inhibitor binds in a similar location to the TCAs (Figure 
45A). Therefore, both OG and CMI induce a similar global conformation of LeuT. However, 
CMI and OG do not significantly alter the distance distribution of H480C/A309C, suggesting that 
the conformation of EL4 remains unchanged (Figure 45E). Since E236C is found in EL3 in close 
proximity to TM6, the data may suggest that these inhibitors produce local structural 
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rearrangements of EL3, TM6 or both. Importantly, the dataset is limited in scope and other 
conformational changes may occur that were not captured here. Nevertheless, the changes imply 
that the Na+/Leu intermediate is distinct from the inhibitor bound structure. 
Tryptophan produces an extreme outward-facing conformation 
 Of all available crystal structures, LeuT adopts a unique conformation in the presence of 
the competitive inhibitor Trp (173). Four Trp molecules are found in this structure with two 
"wedged" into the extracellular permeation pathway and the S1 binding site. As a result, the 
extracellular vestibule expands to accommodate the bulkier amino acid. This structure has been 
interpreted as a trapped "open-to-out" conformation characterized in part by outward 
displacement of EL4 (Figure 46A). Consistent with the crystal structure, the addition of 20mM 
Trp to the Na+ intermediate produces a right shift in the average distance relative to both the Na+ 
and Na+/Leu bound conformations (Figure 46B, Supplemental Figure 19A). Trp also induces a 
right shift in the distance distribution of E478C/E236C relative to the Na+/Leu state 
(Supplemental Figure 19B). As shown in Figure 46, two important observations distinguish this 
inhibited conformation from the outward-facing Na+ state. First, the Trp-bound distance 
distribution overlaps the most extended component in the heterogeneous Na+ ensemble (gray 
dashed box). This suggests that Trp selectively enhances a specific conformation of LeuT 
sampled in the equilibrium of Na+-dependent conformers. Second, the Na+-induced distance 
distribution is wider than in the Trp-bound form, indicating that Trp reduces the intrinsic dynamic 
behavior of EL4. Consistent with a competitive mode of inhibition (173), Leu binding in the S1 
site mostly restores the Na+/Leu distance distribution for H480C/A309C (data not shown).  
 The Trp-dependent changes in global structure are reflected also in the solvent 
accessibility of buried sites reported by the Na+/Leu intermediate. For example, the NiEDDA 
accessibility of A315C in the presence of Trp is twice as much as the Na+ state and more than 
seven-fold larger than the Na+/Leu state (Figure 46C). Other sites in the extracellular vestibule or 
those near the binding site also show increased water penetration reported by a right shift in the  
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Figure 46. Trp binding creates an extreme outward-facing conformation. (A) Expansion of the 
extracellular vestibule upon Trp binding is partly due to outward movement of EL4 (green 
structure). (B) This outward movement is captured by the H480C/A309C spin labeled pair, 
illustrating that Trp stabilizes an exaggerated open state relative to the Na+ intermediate. (C) The 
movement of EL4 also increases access to the vestibule, as shown by A315C. (D) Consistent with 
the role of an inhibitor, the presence of Trp impairs Leu binding as indicated by an attenuated 
change in spectral breadth of the spin labeled F253C mutant. 
 
 
power saturation curves (Supplemental Figure 19C-D). Furthermore, dehydration of the S1 site is 
impaired in the presence of Trp (Figure 46D), consistent with the stabilization of an extreme open 
conformation. Fundamentally, the structural features of Trp-bound LeuT are distinct from the 
outward-facing conformation induced by Na+ binding. Although the Trp-bound state samples a 
Na+-induced conformer, the prominent dynamic features of the Na+-intermediate are missing. A 
possible origin of this distinguishing feature is revealed in molecular dynamics simulations as 
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shown in Figure 47. In the Na+ only configuration, TM6 adopts an outward tilt relative to the 
Na+/Leu state that is similar to the Trp-bound crystal structure and consistent with the 
E478C/E236C distance distribution (Figures 47B-C and Supplemental Figure 19B).  However, 
the simulations also indicate that Trp occupation of the S1 site may prevent configurational 
changes of specific side chains involved in the generation of the Na+ and Na+/Leu intermediate 
states (Figure 47D).  
 
 
 
Figure 47. Molecular dynamics simulations reveal side chain rotamer orientations that stabilize 
the outward-facing conformation. Trp binding produces an outward tilt of TM6 (B) relative to the 
Na+/Leu state (A). A similar movement of TM6 is shown in the Na+ only configuration (C), 
consistent with the formation of Na+-dependent outward-facing state. (D) Changes in the 
rotameric conformation of S1 site residues Phe253 and Phe252 may be involved with stabilizing 
this intermediate state. The presence of Trp in the S1 site occupies a similar space to Phe253 
(dotted circle), which may trap LeuT in an outward-facing conformation. Special thanks to Dr. 
Lei Shi (Cornell University) for producing this figure.  
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Mechanistic implications for Na+-coupled substrate transport 
 The results of the EPR analysis presented above outline the structural features of three 
intermediates associated with a functional transport cycle. In addition, the presence of either non-
competitive or competitive inhibitors alters the structural constraints and effectively differentiates 
between a functional transporter conformation and its inhibited form in solution. Even though 
these structural changes are not nearly as large as those seen in other transporters, such as MsbA 
(223), the results clearly demonstrate significant ion/substrate-dependent conformational 
movement. The data strongly suggest that Na+ binding alone provides a thermodynamic driving 
force to establish an outward-facing state characterized by a novel, dynamic movement of EL4. 
The Na+-driven expansion of the extracellular vestibule increases access to the substrate 
permeation pathway and facilitates substrate binding, consistent with an ordered binding scheme. 
This contests previous molecular dynamics simulations that suggested limited movements occur 
allowing only a few water molecules to penetrate in the absence of Leu (230). On the contrary, 
the large size of NiEDDA relative to water leads to an underestimation of the aqueous 
accessibility of the permeation pathway. Therefore, Na+ and Leu are not only tightly coupled by 
direct interaction at the S1 site, but also through structural rearrangements that expose the binding 
site. Subsequent Leu binding effectively reverses the Na+-induced conformation leading to 
restricted access of the permeation pathway. The Na+/Leu intermediate is predominately formed 
by inward movement of EL4, highlighting a "lid-like" function of this extracellular loop. 
However, TM6 and TM10 may contribute to the formation of an occluded state as shown by 
changes in distance distributions or local environmental parameters. 
 The results of the EPR lineshape changes observed for the F253C mutant suggest that 
Leu binding to the S2 site induces a conformational change in LeuT. Furthermore, this data 
emphasizes the connection between the S1 and S2 binding sites. Mutants that possess wild type 
binding stoichiometry do not show additional global or local effects with substrate binding to the 
S2 site. This implies that binding in the S2 site is not required to form an occluded state. 
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However, small changes, such as side chain re-packing or reorientation, may occur with S2 
binding that are beyond the resolution of the EPR technique. In the absence of the activity assays, 
the complete EPR dataset can be rationalized by a single binding site model, as shown in the 
crystal structure. The high binding affinity of Leu combined with µM reagent concentrations for 
EPR may drive binding to the primary site even in the presence of disrupting mutations such as 
F253C. In this case, attenuated changes in spectral breadth due to CMI binding in the 
extracellular vestibule could then be attributed to steric restriction of functional transporter 
dynamics.  
 However, one important consideration is the limited number of spin labeled positions. 
That is, conformational changes due to substrate occupation of the S2 site may be detectable with 
a more thorough nitroxide scan of structural components. Another consideration is that the 
binding data were collected in the absence of an ion gradient. Since substrate binding in the S2 
site has been proposed to allosterically trigger Na+ symport (188), S2-driven conformational 
changes may require a Na+ gradient. Alternatively, the conformational changes produced by 
binding in the S2 site may be degenerate with those produced by binding in the S1 site alone. 
Validation of this possibility necessitates experimental conditions that selectively enhance 
substrate binding to one site or the other.  
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CHAPTER IV 
 
ION-DEPENDENT CONFORMATIONAL EQUILIBRIA AND SUBSTRATE BINDING 
 
Rationale 
 Previous studies have shown that neurotransmitter transport is critically dependent on 
Na+ as a coupling ion (9,15). Likewise, transport activity in LeuT is Na+-dependent and it was 
proposed that the larger K+ could not fit into the Na+ binding sites (168). Accordingly, the results 
presented in the previous chapter indicate that Na+ binding induces a change in the structure of 
LeuT to facilitate substrate binding. Interestingly, the smaller Li+ has been shown to induce 
uncoupled currents (20), suggesting that this cation may affect the structure of neurotransmitter 
transporters. Li+ has been used pharamacologically to treat depression and bipolar affective 
disorder (82,231), although the mechanism of therapy is not known. Treiser and co-workers 
found that Li+ increased serotonin release in the hippocampus, but that uptake was unaffected 
(232). However, an increased rate of MTSET-driven inactivation and enhanced uncoupled 
currents relative to Na+ suggested that Li+ induced a conformational change in the SERT (233). 
Investigation of the GAT also has suggested that Li+ produces a conformation that supports a Li+ 
leak current, which is abolished in the presence of Na+ (234). In addition, Li+ was found to 
support GABA transport in the presence of low Na+ concentrations, which was interpreted that 
Li+ can replace Na+ at one of its binding sites (235). A subsequent study confirmed these findings 
in the GAT and, based on a similar molecular architecture of LeuT, identified a low affinity Na+ 
binding site for which Li+ can readily substitute (236). Corresponding to the Na2 site in LeuT, Li+ 
binding in this site is controlled by an Asp residue that when mutated eliminates the Li+ leak 
current and Li+ stimulated transport. These results provided solid evidence that Li+ can be co-
transported provided that Na+ occupies the other ion binding site. Recent molecular dynamics 
studies indicated that two different mechanisms are responsible for the robust selectivity of Na+ 
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over other monovalent ions in LeuT. The selectivity at the Na1 site is primarily a function of the 
strong electrostatic field produced by the coordinating residues, whereas structural constraints 
control the selectivity at the Na2 site (237). However, these studies suggested that these sites are 
only modestly discriminatory for Na+ over Li+, and that Li+ could potentially support substrate 
binding (238). The work presented in this chapter outlines the structural impact of Li+ binding to 
LeuT in the absence of Na+ or substrate, highlighting a conformational equilibrium between Apo 
and ion-bound forms. In addition, the results show that Li+, unlike K+, will support substrate 
binding. Preliminary evidence also indicates that substrate binding properties are unique in LiCl 
solution, potentially uncovering different binding modes. 
 
Li+-induced conformational changes underscore a conformational equilibrium 
 Spin labeled sites that demonstrated sensitivity to Na+ binding were used to investigate 
the potential for Li+ to alter the structure of Apo-LeuT. Specifically, spin labels attached to V33C 
in TM1, I111C in TM3 and A315C in EL4 show spectroscopic changes in EPR parameters that 
suggest a Li+-induced structural change. The spin label mobility and solvent accessibility to 
50mM NiEDDA was measured in three biochemical states: Apo, LiCl and NaCl. Notably, the 
spin label at V33C shows a significant (nearly 2-fold) increase in accessibility in the presence of 
200mM Li+ relative to the Apo intermediate (Figure 48B). The Π value in LiCl solution is 
approximately 65% of that observed in NaCl solution. Although the difference in accessibilities 
between Apo and Li+ states at A315C is just outside statistical significance (Table 4), a similar 
upward trend in the mean Π value is observed in the ion-bound form. In contrast to the changes in 
accessibility, the EPR lineshapes of V33C and A315C do not change in the presence of Li+ 
(Figure 48B-C). Therefore, specific tertiary interactions appear to persist at these positions, even 
though the collision frequency of the probe with NiEDDA increases.  
 Relative to A315C, spin labeled I111C demonstrates a smaller, statistically insignificant 
increase in Π in the presence Li+ (Figure 48D). However, the EPR spectrum of I111C does show  
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Figure 48. Li+ alters the local structural environment. (A) Location of spin labeled sites in or near 
the extracellular vestibule relative to the S1 site. (B-D) Ion-dependent changes in EPR spectra 
and solvent accessibility in proteoliposomes. V33C and A315C do not show significant changes 
in lineshape in the presence of Li+. However, a significant increase in NiEDDA accessibility is 
observed for V33C (B). In contrast, the lineshape of I111C suggests the presence of at least two 
motional states (arrows), in which the ion binding enhances the fast motion component (D).  
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Table 4. Ion-dependent changes in solvent accessibility within the extracellular vestibule 
Mutant Π (Apo) Π (LiCl) Π (NaCl) 
NiEDDA O2 NiEDDA O2 NiEDDA O2 
V33C 0.23±0.02 0.14±0.02 0.38±0.04 0.23±0.01 0.58±0.13 0.23±0.04 
A315C 0.17±0.03 0.16±0.01 0.24±0.04 0.17±0.02 0.53±0.10 0.25±0.01 
I111C 0.21±0.01 0.12±0.01 0.24±0.04 0.16±0.01 0.58±0.04 0.28±0.02 
F259G/I111C 0.29±0.02 0.12±0.01 0.62±0.00 0.19±0.01 0.72±0.02 0.22±0.01 
 
 
definitive changes in the three conditions tested. Overall the spin label mobility increases with the 
presence of either ion, with Na+ promoting the most change. Close inspection of the changes in 
EPR spectra suggests that each of the three lineshapes represents the sum of two or more 
motional components arising from spin labels with different rates of rotation. Indeed, lineshape 
fitting routines have so far been unsuccessful in identifying the discrete motional properties of the 
spin label in the Apo state assuming either one or two components with standard g and hyperfine 
tensor values (Figure 49). Qualitatively, the presence of multiple components is most evident in 
the Na+ intermediate where at least two different spin label populations (arrows Figure 48D) are 
demarcated by an inflection in the low field resonance lineshape. Each of the two populations, 
which arise from a fast and slow motion component in the EPR spectrum, may reflect two 
conformational extremes of the spin label. In addition, these extreme components are unresolved 
(Figure 49B), suggesting the presence of an ensemble of intermediate states as well. Thus, an 
exchange model that accounts for interconversion between two rotational rates may be necessary 
to properly fit the spectra. Relative to the Apo state, the presence of either ion increases the 
population(s) of spin labels sampling higher rotational rates, but to different extents.  
 Collectively, the dataset described above can be modeled by a conformational 
equilibrium between the Apo and ion-bound intermediates (Figure 50). In the Apo state, the EPR 
spectrum of I111C is predominately a single component characterized by a population of spin 
labels exhibiting highly restricted motion. Although the addition of either Li+ or Na+ increases the 
overall mobility, the slow motion component does not completely disappear. Importantly, Li+  
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Figure 49. Non-linear least squares fits (red trace) of the EPR spectrum of I111C in the Apo 
state. (A) Single component and (B) two component fits using standard g and A tensor values. 
 
 
elicits a subtle increase in probe mobility in between the Apo and Na+ states. In applying the 
results from Chapter 3, this result suggests that Li+ binding induces a right shift in the equilibrium 
between a closed and open state toward an outward-facing conformation (Figure 50). The 
maximal shift toward the open state is achieved by the binding of Na+. This model also explains 
the incremental increase in solvent accessibility at V33C and A315C with Li+ binding. The nature 
of the power saturation technique captures an average Π value weighted by the populations in the 
spin ensemble (207).  
  
 
 
Figure 50. Ions shift the conformational equilibrium toward an outward-facing state. In the Apo 
state, the transporter predominately resides in a closed conformation. The binding of either Li+ or 
Na+ shifts the equilibrium towards an open state. 
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 Two additional lines of evidence support the presence of an ion-dependent equilibrium 
shift between open and closed conformers of LeuT. Incorporation of the background mutant 
F259G into the I111C construct exaggerates the observed changes in both the EPR lineshape and  
solvent accessibility. As will be discussed later, the F259G mutation disturbs substrate binding at  
 
 
 
Figure 51. Increased ion sensitivity in the F259G background. Mutation of Phe259 near the 
ion/substrate binding sites (A) increases the mobility of the spin label at I111C relative to the 
single mutant background (B). This effect is also manifested in the NiEDDA accessibility (C), 
suggesting that the F259G mutation creates a bias toward the open state in the conformational 
equilibrium. 
 
 
the S1 site. In this background, the spin label at I111C reports changes in lineshape in all three 
states relative to the I111C mutant alone (Figure 51B). Immediately noticeable is the amplified 
population(s) of higher mobility spin labels in the ion-bound states and the increase due to Li+ 
binding approaches the level due to Na+ binding. This result is mirrored by similar levels of 
NiEDDA accessibility (Figure 51C). The low field resonance line of Apo-I111C/F259G also 
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shows an increase in width in the EPR spectrum and solvent accessibility increases by a small 
margin. Collectively, these results suggest that the background mutation creates an inherent bias 
towards an open state in the equilibrium which enhances the sensitivity of LeuT to Li+ and Na+ 
binding. Despite this bias, the immobilized component in the EPR spectra persists in the ion-
bound states of this double mutant. 
 
 
 
Figure 52. Increased global dynamic behavior in the F259G background. (A) Distance 
measurements were made between EL6 and EL4 to determine the impact of Li+ binding on global 
changes in structure. Although the local effect of Li+ binding is not resolved at a global level with 
DEER spectroscopy (top panel in B), broader distance distributions and ion-dependent 
enhancements of specific LeuT conformers are observed in the F259G background (arrows). (C) 
These results suggest that the F259G mutation increases the probability of an open conformation 
in the Apo and ion bound states.  
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 Secondly, these results are directly in line with the shape of the distance distributions of 
H480C/A309C as described in Chapter 3. The Apo intermediate displayed multiple distance 
components with a prominent short distance population occupying the vast majority of all 
interspin distances. Also, Na+ binding enhanced the lower probability distance populations 
without completely eliminating the shortest distance component. These data are consistent with a 
Na+-driven shift in the conformational equilibrium toward an open state. However, the Li+-
induced structural change is too small to be resolved by global distance analysis (Figure 52B). 
Yet, the incorporation of the F259G mutation into the H480C/A309C mutant broadens the Apo 
state distribution and increases the sensitivity of ion binding to be detected by DEER analysis, 
which is  consistent with a mutation-driven shift toward an open state (Figure 52B-C).  
 
 
 
Evidence that Li+ supports substrate binding 
 The results described above suggest that the presence of Li+ leads to structural changes in 
LeuT that may facilitate substrate binding. The experiments described below attempt to 
spectroscopically characterize Li+-supported binding of two substrates: Leu and Ala. The major 
difference between these two substrates is that Ala has a lower binding affinity (at least 15-fold) 
and larger kcat (5-fold), making Ala a much more informative amino acid to measure transport 
activity (173). However, crystal structures with Ala are nearly identical to the Leu-bound 
structures (173). Furthermore, EPR lineshape analysis of L400C (and other sites) indicates that 
Na+-dependent Ala binding induces a similar conformational change to Leu binding (Chapter 3).  
Li+ supports Leu binding 
 Functional analysis suggests that total binding of 100nM [3H]-Leu to wild type LeuT is 
reduced by ~50% (consistent with 1:1 stoichiometry) and substrate transport is eliminated in the 
presence of Li+ (Figure 53A-B). Incorporation of mutants that prevent substrate binding only to  
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Figure 53. Functional analysis of LeuT in the presence of Li+. (A) Li+ does not support Ala 
transport. (B) Leu binding is reduced by ~50% in the presence of Li+ relative to the Na+ control 
according to SPA analysis. Mutation of S1 binding site residues (Phe253 and Phe259) does not 
change the Leu binding profile relative to Na+. However, mutation of S2 site residues (i.e. I111) 
eliminates Li+-dependent binding, suggesting that Li+ promotes Leu binding to the S2 site. (C) 
Location of binding site residues shown in (B) and subsequently used for substrate binding 
studies by EPR. (D) Na+ and Li+-dependent Leu binding is eliminated in the presence CMI which 
binds in the extracellular vestibule and blocks substrate binding to the S2 site. 
 
 
the S2 site completely abolish Li+-dependent Leu binding activity (Figure 53B). However, site 
directed mutagenesis of positions that contribute to the S1 binding site (F253C, F259G) does not 
disrupt Li+-dependent Leu binding relative to wild type (Figure 53B) and Na+ controls. Thus, the 
SPA analysis suggests that Li+ promotes Leu binding only to the S2 site. Consistent with this 
observation, the EPR spectrum of S1 site mutant F253C indicates that Li+ supports binding of 
Leu to the S2 site similar to Na+ (Figure 54A-C). Furthermore, Li+-dependent Leu binding is 
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reduced in the presence of CMI (Supplemental Figure 20). Global distance analysis as measured 
by H480C/A309C also indicates that Leu binding drives the formation of an occluded state in the 
presence of Li+ (Figure 54D).  
 
 
 
Figure 54. EPR lineshape analysis suggests Li+ supports Leu binding. (A) Spectroscopic changes 
in EPR lineshape at F253C in the presence of Na+. (B) Although Li+ does not alter spectral 
features of the Apo state, a decrease in spectral breadth (arrows) indicates that Leu will bind in 
the presence of Li+. (C) The Leu-induced changes in the EPR spectrum of (A) and (B) are 
dependent on the presence of the ion, since Leu alone does not alter the Apo state spectrum (thick 
purple trace). (D) Leu also establishes a similar globally occluded intermediate in the presence of 
Li+.  
 
 
 Unexpectedly, changes in the EPR lineshape at the S2 site mutants L400C and I111C are 
consistent with Li+-dependent Leu binding to the S1 site (Figure 55). This result was obtained 
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with 20µM LeuT and a 1:1 Leu-to-LeuT molar ratio and may suggest that these reagent 
concentrations are above the KDLeu of the S1 site in the presence of Li+. Supporting this possibility 
is the observation that Li+ appears to support a 2:1 binding stoichiometry provided the [Leu] is in 
the µM range (SPA analysis data not shown). However, lower reagent concentrations do not 
prevent Li+-dependent binding to the S1 site (Supplemental Figure 21). Even incorporating an S1 
site mutant background (F259G) does not prevent Leu binding as measured by changes in 
lineshape at either L400C or I111C (Figure 55, Supplemental Figure 21). Since the difference 
between the KDLeu measured for the S1 and S2 sites is reportedly marginal, it appears that the 
affinity of Leu is too high to observe differential binding effects of the S1 and S2 sites by EPR.  
 
 
 
Figure 55. Li+-dependent Leu binding in S1- and S2-site disrupting backgrounds. Although 
functional analysis indicates that Leu will not bind to mutant LeuT with a disturbed S2 site, both 
L400C (A) and I111C (B) show similar Leu-induced changes in EPR spectra in the presence of 
either ion. Furthermore, incorporation of the F259G background (an S1 site mutant) does not 
prevent Leu binding, suggesting that the binding affinity of Leu is too high to correlate spectral 
changes with substrate occupation of a specific binding site by EPR.  
132 
 
Preliminary characterization of Li+-dependent Ala binding 
 The EPR spectrum of 20µM L400C shows that 20µM Ala induces similar changes in the 
lineshape in the presence of either Li+ or Na+ (Figure 56).  
 
 
 
Figure 56. Ion-dependent Ala binding is abolished in the F259G background. The degree of spin 
label restriction at L400C due to stoichiometric Ala binding is reduced relative to the Leu-bound 
state (arrows in A and B), albeit to a lesser extent in LiCl solution (top panel of B). However, 
incorporation of the F259G background mutation eliminates Ala-induced spectral changes 
relative to the ion-bound state, suggesting that the change in spin label mobility is due to substrate 
occupation of the S1 site.  
 
 
However, the degree of restricted spin label motion is less than that with Leu as a substrate at 
identical concentrations, which may be reflective of the lower intrinsic binding affinity of Ala to 
LeuT. This interpretation is supported by the observation that 2µM LeuT and Ala reports little 
133 
 
ion-dependent change in EPR lineshape relative to the Apo intermediate, although the spin label 
mobility is completely restricted in the presence of Leu (Supplemental Figure 21). The tight 
binding of Leu prevents an estimation of binding affinity by EPR methods using µM reagent 
concentrations. In contrast, titration of L400C with Ala in the presence of Na+ shows a monotonic  
 
 
 
Figure 57. Li+ alters the binding affinity of Ala. (A) The Li+/Ala titration curve of L400C 
revealed a left shift relative to Na+, suggesting a Li+-dependent increase in Ala binding affinity. 
(B-C) The background mutation, F259G, strongly shifts the binding curve to the right, suggesting 
a substantial decrease in Ala binding affinity in the double mutant. (D) The ion-dependent 
differences in binding isotherms observed in (A) are eliminated in the double mutant.  
 
 
change in EPR lineshape that saturates at ~5:1 (Ala-to-LeuT) molar ratio (Figure 57A). Non-
linear least squares analysis using a single site binding model to fit the data estimates a KDAla of 
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1.7µM. Interestingly, the binding curve is shifted to the left in the presence of Li+, consistent with 
an increase in Ala binding affinity relative to Na+ (Figure 57A). Incorporation of the F259G 
background mutation abrogates Ala binding at a 1:1 molar ratio regardless of the ion identity 
(Figure 56). Generation of an Ala binding isotherm (Figure 57B-D) in this double mutant shows 
two important differences with respect to that reported in Figure 57A. In contrast to L400C, the 
signal saturates at much higher Ala concentrations, consistent with an overall increase in the 
KDAla. This may suggest that the changes in EPR lineshape of spin labeled L400C are contingent 
on Ala binding in the S1 site. Secondly, the apparent difference in affinity between the Na+- and 
Li+-dependent curves is no longer observed.  
 Li+-dependent Ala binding is also observed with the F253C mutant, which is evident by a 
decrease in 2Azz. Maximal changes in the EPR spectrum are seen with a 5:1 molar ratio, which is 
attenuated in the presence of 10mM CMI (Figure 58B, F). Interestingly, the Na+/Ala spectrum 
shows evidence of two components at this molar ratio (Figure 58C-D). An overlay of the Li+/Ala 
spectrum suggests that the outermost intensities of the Na+/Ala spectrum represent a population of 
unbound LeuT. Increasing the concentration of Ala decreases this spin population and the EPR 
spectrum converges to a single component at ~50:1 molar ratio (Figure 58E). These observations 
are consistent with a Li+-dependent enhancement of Ala binding affinity to the S2 site.  
 
 
Concluding comments 
 Overall, the results presented here indicate that the presence of Li+ will induce a 
conformational change and that Li+, unlike K+, will support substrate binding to LeuT. In 
combination with structural analysis described in Chapter 3, the Li+ binding studies highlight a 
dynamic conformational equilibrium between a predominately closed, Apo state and more open, 
ion-bound intermediates. Small, but significant changes in local environmental parameters reflect 
a subtle shift in the equilibrium toward an outward-facing conformation in the presence of Li+.  
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Figure 58. Li+ enhances Ala binding to an S1 site mutant. Ion-dependent Ala binding to F253C is 
shown by a decrease in spectral breadth (A-B). In contrast to Leu, the spectral change requires 
~5-fold more Ala than the equivalent Leu-dependent change. (C) The EPR spectrum of Na+/Ala 
appears to be two components, suggesting that some LeuT remains unbound when compared to 
the Leu-bound state or to the Li+/Ala bound state (D). (E) ~50-fold molar excess is required to 
complete Ala binding in the presence of Na+. (F) Li+-dependent Ala binding is impaired in the 
presence of CMI. Collectively, the data set is consistent with an enhancement of substrate binding 
to the S2 site in the presence of Li+. 
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However, the finely tuned architecture of the ion binding sites promotes a maximal shift in the 
equilibrium when these sites are occupied by Na+.  
 Similar to Na+, the Li+-induced conformational change facilitates binding of either Leu or 
Ala. The EPR lineshapes and global distance analysis suggest that structural changes induced by 
Li+ and substrate are similar to those induced by Na+ and substrate. According to the SPA  
analysis, Li+ selectively enhances Leu binding to the S2 site at nM reagent concentrations. A 
fundamental discrepancy in the results shown here is the spectroscopic observation of Li+-
dependent Leu binding to the S1 site, even in the presence of S1-disrupting mutations (Figure 
55). Most likely, this is attributed to a combination of nM Leu binding affinity and the µM 
concentrations of reagent used for the EPR analysis. Under these conditions, it is difficult to 
directly compare the functional and spectroscopic results, and thus provide a unique structure-
based interpretation of mechanism.  
 Interestingly, ion-dependent Ala binding seems to uncover distinctive characteristics of 
LeuT behavior. Remarkably, the KDAla is at least 6-fold less in Li+ than in Na+ for the spin labeled 
L400C mutant (Figure 57). At this time, the origin of this difference in affinity is not clear. In 
contrast to Leu binding, SPA reveals that Ala will bind to LeuT with a molar stoichiometry of 2:1 
(Ala-to-LeuT) at sufficiently high (µM) Ala concentrations in the presence of Li+, but 1:1 in the 
presence of Na+ (data not shown). This unexpected result suggests that the mode of Ala binding is 
a function of ion identity. Furthermore, it may be interesting to consider that the ion-dependent 
difference in binding isotherms observed at L400C is a manifestation of differences in binding 
stoichiometry. Indeed, the F259G/L400C mutation, which presumably disrupts Ala binding to the 
S1 site, seems to abolish the ion-dependent difference in the binding curves (Figure 57). 
Alternatively, the difference in L400C binding curves may also be explained by altered 
interactions of Li+ and Ala within the binding sites that may be disturbed in the F259G/L400C 
double mutant. Importantly, the substantial decrease in substrate binding of this double mutant 
relative to L400C emphasizes the cooperativity between the S1 and S2 sites. Therefore, a 
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mechanistic interpretation of these results must be tempered by the possibility that point 
mutations within one binding site may perturb Ala binding to both sites. Crystallization of LeuT 
in the presence of Li+/Leu and Li+/Ala may help to decipher the spectroscopic and functional 
results.  
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CHAPTER V 
 
PERSPECTIVES ON FUTURE INVESTIGATIONS 
 
Synopsis 
 The crystallographic analysis of LeuT provided a single, high resolution snapshot of a 
ligand-bound Na+-coupled transporter evolutionarily related to the NSS superfamily. However, 
the structural dynamic properties that mediate activity could only be speculated in the absence of 
experiments that resolve transporter behavior in solution. The work presented here describes the 
first spectroscopic characterization of the conformational changes that couple to ion-dependent 
substrate binding in LeuT, thereby establishing a dynamic dimension to an emerging model of 
substrate symport. The global and local EPR analysis provide novel constraints that define the 
structural features of three biochemical intermediate states putatively associated with the first two 
steps of a transport cycle. As a result, the experiments explicitly identify structural elements, such 
as EL4, that participate in conformational rearrangements in close proximity to the extracellular 
vestibule. Access to the internal binding sites is restricted in the Apo and Na+/Leu states. The 
structural transition from an empty, predominately closed state to a more open intermediate 
proceeds through a shift in a conformational equilibrium in the Apo state that is modulated by the 
presence of ions. The results clearly show that Na+ binding establishes an outward-facing 
conformation relative to the Apo and Na+/Leu intermediates that exposes the extracellular 
permeation pathway to solvent. Subsequent Leu binding to the S1 site in the Na+ state drives the 
formation of a distinct occluded intermediate. Based on experiments with S1-site mutations, it 
may be possible to form a similar occluded state by substrate binding in the S2 site. However, this 
bound configuration is not conducive to symport as defined by the S1/S2 mechanism given that 
substrate is not bound in the S1 site (188). Since binding of the inhibitors CMI and OG induce a 
similar change in EPR parameters, the original crystal structure of LeuT (which has bound OG in 
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the extracellular vestibule) is not likely to represent a functionally relevant form (189). Based on 
the data described here, a qualitative description of the conformational dynamics that occur in 
LeuT is summarized in Figure 59. 
 
 
 
Figure 59. Cartoon model of LeuT functional dynamics. (A-B) The transporter exists in a 
conformational equilibrium characterized by transitions between a closed and open extracellular 
gate. In the absence of a functional ion, this equilibrium is shifted heavily towards a closed state. 
Ion binding "stabilizes" the outward-facing state formed in part by the movement of EL4. This 
outward-facing state is poised to bind substrate. (C) The subsequent binding of substrate in the S1 
site drives conformational changes in EL4, TM6 and TM10 to occlude the extracellular 
permeation pathway. Substrate binding in the S2 may also induce similar rearrangements in the 
extracellular vestibule.  
 
 
 How conserved is this mechanism of structural dynamics of a prokaryotic transporter 
with the proposed conformational changes of the medically relevant eukaryotic transporters?  The 
high conservation of residues involved in the ion/substrate binding sites suggests a common mode 
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of interactions and perhaps the dynamic properties as well. The predictive power of the LeuT 
crystal structure has enabled rational experimental design to investigate structural elements within 
other members of the NSS superfamily. The results of these experiments strongly suggest that 
low to medium resolution structural models of the NSS can be built from the high resolution 
LeuT fold (239). Furthermore, specific regions within these NSS models exhibit state-dependent 
accessibility changes to MTS reagents. These regions include those that correspond to the LeuT 
segments that undergo conformational changes as shown in Figure 59. For example, a number of 
studies using cysteine accessibility experiments indicate that TM6 forms part of the extracellular 
permeation pathway of the SERT (176,239,240). In addition, accessibility to engineered cysteines 
is reduced in the presence of serotonin (176,239), consistent with the model presented in Figure 
59 of TM6 movement contributing to the formation of a substrate-bound occluded state.  
 Despite lower sequence identity in the loop regions, EL2 and EL4 are likely conserved 
among other NSS proteins (5). Prior to the release of the LeuT structure, cysteine scanning 
mutagenesis and accessibility measurements in the SERT suggested that EL4 was composed of 
two α-helical segments separated by a short turn with similar topology to that revealed in LeuT 
(241). Generation of a SERT/NET chimera in which the EL4 sequence from the NET replaced 
the corresponding sequence in the SERT significantly reduced transport activity, even though 
plasma membrane expression remained unaltered. This suggested that this loop segment was 
involved in conformational changes associated with transport (163). Subsequently, altered 
cysteine accessibility to MTS reagents in the presence of coupling ions and substrate supported 
the notion that EL4 participates in functional dynamics of the SERT and the GAT (161,241,242). 
These observations suggest that conformational movement associated with the transport 
mechanism is most likely conserved among members of the NSS superfamily.  
 Importantly, the focus of the experiments described in this dissertation is the 
cation/substrate-dependent changes in the extracellular region. Therefore, the analysis is limited 
in scope and does not extensively report on structural rearrangements outside of the vestibule. A 
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complete picture of transporter dynamics requires a spectroscopic investigation of ion/substrate-
dependent changes in other regions of LeuT. Four possible areas of focus are described below 
with their relationship to the current results.  
 
Global analysis of conformational movement 
 From a global perspective, the non-exhaustive set of pairwise spin label distances 
suggests that most of the conformational motion occurs within the extracellular vestibule. 
However, it is not known if the dynamics observed in the loop segments are facilitated by 
conformational changes of specific transmembrane helices. Two examples can be evoked from 
the current dataset. The Leu-dependent decrease in distance between spin labels observed with 
the H478C/E236C mutant suggests that EL6 and the C-terminus of EL3 move toward each other 
(Figure 35). As described in Chapter 3, this movement may be associated with a rearrangement of 
TM6, although this possibility has not been explicitly tested. Secondly, the conformational  
change of EL4 may be related to movement of TM7 that directly precedes this loop. The binding 
of Na1 in the LeuT crystal structure is facilitated in part by coordination with the Glu290 side 
chain in TM7 (168). Furthermore, a recent report from Forrest and colleagues suggested that the 
major conformation change in LeuT to an inward-facing state involves tilting of a four-helix 
bundle which includes TMs 1, 2, 6 and 7 (187). A series of distance measurements by placing 
spin labels in TM2, TM6 and TM7 should completely characterize their movement relative to 
each other as well as to the vestibule (Figure 60). In addition, the peripheral location of TM2 and 
TM7 may confer sensitivity to ion/substrate-dependent changes in exposure to the lipid phase, 
which may be detectable in solvent accessibility measurements. Furthermore, conformational 
changes may be propagated to other lipid exposed transmembrane segments. Figure 60 illustrates 
potential spin label sites in these helices near the extracellular region that may capture such 
relative movement through distance analysis.  
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Figure 60. Global and local structural characterization of transmembrane helix movement. (A) 
Explicit movement of TM1 (position 39), TM6 (position 240) and TM7 (position 306) may be 
assessed by dipolar coupling to EL6 (position 478). Relative movement between TM1 and TM6 
may be investigated by spin-spin interaction of 39/240. (B) Parts of TM2 and TM7 are exposed to 
the lipid environment according to the crystal structure. Substrate and/or ion binding could alter 
the packing arrangement, which can be directly assessed through spin label mobility and solvent 
accessibility experiments. (C-D) Distance analysis of peripheral transmembrane helices may 
uncover dynamic modes of structural segments outside of the vestibule region. 
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Structural dynamics of the intracellular region 
 Isomerization of an outward-facing to an inward-facing conformation is critical to 
achieve cytoplasmic Na+/substrate release. Because the spectroscopic analysis presented here is 
limited to the extracellular region, data interpretation is blind to the conformation of the 
intracellular permeation pathway (i.e. the intracellular gate). One may anticipate, based on the 
current results of the extracellular side, that Na+ induces an opposite effect on the intracellular 
side. That is, Na+ binding closes the intracellular gate. Likewise, substrate binding may be 
expected to elicit an opening of the intracellular gate. In a related bacterial homolog, two 
intracellular cysteines (based on alignment with LeuT) in the tyrosine transporter Tyt1 displayed 
altered sensitivity to the sulfhydryl-alkylating reagent NEM depending on solution conditions. In 
the presence of Na+, transport inhibition by NEM was reduced, consistent with a decrease in 
cysteine reactivity. In contrast, in the Apo state or in the presence of Tyr, reactivity with NEM 
increased and exacerbated its inhibitory effect on transport (170). These results are consistent 
with an alternating access mechanism in which Na+ binding decreases accessibility to the 
cytoplasmic region of Tyt1, whereas Tyr binding increases it. However, complete 
characterization of the nature and magnitude of the proposed conformational changes has not 
been measured. In the crystal structure of LeuT, the packing of the intracellular region is much 
more extensive than the extracellular side (168). This may suggest that more substantial 
conformational changes must occur for substrate translocation. In the original model of LeuT 
structural dynamics, TM1 and TM6 play a substantial role in the formation of the inward-facing 
form mediated by the flexibility of helical discontinuity (168). A nitroxide scan of the 
intracellular portion of these helices may support this proposal by determining changes in local 
structural constraints (Figure 61). In the context of the proposed S1/S2 allosteric mechanism, 
substrate occupation of the S2 site activates cytoplasmic release of Na+ and substrate in the 
primary site. Even though the vast majority of the EPR results do not appear to capture the effects 
of S2 binding in the extracellular region, changes in the pattern of spin label mobility, solvent 
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accessibility and spin-spin interactions fingerprinting the intracellular fold may be sensitive to 
substrate binding in the S2 site.  
 
 
 
Figure 61. Investigation of the role of TM1 and TM6 in the cytoplasmic gating mechanism. 
Movement of TM1 and TM6 has been proposed to be essential for the formation of an inward-
facing state. The highlighted positions may be informative toward site-specific changes in local 
structure associated with ion/substrate binding. 
 
 
Coupling of the extracellular and intracellular gates 
 The alternating access model mechanism predicts that the empty, centralized binding site 
is exposed to one side of the membrane and that substrate occupation drives transporter 
reorientation toward the opposite side of the bilayer. In this mechanism, the opening of one "gate" 
requires the closing of the other. Therefore, the movement of substrate from one side of the 
membrane to the other is critically coupled to the dynamics of the gating mechanism. 
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Specifically, to maintain strict ion/substrate-coupling in a symport mechanism, the intracellular 
gate must close prior to the opening of the extracellular gate. In doing so, the coordinated 
movement of both gating processes is likely to prevent indiscriminate flux of ions into the cell. 
Indeed, ion channels in the NSS may be associated with simultaneous opening of both gates, but 
are typically low probability events (19). The mechanism by which the dynamics of both gates 
are coupled to the formation of discrete intermediate states is fundamental to the overall transport 
process. Based on the data presented here, Na+ binding may be regarded as a key to open the 
extracellular gate to establish a binding competent intermediate, but also provides the energy to 
close the intracellular gate.  
 
 
 
Figure 62. A network of interactions on the intracellular side of LeuT. (A) Full side view of the 
location of the network relative to extracellular loops. (B) Tyr268 is a hub for the interaction 
network. Mutation of this residue increases dynamics of the intracellular and extracellular regions 
of LeuT. The figure was inspired from Ref 181. 
 
 
 Recent evidence suggests that a conserved network of interactions on the cytoplasmic 
side of these transporters may play a pivotal role in the formation of the outward-facing 
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conformation (Figure 62) (181). Similar to the proposed function of a salt bridge between Arg 
and Asp residues on the extracellular side of LeuT, the ionic interaction between Arg60 and 
Asp436 in the DAT (Arg5 and Asp369 in LeuT) may form an intracellular latch. Additional 
cation-π and hydrogen bonding interactions contribute to the stability of the latch. Site directed 
mutagenesis within the network substantially decreased Vmax and Km of transport, although cell 
surface expression was comparable to the wild type DAT. Molecular dynamics simulations 
showed that mutation of a tyrosine residue in this network increased structural flexibility by 
disrupting specific hydrogen bonding interactions. Furthermore, normal mode analysis suggested 
that a disrupted interaction network will impair dynamic properties of the extracellular region. 
EPR analysis of spin labeled mutants in the extracellular region of LeuT on the background of 
point mutants that disrupt this intracellular network may demonstrate the dependence of the 
outward-facing conformation and substrate binding on the "locking" potential of the intracellular 
gate. Global structural analysis may be particularly informative in determining the capacity of 
these cytoplasmic positions to influence the conformation of segments shown to be involved in 
dynamic fluctuations associated with ion and substrate binding.  
 
Impact of Cl- binding 
 Unlike the NSS, LeuT and Tyt1 function independently of Cl- binding and/or transport 
(168,170). The discovery of negatively charged residues that partially form the Na1 binding site 
in LeuT led to the identification of the Cl- binding site in the SERT, DAT and GAT (171,172). 
The negatively charged residues, Glu or Asp, functionally replace the role of Cl- in prokaryotic 
transporters. Interestingly, site directed mutagenesis of Glu290 in TM7 of LeuT or Asp259 in 
Tyt1 results in a Cl--dependent transport activity (Figure 63). Subsequent studies have shown that 
substrate transport in Tyt1 is stimulated by a outwardly-directed H+ gradient in the prokaryotic 
transporters (13). Indeed, Vmax in proteoliposomes increased ~6-fold when the pH of the external 
solution and internal solution was 8.5 and 6.5, respectively. These results were shown to be 
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consistent with H+ antiport via a protonation/deprotonation cycle of an Asp (or Glu) residue that 
participates directly in Na+ binding. However, H+ antiport is abolished in Tyt1 mutants that are 
Cl--dependent. Collectively, the researchers suggested that influx of Cl- or efflux of H+ 
counterbalances the depolarizing Na+ influx and is essential for maximal activity. The putative  
 
 
 
Figure 63. The negatively charged Glu290 contributes to the Na1 binding site. Mutation of 
Glu290 to Ser confers Cl- dependence to LeuT transport. Experiments with E290S-LeuT may 
resolve Cl--dependent conformational dynamics.  
 
 
direct interaction of Cl- with Na+ may suggest that Cl- binding impacts the formation of 
intermediate states. If this is the case, EPR analysis of Cl--dependent LeuT may demonstrate 
conformational changes that are functionally related to Cl- binding, effectively establishing an 
unambiguous structural role for the anion in the dynamics of symport.  
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APPENDIX A 
 
SUPPLEMENTAL MATERIAL 
 
 
Supplemental Figure 1. EPR analysis of the crystallographic dimer interface. EPR lineshapes do 
not show the expected spin-spin interaction at positions contributing to the oligomeric state of 
LeuT. EPR spectra for site 480 and 482 are shown in DDM micelles and proteoliposomes. EPR 
spectra for sites 484-487 are shown in DDM micelles only. Leu, colored yellow, is shown as a 
space-filling model at the primary binding site.  
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Supplemental Figure 2. DEER analysis of LeuT double mutants. The time-dependent spin echo 
decays (dots) and the fit (line) from Tikhonov regularization are shown in (A). The optimal 
regularization paramater (α), and thus the best distance distributions shown in Figures 31 and 35, 
was determined from the elbow of the L-curves shown in (B). 
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Supplemental Figure 3. DEER analysis of LeuT double mutants continued. Panels in A and B 
are the same to that described in legend of Supplemental Figure 2.  
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Supplemental Figure 4. Multi-Gaussian fits of distance distributions obtained from Tikhonov 
regularization. The parameters for each of the fits can be found in Table 2. 
 
 
 
 
 
Supplemental Figure 5. DEER analysis of H480C/A309C in proteoliposomes. The distance 
distributions (A) suggest a similar conformational cycle of EL4 to those in DDM micelles. The fit 
of the time-dependent decay of the DEER signal (B) and L-curve analysis (C) are described in the 
legend of Supplemental Figure 2.  
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Supplemental Figure 6. Changes in spin label oxygen accessibility mapped on to the crystal 
structure of LeuT. The pattern of O2 accessibility in the Na+-bound (A) and Leu-bound states (B) 
support the conclusions made from the pattern of NiEDDA changes shown in Figures 32 and 36.  
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Supplementary Table 1: O2 accessibility of LeuT single Cys mutants. 
Values are reported with confidence intervals for a single experiment. (*) 
indicates the mean ± S.D. obtained from three independently determined П 
values. 
Position П (Apo) П (NaCl) П (Na/Leu) 
TM1 25 0.06  ±  0.01 0.08  ±  0.01 0.06  ±  0.01 
 29 0.08  ±  0.02 0.08  ±  0.01 0.05  ±  0.01 
 33* 0.13  ±  0.03 0.22  ±  0.01 0.12  ±  0.02 
 34 0.40  ±  0.03 0.37  ±  0.02 0.36  ±  0.03 
TM3 111* 0.08  ±  0.004 0.14  ±  0.01 0.12  ±  0.01 
 114 0.12  ±  0.01 0.11  ±  0.02 0.08  ±  0.01 
EL2 136 1.27  ±  0.02 1.17  ±  0.02 1.22  ±  0.02 
 137 0.48  ±  0.02 0.45  ±  0.02 0.49  ±  0.02 
 138 0.68  ±  0.02 0.68  ±  0.03 0.74  ±  0.02 
 139 1.21  ±  0.05 1.01  ±  0.03 1.16  ±  0.03 
 140 0.33  ±  0.01 0.37  ±  0.02 0.27  ±  0.01 
 141 0.39  ±  0.02 0.41  ±  0.01 0.41  ±  0.02 
 142 0.89  ±  0.02 0.96  ±  0.04 0.90  ±  0.04 
 143 0.62  ±  0.01 0.59  ±  0.02 0.62  ±  0.02 
 144 0.17  ±  0.01 0.15  ±  0.02 0.17  ±  0.01 
 145 0.28  ±  0.01 0.25  ±  0.01 0.22  ±  0.01 
 146 0.63  ±  0.02 0.59  ±  0.02 0.57  ±  0.02 
 147 0.34  ±  0.02 0.22  ±  0.02 0.46  ±  0.02 
 148 0.32  ±  0.02 0.24  ±  0.03 0.19  ±  0.06 
 149 0.17  ±  0.01 0.16  ±  0.01 0.20  ±  0.01 
 150 0.66  ±  0.02 0.61  ±  0.03 0.61  ±  0.03 
TM6 243 0.33  ±  0.02 0.26  ±  0.03 0.29  ±  0.04 
 246 0.14  ±  0.01 0.12  ±  0.01 0.12  ±  0.02 
 249 0.10  ±  0.01 0.10  ±  0.01 0.14  ±  0.02 
 253* 0.11  ±  0.01 0.09  ±  0.01 0.09  ±  0.03 
EL4 305 0.39  ±  0.01 0.38  ±  0.02 0.41  ±  0.01 
 307 0.12  ±  0.02 0.13  ±  0.02 0.13  ±  0.01 
 309 1.00  ±  0.02 0.99  ±  0.02 0.97  ±  0.04 
 311 0.13  ±  0.01 0.13  ±  0.01 0.14  ±  0.01 
 314 0.37  ±  0.01 0.38  ±  0.01 0.35  ±  0.01 
 315* 0.12  ±  0.01 0.20  ±  0.03 0.11  ±  0.01 
 317 0.54  ±  0.03 0.50  ±  0.04 0.58  ±  0.03 
 320* 0.10  ±  0.01 0.11  ±  0.01 0.12  ±  0.02 
 324 0.14  ±  0.02 0.14  ±  0.02 0.15  ±  0.02 
 325 0.25  ±  0.02 0.29  ±  0.02 0.24  ±  0.02 
 333 0.49  ±  0.02 0.55  ±  0.02 0.57  ±  0.02 
TM10 397 0.23  ±  0.03 0.31  ±  0.03 0.25  ±  0.04 
 400* 0.24  ±  0.02 0.21  ±  0.04 0.08  ±  0.04 
 404 0.16  ±  0.02 0.14  ±  0.01 0.10  ±  0.01 
 405 0.28  ±  0.01 0.29  ±  0.01 0.18  ±  0.02 
EL6 480 0.61  ±  0.02 0.56  ±  0.02 0.56  ±  0.03 
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Supplemental Figure 7. Distance analysis of A317C/K145C. (A) Dipolar coupling is observed 
in all intermediate states (red line) compared to the spectral sum of singles (black line). However, 
the presence of Na+ increases the strength of the interaction, consistent with a decrease in 
distance. (B) Non-linear least squares analysis (blue line) of the spin-spin interaction for each 
state, assuming a two-Gaussian model. The parameters for the fits are found in the table. 
 
 
 
Supplemental Figure 8. K+ does not support Leu binding in proteoliposomes as indicated by a 
lack of lineshape changes. Compare these three spectra with those found in Figure 39A for 
I111C. 
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Supplemental Figure 9. EPR spectra of TM1 and TM3 spin labeled mutants in DDM micelles 
and proteoliposomes. EPR spectra of V33C in proteoliposomes can be found in Figures 32 and 
36. Most sites shown in this figure and in Supplemental Figures 10-16 demonstrate similar EPR 
lineshapes in DDM and liposomes.  
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Supplemental Figure 10. EPR lineshapes of EL2 in DDM micelles and proteoliposomes. 
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Supplemental Figure 11. EPR spectra of EL2 mutants continued.  
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Supplemental Figure 12. EPR spectra of EL2 mutants continued.  
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Supplemental Figure 13. EPR spectra of spin labeled TM6 mutants in DDM micelles and 
proteoliposomes. In the crystallographic model shown below the spectra, the position of G249 is 
highlighted by an arrow.  
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Supplemental Figure 14. EPR spectra of spin labeled EL4 mutants in DDM micelles and 
proteoliposomes. In the crystallographic model shown beside the spectra, the position of G307 is 
highlighted by an arrow. 
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Supplemental Figure 15. EPR spectra of EL4 mutants continued. 
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Supplemental Figure 16. EPR spectra of spin labeled TM10 mutants in DDM micelles and 
proteoliposomes. EPR spectra of F405C in proteoliposomes can be found in Figure 37. 
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Supplemental Figure 17. Correlation of global structural changes with Leu binding 
stoichiometry. (A) [Leu]-dependent changes in the time domain DEER signal of H480C/A309C. 
The resulting distance distributions are shown in Figure 42E. (B) The spin echo decay in the Leu-
bound form for the H480C/A309C pair is similar in the presence and absence of an S2-site 
disrupting mutation (L400S). The resulting distance distributions is shown in Figure 42F. 
 
 
 
 
 
Supplemental Figure 18. Inhibitor-dependent changes in distance measured by E478C/E236C. 
The time-dependent decay of the DEER signal shifts to the left (arrow) in the presence of either 
OG or CMI inhibitors, consistent with a decrease in distance between the probes relative to the 
Na+/Leu intermediate. The resulting distance distributions are shown in Figure 45B and C.  
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Supplemental Figure 19. Spectroscopic analysis of Trp binding. (A) The DEER signal decay 
shifts to the right (arrow) in the presence of Trp, consistent with an increase in distance relative to 
both the Na+ and Na+/Leu states. The resulting distance distributions are shown in Figure 46B. 
(B) The distance distributions between EL6 and EL3 showing that the position of EL3 (and likely 
TM6a) in Trp-bound state is similar to the Na+ only configuration. This behavior was also 
observed in MD simulations found in Figure 47. (C and D) Trp binding increases the accessibility 
of the extracellular vestibule to NiEDDA as evidenced by a right shift in the power saturation 
curves of A315C and L400C. (E and F) Although no significant change in the EPR spectra at 
A315C is observed in presence of Trp, a mobile component (arrow) is observed at L400C, 
consistent with decreased packing interactions relative to the Leu-bound state. 
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Supplemental Figure 20. Li+-dependent Leu binding is impaired by CMI.  
 
 
Supplemental Figure 21. Correlation of ion-dependent binding behavior of Leu and Ala with 
binding site mutations. (A) Leu binds to LeuT at low [Leu] and [LeuT] in the presence of either 
Na+ or Li+, even in the presence of an S1-site disrupting mutation (B), consistent high affinity Leu 
binding. (C) In contrast, no binding is observed with Ala at low [Ala] and [LeuT], consistent with 
the lower binding affinity of Ala relative to Leu.  
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APPENDIX B 
 
EXPERIMENTAL METHODS 
 
Mutagenesis 
 The synthetic LeuT DNA sequence containing an N-terminal His10 tag was inserted into a 
pQE-derivative expression vector (designed by Matthias Quick at Columbia University, New 
York) controlled by the T5 promoter. Cysteine residues were introduced, individually or in 
combination, in recombinant LeuT by the QuikChange site-directed mutagenesis protocol 
(Agilent Technologies) that uses two complementary oligonucleotides containing the desired 
mutation and a high fidelity polymerase to synthesize a mutant, double-stranded DNA. The 
methylated parental DNA template in the PCR reaction was subsequently digested by DPN1 
endonuclease. Following digestion, the synthetic DNA product was transformed into E. coli XL1-
Blue cells and plated on LB agar containing 100 µg·mL-1 ampicillin. DNA was extracted from 
colonies (Qiagen) and screened for the LeuT sequence insertion by combining a restriction digest 
of the product at flanking NcoI and HindIII sites with ensuing 1% (w/v) agarose gel 
electrophoresis stained with ethidium bromide. DNA samples demonstrating the appropriate 
molecular weight insertion were sent for sequencing at the Vanderbilt DNA sequencing core to 
confirm the presence of the desired mutation and the absence of unwanted changes using the 
following three primers: 
5'-3' Upstream (bases 51-71)—AAT AGA TTC AAT TGT GAG CGG 
5'-3' Mid-length (bases 651-671)—ATT GGC GTG CCG AAA GGC GAT 
3'-5' Reverse Terminator (bases 1832-1812)—TCA CCA CTT TGT ACC ACG TGC 
Following sequence analysis, mutants were transformed into E. coli BL21(DE3) cells for 
expression.  
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Expression and Purification 
 One colony from the BL21(DE3) transformation was used to inoculate 10 mL of LB 
broth containing 100 µg·mL-1 ampicillin, which was grown overnight at 37° C for no more than 
15 hrs. All of the seed culture was added to 1 L of minimal media (1 g ammonium sulfate, 4.5 g 
KPi monobasic, 10.5 g KPi dibasic, 0.5 g sodium citrate) supplemented with 1 mM magnesium 
sulfate, 100 µg·mL-1 ampicillin, 1 mL of 50x amino acid mixture, 0.5% (v/v) glycerol and 2.5 mg 
thiamine. Cells were grown for 7 hrs at 37° C (Supplemental Figure 22A) and induced with 1 
mM IPTG at 20° C for 16 hrs. Cells harvested by centrifugation were re-suspended in 100 mM 
KPi pH 7.5 buffer and lysed by sonication. Cell debris was removed by centrifugation at 9000 rcf 
for 10 min and the membrane fraction of the supernatant was subsequently isolated by 
ultracentrifugation at 310,000 rcf for 50 min.  
 The E. coli membranes were washed three times in 200 mM Tris/Mes pH 7.5, 20% 
glycerol buffer in the presence of 10mM DTT to remove endogenous Leu bound to LeuT during 
expression. 40 mM (2% w/v) DDM (Anatrace) was used to extract LeuT mutants from the native 
membranes. Solubilized mutants were purified by Ni2+ affinity chromatography with a 50mM 
imidazole wash step and elution with 250mM imidazole. Immediately following, single Cys 
mutants were labeled with a total of 40x MTSSL (Toronto Research Chemicals, Inc) over 4 hrs at 
23°C and placed on ice overnight. Double Cys mutants were labeled with a total of 80x MTSSL 
over a 6hr period. To generate the Apo intermediate and remove unbound spin label, LeuT 
mutants were subjected to size exclusion chromatography on a Shodex KW-803 column 
(Supplemental Figure 22B) and subsequent desalting on a HiTrap desalting column (GE 
Healthcare) into 200 mM Tris/Mes pH 7.2 buffer containing 0.025% (w/v) DDM and 20% (v/v) 
glycerol. SDS-PAGE analysis indicated that LeuT is highly purified under these conditions 
(Supplemental Figure 22C). Protein concentration was determined using an extinction coefficient 
of 1.91 cm2/mg at 280 nm. 
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Supplemental Figure 22. Expression and purification of LeuT. (A) Time-dependent increase in 
E. coli optical density using either C41(DE3) or BL21(DE3) cells. (B) Gel filtration profile of 
LeuT-WT showing the separation of protein from solution salts. (C) SDS-PAGE of a variety of 
LeuT mutants. (D) The Trp fluorescence profile of LeuT is consistent with a folded protein in all 
biochemical conditions tested.  
 
 
Reconstitution 
 Apo-LeuT mutants were reconstituted into 200 nm unilamellar liposomes made from a 
3:1 (w/w) ratio of E. coli polar lipids and phosphatidylcholine (Avanti Polar Lipids, Inc) loaded 
with 0.1 M KPi pH 6.5 buffer using a 5000:1 (mol/mol) lipid-to-DDM ratio. Detergent was 
removed during reconstitution by three hourly additions of 60 mg·mL-1 SM-2 bio-beads (Bio-
Rad) to the protein/lipid mixture. After overnight incubation at 4° C, proteoliposomes were 
filtered to remove the bio-beads, harvested by ultracentrifugation at 310,000 rcf and re-suspended 
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in 200 mM Tris/Mes pH 7.2 buffer. For EPR lineshape and solvent accessibility analysis, single 
cysteine mutants were reconstituted with a 1000:1 (mol/mol) lipid-to-protein ratio. For DEER 
analysis, the lipid-to-protein ratio was increased to 2000:1 to reduce non-specific intermolecular 
dipolar coupling. 
Scintillation Proximity Assay 
Binding studies were performed by scintillation proximity assay (SPA) with 100 nM 
[3H]-Leu (112 Ci mmol-1) and 50 mM NaCl, with and without spin label. 25 ng of Ni2+ affinity 
purified LeuT was bound to Cu2+ chelate YSi scintillation beads (GE Healthcare). Upon [3H]-Leu 
binding, the scintillation beads emit light which is detected by a photomultiplier tube. Since 
binding of LeuT to the beads is facilitated by the N-terminal His10 tag, nonspecific radiolabeled 
ligand binding can be determined in the presence of a high concentration (400 mM) of imidazole. 
A standard curve was generated to convert the counts per minute (cpm) into pmol. The Leu 
equilibrium binding constant (EC50) and molar stoichiometry were determined by varying the 
[3H]-Leu concentration from 0.5 – 1000 nM and performing a nonlinear regression fitting of the 
data in Prism 4.  
Transport Assay 
The time course of 1 µM [3H]-Ala uptake was performed with proteoliposomes 
containing LeuT-WT or –F253C and with control liposomes in the presence of an inwardly-
directed Na+ electrochemical gradient (25 mM external NaCl) or by dissipation of the gradient 
with gramicidin, yielding the total accumulation and specific binding, respectively. Specific 
substrate transport was determined by the difference between total accumulation and specific 
binding. 
EPR Spectroscopy 
Lineshape Analysis 
EPR spectra were collected at room temperature on a Bruker EMX spectrometer (X-
band) at an incident power of 10 mW and 1.6 Gauss modulation amplitude in DDM micelles or 
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proteoliposomes. Substrates were allowed to incubate with LeuT mutants on ice for at least 20 
minutes before collection of EPR spectra. The addition of 200 mM NaCl to the Apo intermediate 
was used to create the Na+ state. The Na+/Leu state was produced by adding Leu to the Na+ state.  
Solvent Accessibility 
Proteoliposome samples were loaded into a gas permeable TPX capillary tube and 
subjected to either 20% O2 (g) or 50 mM Ni(II)ethylenediaminediacetic acid (NiEDDA) 
equilibrated with N2 (g) on a Bruker Elexsys E500 spectrometer to generate power saturation 
curves. P1/2 was determined from a nonlinear least-squares fit of the power saturation curves in 
the program Origin (OriginLab Inc.) to the equation: 
𝐴 = 𝐼𝑃1/2[1 + �21/𝜀 − 1�𝑃
𝑃1/2 ]−𝜀 
Where A is the signal amplitude, I is a scaling factor, P is the microwave power and ε reports the 
degree of homogeneous saturation. Signal saturation in the absence of fast-relaxing agents was 
measured under N2 (g). ΔP1/2 for O2 and NiEDDA was determined by subtracting the P1/2(N2) 
from the P1/2(O2) and P1/2 (NiEDDA). The accessibility parameter П was normalized using spin 
labeled T4L-K135C as a standard. The experimental error was less than 20% based on the mean 
± S.D. of three independently determined П values (denoted as (*) in Table 3). 
Double Electron Electron Resonance 
Distance measurements were carried out on a Bruker 580 pulsed EPR spectrometer 
operating at X-band frequency (9.5 GHz) using double electron electron resonance (DEER) with 
a standard four-pulse protocol. Glycerol was added to 30% (w/w) prior to cooling for both 
detergent and liposome samples. Deuterated buffer and glycerol was used to enhance the phase 
memory time for liposome samples. All DEER experiments were performed at 83K. The DEER 
signals were analyzed by Tikhonov regularization to yield the distance distributions. Some of the 
resulting distributions were subjected to multiple Gaussian peak picking to model the changes in 
the distance and width of the distributions.  
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